<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antibiotic prophylaxis for elective hysterectomy - Ayeleke, RO - 2017 | Cochrane Library</title> <meta content="Antibiotic prophylaxis for elective hysterectomy - Ayeleke, RO - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004637.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antibiotic prophylaxis for elective hysterectomy - Ayeleke, RO - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004637.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004637.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Antibiotic prophylaxis for elective hysterectomy" name="citation_title"/> <meta content="Reuben Olugbenga Ayeleke" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="Selma M. Mourad" name="citation_author"/> <meta content="Radboud University Medical Centre" name="citation_author_institution"/> <meta content="Jane Marjoribanks" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="Karim A Calis" name="citation_author"/> <meta content="National Institutes of Health" name="citation_author_institution"/> <meta content="Vanessa Jordan" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="v.jordan@auckland.ac.nz" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD004637.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/06/18" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004637.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004637.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004637.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti-Bacterial Agents [*therapeutic use]; *Antibiotic Prophylaxis; Antiprotozoal Agents [therapeutic use]; Bacterial Infections [*prevention &amp; control]; Cephalosporins [therapeutic use]; Elective Surgical Procedures [*adverse effects]; Fever [epidemiology]; Hysterectomy [*adverse effects, methods]; Lincosamides [therapeutic use]; Pelvis; Penicillins [therapeutic use]; Postoperative Complications [*prevention &amp; control]; Randomized Controlled Trials as Topic; Sulfonamides [therapeutic use]; Urinary Tract Infections [epidemiology, prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004637.pub2&amp;doi=10.1002/14651858.CD004637.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="ZCrlluee";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004637\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004637\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","fr","zh_HANS","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004637.pub2",title:"Antibiotic prophylaxis for elective hysterectomy",firstPublishedDate:"Jun 18, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZCrlluee&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004637.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004637.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004637.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004637.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004637.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004637.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004637.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004637.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004637.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004637.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>7049 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004637.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-sec-0472"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-sec-0054"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-sec-0456"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/appendices#CD004637-sec-0477"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/table_n/CD004637StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/table_n/CD004637StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antibiotic prophylaxis for elective hysterectomy</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/information#CD004637-cr-0002">Reuben Olugbenga Ayeleke</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/information#CD004637-cr-0003">Selma M. Mourad</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/information#CD004637-cr-0004">Jane Marjoribanks</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/information#CD004637-cr-0005">Karim A Calis</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004637.pub2/information#CD004637-cr-0006"><i class="icon corresponding-author fa fa-envelope"></i>Vanessa Jordan</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/information/en#CD004637-sec-0487">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 18 June 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004637.pub2">https://doi.org/10.1002/14651858.CD004637.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004637-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004637-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004637-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004637-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004637-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004637-abs-0009">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004637-abs-0001" lang="en"> <section id="CD004637-sec-0001"> <h3 class="title" id="CD004637-sec-0001">Background</h3> <p>Elective hysterectomy is commonly performed for benign gynaecological conditions. Hysterectomy can be performed abdominally, laparoscopically, or vaginally, with or without laparoscopic assistance. Antibiotic prophylaxis consists of administration of antibiotics to reduce the rate of postoperative infection, which otherwise affects 40%‐50% of women after vaginal hysterectomy, and more than 20% after abdominal hysterectomy. No Cochrane review has systematically assessed evidence on this topic. </p> </section> <section id="CD004637-sec-0002"> <h3 class="title" id="CD004637-sec-0002">Objectives</h3> <p>To determine the effectiveness and safety of antibiotic prophylaxis in women undergoing elective hysterectomy. </p> </section> <section id="CD004637-sec-0003"> <h3 class="title" id="CD004637-sec-0003">Search methods</h3> <p>We searched electronic databases to November 2016 (including the Cochrane Gynaecology and Fertility Group Specialised Register, the Cochrane Central Register of Studies (CRSO), MEDLINE, Embase, PsycINFO, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL), as well as clinical trials registers, conference abstracts, and reference lists of relevant articles. </p> </section> <section id="CD004637-sec-0004"> <h3 class="title" id="CD004637-sec-0004">Selection criteria</h3> <p>All randomised controlled trials (RCTs) comparing use of antibiotics versus placebo or other antibiotics as prophylaxis in women undergoing elective hysterectomy. </p> </section> <section id="CD004637-sec-0005"> <h3 class="title" id="CD004637-sec-0005">Data collection and analysis</h3> <p>We used Cochrane standard methodological procedures.</p> </section> <section id="CD004637-sec-0006"> <h3 class="title" id="CD004637-sec-0006">Main results</h3> <p>We included in this review 37 RCTs, which performed 20 comparisons of various antibiotics versus placebo and versus one another (6079 women). The quality of the evidence ranged from very low to moderate. The main limitations of study findings were risk of bias due to poor reporting of methods, imprecision due to small samples and low event rates, and inadequate reporting of adverse effects. </p> <p><b>Any antibiotic versus placebo</b> </p> <p><i>Vaginal hysterectomy</i> </p> <p>Low‐quality evidence shows that women who received antibiotic prophylaxis had fewer total postoperative infections (risk ratio (RR) 0.28, 95% confidence interval (CI) 0.19 to 0.40; four RCTs, N = 293; I<sup>2</sup> = 85%), less urinary tract infection (UTI) (RR 0.58, 95% CI 0.43 to 0.77; eight RCTs, N = 1473; I<sup>2</sup> = 44%), fewer pelvic infections (RR 0.28, 95% CI 0.20 to 0.39; 11 RCTs, N = 1693; I<sup>2</sup> = 57%), and fewer postoperative fevers (RR 0.43, 95% CI 0.34 to 0.54; nine RCTs, N = 1562; I<sup>2</sup> = 47%) than women who did not receive such prophylaxis. This suggests that antibiotic prophylaxis reduces the average risk of postoperative infection from about 34% to 7% to 14%. Whether this treatment has led to differences in rates of other serious infection remains unclear (RR 0.20, 95% CI 0.01 to 4.10; one RCT, N = 146; very low‐quality evidence). </p> <p>Data were insufficient for comparison of adverse effects.</p> <p><i>Abdominal hysterectomy</i> </p> <p>Women who received antibiotic prophylaxis of any class had fewer total postoperative infections (RR 0.38, 95% CI 0.21 to 0.67; one RCT, N = 158; low‐quality evidence), abdominal wound infections (RR 0.51, 95% CI 0.36 to 0.73; 11 RCTs, N = 2247; I<sup>2</sup> = 6%; moderate‐quality evidence), UTIs (RR 0.41, 95% CI 0.31 to 0.53; 11 RCTs, N = 2705; I<sup>2</sup> = 28%; moderate‐quality evidence), pelvic infections (RR 0.50, 95% CI 0.35 to 0.71; 11 RCTs, N = 1883; I<sup>2</sup> = 11%; moderate‐quality evidence), and postoperative fevers (RR 0.59, 95% CI 0.50 to 0.70; 11 RCTs, N = 2394; I<sup>2</sup> = 55%; moderate‐quality evidence) than women who did not receive prophylaxis, suggesting that antibiotic prophylaxis reduces the average risk of postoperative infection from about 16% to 1% to 6%. Whether this treatment has led to differences in rates of other serious infection remains unclear (RR 0.44, 95% CI 0.12 to 1.69; two RCTs, N = 476; I<sup>2</sup> = 29%; very low‐quality evidence). </p> <p>It is unclear whether rates of adverse effects differed between groups (RR 1.80, 95% CI 0.62 to 5.18; two RCTs, N = 430; I<sup>2</sup> = 0%; very low‐quality evidence). </p> <p><b>Head‐to‐head comparisons between antibiotics</b> </p> <p><i>Vaginal hysterectomy</i> </p> <p>We identified four comparisons: cephalosporin versus penicillin (two RCTs, N = 470), cephalosporin versus tetracycline (one RCT, N = 51), antiprotozoal versus lincosamide (one RCT, N = 80), and cephalosporin versus antiprotozoal (one RCT, N = 78). Data show no evidence of differences between groups for any of the primary outcomes, except that fewer cases of total postoperative infection and postoperative fever were reported in women who received cephalosporin than in those who received antiprotozoal. </p> <p>Only one comparison (cephalosporin vs penicillin; two RCTs, N = 451) yielded data on adverse effects and showed no differences between groups. </p> <p><i>Abdominal hysterectomy</i> </p> <p>We identified only one comparison: cephalosporin versus penicillin (N = 220). Data show no evidence of differences between groups for any of the primary outcomes. Adverse effects were not reported. </p> <p><b>Combined antibiotics versus single antibiotics</b> </p> <p><i>Vaginal hysterectomy</i> </p> <p>We identified three comparisons: cephalosporin plus antiprotozoal versus cephalosporin (one RCT, N = 78), cephalosporin plus antiprotozoal versus antiprotozoal (one RCT, N = 78), and penicillin plus antiprotozoal versus penicillin (one RCT, N = 18). Data were unavailable for most outcomes, including adverse effects. We found no evidence of differences between groups, except that fewer women receiving cephalosporin with antiprotozoal received a diagnosis of total postoperative infection, UTI, or postoperative fever compared with women receiving antiprotozoal. </p> <p><i>Abdominal hysterectomy</i> </p> <p>We identified one comparison (penicillin plus antiprotozoal vs penicillin only; two RCT, N = 155). Whether differences between groups occurred was unclear. Adverse effects were not reported. </p> <p><b>Comparison of cephalosporins in different regimens</b> </p> <p>Single small trials addressed dose comparisons and provided no data for most outcomes, including adverse effects. Whether differences between groups occurred was unclear. No trials compared route of administration. </p> <p>The quality of evidence for all head‐to‐head and dose comparisons was very low owing to very serious imprecision and serious risk of bias related to poor reporting of methods. </p> </section> <section id="CD004637-sec-0007"> <h3 class="title" id="CD004637-sec-0007">Authors' conclusions</h3> <p>Antibiotic prophylaxis appears to be effective in preventing postoperative infection in women undergoing elective vaginal or abdominal hysterectomy, regardless of the dose regimen. However, evidence is insufficient to show whether use of prophylactic antibiotics influences rates of adverse effects. Similarly, evidence is insufficient to show which (if any) individual antibiotic, dose regimen, or route of administration is safest and most effective. The most recent studies included in this review were 14 years old at the time of our search. Thus findings from included studies may not reflect current practice in perioperative and postoperative care and may not show locoregional antimicrobial resistance patterns. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004637-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004637-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD004637-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD004637-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004637-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004637-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD004637-abs-0010">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD004637-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004637-abs-0004" lang="en"> <h3>Antibiotic prophylaxis for elective hysterectomy</h3> <p><b>Review question</b> </p> <p>Are antibiotics effective and safe for preventing postoperative infection in women undergoing elective (non‐urgent) hysterectomy? </p> <p><b>Background</b> </p> <p>Surgical operation carried out to remove the uterus (hysterectomy) is commonly performed. Most cases are performed as non‐urgent (elective) procedures for non‐cancerous (benign) conditions affecting the uterus, such as menstrual pain or abnormal bleeding patterns. Antibiotics are usually given before the operation is performed (prophylactic antibiotics, or antibiotic prophylaxis) to prevent or reduce the occurrence of infection after the procedure. Researchers in the Cochrane Collaboration reviewed the evidence on effectiveness and safety of antibiotics used to prevent infection after non‐urgent surgical operation to remove the uterus. Evidence is current to November 2016. </p> <p><b>Study characteristics</b> </p> <p>We identified 37 randomised controlled trials (RCTs), which included a total of 6079 women and compared 20 different types of antibiotics versus placebo (an inactive pill) or versus one another. </p> <p><b>Key results</b> </p> <p>This review found moderate‐quality evidence showing that antibiotics appear to be effective in preventing infection in women undergoing non‐urgent surgical removal of the uterus through the vagina or abdomen. This suggests that antibiotic prophylaxis reduces the average risk of postoperative infection after vaginal hysterectomy from about 62% to 12% to 25%, and after abdominal hysterectomy from about 39% to 8% to 26%. </p> <p>However, evidence is insufficient to show whether use of prophylactic antibiotics influences rates of adverse effects (side effects), or whether any one antibiotic is more effective or safer than the others. </p> <p>When antibiotics are compared head‐to‐head or in combination versus single antibiotics, it is unclear which individual antibiotic was more effective and safer, or whether combined antibiotics were more effective and safer than single antibiotics. The quality of the evidence for these comparisons is very low. </p> <p>It is also unclear which dose regimen or route of administration of antibiotics is safest or most effective in women undergoing elective hysterectomy. </p> <p>The most recent of the studies included in this review was published 14 years ago, at the time of our search. Thus findings from the included studies may not reflect current practice in perioperative and postoperative care and may not show locoregional antimicrobial resistance patterns. </p> <p><b>Quality of the evidence</b> </p> <p>The quality of evidence for our main comparisons ranged from very low to moderate. The main limitations of this evidence are risk of bias due to poor reporting of randomisation methods, imprecision due to small sample sizes and low event rates, and inadequate reporting of adverse effects. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004637-sec-0472" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004637-sec-0472"></div> <h3 class="title" id="CD004637-sec-0473">Implications for practice</h3> <section id="CD004637-sec-0473"> <p>Antibiotic prophylaxis appears to be effective in preventing postoperative infection in women undergoing elective vaginal or abdominal hysterectomy, regardless of the dose regimen. However, evidence was insufficient to show whether their use influences rates of adverse effects. Similarly, evidence was insufficient to show which (if any) individual antibiotic, dose regimen, or route of administration is safest and most effective. In interpreting results, it is important to realise that the most recent of the included studies was published 14 years ago, at the time of our search. Thus findings from included studies might not reflect current practice in perioperative and postoperative care or might not show locoregional antimicrobial resistance patterns. </p> </section> <h3 class="title" id="CD004637-sec-0474">Implications for research</h3> <section id="CD004637-sec-0474"> <p>More studies including large numbers of women and based on sound methods are needed to detect meaningful differences in efficacy between various antibiotics and to properly evaluate adverse effects associated with their use as prophylaxis for women undergoing elective hysterectomy. Also needed are more studies investigating various antibiotics in different combinations, dose regimens, and routes of administration to determine which combinations, dose regimens, and routes of administration are associated with better efficacy and fewer adverse effects. Laparoscopic hysterectomy is now commonly performed; thus future research should focus on the use of prophylaxis in laparoscopic hysterectomy (total or subtotal laparoscopic hysterectomy or laparoscopically assisted vaginal hysterectomy). </p> <p>In addition, trial publications should adequately report trial methods in accordance with the CONSORT statement. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004637-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004637-sec-0022"></div> <div class="table" id="CD004637-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotics compared with placebo for prophylaxis in elective vaginal hysterectomy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antibiotics compared with placebo for prophylaxis in elective vaginal hysterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> women having elective vaginal hysterectomy<br/> <b>Settings:</b> hospital<br/> <b>Intervention:</b> antibiotics<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Total postoperative infections ‐ early and late</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.28</b> <br/> (0.19 to 0.4) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>293<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> low<sup>b,c,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>618 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>173 per 1000</b><br/> (117 to 247) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Urinary tract infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.58</b> <br/> (0.43 to 0.77) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1473<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>127 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>74 per 1000</b><br/> (55 to 98) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Pelvic infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.28</b> <br/> (0.20 to 0.39) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1693<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>134 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>38 per 1000</b><br/> (27 to 52) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Other serious infections</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.20</b> <br/> (0.01 to 4.10) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>146<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>b,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>5 per 1000</b><br/> (0 to 111) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Postoperative fever</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.43</b> <br/> (0.34 to 0.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1562<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>219 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>94 per 1000</b><br/> (74 to 118) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total adverse effects</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>This outcome was not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and <b>relative effect</b> of the intervention (and its 95% CI)<br/> CI: confidence interval; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Median baseline risk of control group<br/> <sup>b</sup>Downgraded one level for serious risk of bias: sequence generation and allocation concealment assessed as "unclear" in some studies owing to poor reporting<br/> <sup>c</sup>Substantial heterogeneity for this comparison (I<sup>2</sup> = 85%). The quality of the evidence was not downgraded for inconsistency, as the direction of effect was consistent and all inconsistency was attributable to a study that measured only early postoperative infection rates (to hospital discharge), whereas the other three studies measured both early and late infection<br/> <sup>d</sup>Substantial heterogeneity for this comparison (I<sup>2</sup> = 57%), but the quality of the evidence was not downgraded for inconsistency, as the direction of effect was consistent<br/> <sup>e</sup>Downgraded two levels for very serious imprecision: small sample size and effect estimate with wide confidence interval </p> <p><sup>f</sup>Downgraded two levels for serious imprecision: small sample size </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004637-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antibiotics compared with placebo for prophylaxis in elective abdominal hysterectomy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antibiotics compared with placebo for prophylaxis in elective abdominal hysterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> women having elective abdominal hysterectomy<br/> <b>Settings:</b> hospital<br/> <b>Intervention:</b> antibiotics<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Total postoperative infections ‐ early and late</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.38</b> <br/> (0.21 to 0.67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>158<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>388 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>147 per 1000</b><br/> (82 to 260) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Abdominal wound infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.51</b> <br/> (0.36 to 0.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2247<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>65 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b><br/> (23 to 47) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Urinary tract infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.41</b> <br/> (0.31 to 0.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2705<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>132 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>54 per 1000</b><br/> (41 to 70) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Pelvic infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.50</b> <br/> (0.35 to 0.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1883<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>83 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b><br/> (29 to 59) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Other serious infections</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.44</b> <br/> (0.12 to 1.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>476<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>b,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b><br/> (3 to 46) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Postoperative fever</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.59</b> <br/> (0.50 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2394<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>242 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>143 per 1000</b><br/> (121 to 169) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Total adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.80</b> <br/> (0.62 to 5.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>430<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>b,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>23 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>41 per 1000</b><br/> (14 to 119) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and <b>relative effect</b> of the intervention (and its 95% CI)<br/> CI: confidence interval; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Median baseline risk of control group<br/> <sup>b</sup>Downgraded one level for serious risk of bias: sequence generation and/or allocation concealment assessed as "unclear" in some studies owing to poor reporting<br/> <sup>c</sup>Downgraded one level for serious imprecision: small sample size<br/> <sup>d</sup>Substantial heterogeneity for this comparison (I<sup>2</sup> = 51%), but the quality of the evidence was not downgraded for inconsistency, as the direction of effect was consistent<br/> <sup>e</sup>Downgraded two levels for very serious imprecision: small sample size and effect estimate with wide confidence interval </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004637-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Head‐to‐head comparisons of antibiotics for prophylaxis in elective vaginal hysterectomy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Antibiotics compared with alternative antibiotics for prophylaxis in elective vaginal hysterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Population:</b> women having elective vaginal hysterectomy<br/> <b>Settings:</b> hospital<br/> <b>Intervention:</b> antibiotics<br/> <b>Comparison:</b> alternative antibiotics </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Illustrative comparative risks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antibiotics vs alternative antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD004637-list-0001"> <li> <p><b>Total postoperative infections ‐ early and lat</b>e </p> </li> <li> <p><b>Urinary tract infection</b> </p> </li> <li> <p><b>Pelvic infection</b> </p> </li> <li> <p><b>Other serious infections</b> </p> </li> <li> <p><b>Postoperative fever</b> </p> </li> </ul> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>When data were available, no evidence showed a difference between any groups compared for any of our primary outcomes, except: </p> <p> <ul id="CD004637-list-0002"> <li> <p>fewer cases of total postoperative infection and postoperative fever in women who received cephalosporin than in those who received antiprotozoal </p> </li> <li> <p>fewer cases of total postoperative infection, UTI, or postoperative fever in women receiving cephalosporin with antiprotozoal than in those receiving antiprotozoal only </p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD004637-list-0003"> <li> <p>cephalosporin vs penicillin (2 RCTs, 470 women)</p> </li> <li> <p>cephalosporin vs tetracycline (1 RCT, 51 women)</p> </li> <li> <p>cephalosporin vs antiprotozoal (1 RCT, 78 women)</p> </li> <li> <p>antiprotozoal vs lincosamide (1 RCT, 80 women)</p> </li> <li> <p>cephalosporin plus antiprotozoal vs cephalosporin only (1 RCT, 78 women)</p> </li> <li> <p>cephalosporin plus antiprotozoal vs antiprotozoal only (1 RCT, 78 women)</p> </li> <li> <p>penicillin plus antiprotozoal vs penicillin only (1 RCT, 18 women)</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p> <ul id="CD004637-list-0004"> <li> <p>No evidence of a difference between cephalosporin and penicillin.</p> </li> <li> <p>No data available for other comparisons</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004637-list-0005"> <li> <p>cephalosporin vs penicillin (2 RCTs, 451 women)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>CI: confidence interval; RCT: randomised controlled trial</p> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for very serious imprecision with very few events and wide confidence intervals<br/> <sup>b</sup>Downgraded one level for serious risk of bias: methods were poorly reported in most studies </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004637-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Head‐to‐head comparisons of antibiotics for prophylaxis in elective abdominal hysterectomy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Head‐to‐head comparisons of antibiotics for prophylaxis in elective abdominal hysterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Population:</b> women having elective abdominal hysterectomy<br/> <b>Settings:</b> hospital<br/> <b>Intervention:</b> antibiotics<br/> <b>Comparison:</b> alternative antibiotics </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Illustrative comparative risks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antibiotics vs alternative antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD004637-list-0006"> <li> <p><b>Total postoperative infections ‐ early and late</b> </p> </li> <li> <p><b>Abdominal wound infection</b> </p> </li> <li> <p><b>Urinary tract infection</b> </p> </li> <li> <p><b>Pelvic infection</b> </p> </li> <li> <p><b>Other serious infections</b> </p> </li> <li> <p><b>Postoperative fever</b> </p> </li> </ul> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p> <ul id="CD004637-list-0007"> <li> <p>No clear evidence of differences between groups</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD004637-list-0008"> <li> <p>cephalosporin vs penicillin (1 RCT, 220 women)</p> </li> <li> <p>penicillin plus antiprotozoal vs penicillin only (2 RCT, 155 women)</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004637-list-0009"> <li> <p><b>Total adverse effects</b> </p> </li> </ul> </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign=""> <p> <ul id="CD004637-list-0010"> <li> <p>No data reported on adverse effects</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>CI: confidence interval; RCT: randomised controlled trial</p> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for very serious imprecision with very few events and wide confidence intervals<br/> <sup>b</sup>Downgraded one level for serious risk of bias: methods were poorly reported in most studies </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004637-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004637-sec-0023"></div> <section id="CD004637-sec-0024"> <h3 class="title" id="CD004637-sec-0024">Description of the condition</h3> <p>Hysterectomy is one of the most commonly performed operations, particularly in the United States, where the lifetime risk of a hysterectomy is 45% (<a href="./references#CD004637-bbs2-0167" title="MerrillRM . Hysterectomy surveillance in the United States ‐ 1997 through 2005. Medical Science Monitor2008;14:CR24‐CR31. ">Merrill 2013</a>). Most hysterectomies are elective (non‐urgent) procedures for benign gynaecological conditions; the most common of these in the United States is leiomyoma (fibroids). Other common indications include endometriosis, heavy menstrual bleeding, and uterovaginal prolapse. This surgery can be performed abdominally, laparoscopically, or vaginally, with or without laparoscopic assistance (<a href="./references#CD004637-bbs2-0158" title="FarquharC , SteinerA . Hysterectomy rates in the United States 1990‐1997. Obstetrics &amp; Gynecology2002;99(2):229‐34. ">Farquhar 2002</a>). The incidence of postoperative infection after hysterectomy was found to be 2% in a recent large cohort from the United States, in which women had surgery between 2012 and 2015 (<a href="./references#CD004637-bbs2-0179" title="UppalS , HarrisJ , Al‐NiaimiA , SwensonCW , PearlmanMD , ReynoldsRK , et al. Prophylactic antibiotic choice and risk of surgical site infection after hysterectomy. Obstetrics and Gynecology2016;127(2):321‐9. ">Upall 2016</a>). In older cohorts, this percentage is likely to be higher owing to factors such as longer hospital stay and prolonged postoperative urinary catheterisation. Some types of hysterectomy may be more susceptible to infectious complications than others, depending on the extent of the breach in body tissues and in the genital tract. </p> <p>Even with the best surgical and postoperative care, hysterectomy is unavoidably associated with high risk of infection because the procedure breaches the genital tract ‐ an area commonly colonised by a wide variety and large numbers of micro‐organisms. In addition, most women undergoing hysterectomy require an indwelling urinary catheter for the first 24 hours, which increases the risk of urinary tract infection. Common sites of infection after hysterectomy include bladder, pelvic floor, the cuff of tissue at the top of the vagina (vaginal vault), and the abdominal wound; related complications include pelvic abscess, infected haematoma (accumulation of blood from the wound), septicaemia (infection of the blood), and pneumonia (<a href="./references#CD004637-bbs2-0156" title="DuffP , ParkRC . Antibiotic prophylaxis in vaginal hysterectomy: a review. Obstetrics &amp; Gynecology1980;55(5 Suppl):193S‐202S. ">Duff 1980</a>; <a href="./references#CD004637-bbs2-0157" title="Faro2001 . Postoperative infections. In: GershensenCM , DeCheneyAH , CurrySL , BrubakerL editor(s). Operative Gynecology. 2nd Edition. Philadelphia: WB Saunders, 2001:123‐31. ">Faro 2001</a>). Such infections are usually caused by a mixture of bacteria from the woman's own vaginal or urethral tissues ‐ both Gram‐positive and Gram‐negative, and both aerobic and anaerobic (these terms refer to the staining techniques used in identification, and whether the bacteria are oxygen dependent). The individual woman's susceptibility to infection depends upon the effectiveness of her immune system, the virulence of the bacteria present, and the extent of tissue trauma and fluid collection resulting from surgery (<a href="./references#CD004637-bbs2-0156" title="DuffP , ParkRC . Antibiotic prophylaxis in vaginal hysterectomy: a review. Obstetrics &amp; Gynecology1980;55(5 Suppl):193S‐202S. ">Duff 1980</a>). </p> </section> <section id="CD004637-sec-0025"> <h3 class="title" id="CD004637-sec-0025">Description of the intervention</h3> <p>"Antibiotic prophylaxis" refers to administration of antibiotics to prevent infection: It has been used in surgery since antibiotics were introduced in the 1950s, in an attempt to reduce the rate of postoperative infection. Such infection not only causes patient morbidity but may result in additional costs, extended hospital stay, and increased antibiotic use, which promotes the emergence of antimicrobial resistant organisms (<a href="./references#CD004637-bbs2-0153" title="DellingerEP , GrossPA , BarrettTL , KrausePJ , MartoneWJ , McGowanJE , et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Clinical Infectious Diseases1994;18:422‐7. ">Dellinger 1994</a>). Antibiotic prophylaxis for hysterectomy has been extensively studied, and it has been estimated that such prophylaxis has reduced the rate of postoperative infection by more than half; otherwise, about 40% to 50% of women would develop infection after vaginal hysterectomy, and more than 20% after abdominal hysterectomy (<a href="./references#CD004637-bbs2-0156" title="DuffP , ParkRC . Antibiotic prophylaxis in vaginal hysterectomy: a review. Obstetrics &amp; Gynecology1980;55(5 Suppl):193S‐202S. ">Duff 1980</a>; <a href="./references#CD004637-bbs2-0168" title="MittendorfR , AronsonMP , BerryRE , WilliamsMA , KipelnickB , KlicksteinA , et al. Avoiding serious infections associated with abdominal hysterectomy: a meta‐analysis of antibiotic prophylaxis. American Journal of Obstetrics and Gynecology1993;169:1119‐24. ">Mittendorf 1993</a>). National guidelines now recommend this practice for all types of hysterectomy (<a href="./references#CD004637-bbs2-0144" title="ACOG (American College of Obstetricians and Gynecologists). Antibiotic prophylaxis for gynecologic procedures. Obstetrics &amp; Gynecology2009;reaffirmed 2016(113):1180‐9. ">ACOG 2009</a>; <a href="./references#CD004637-bbs2-0147" title="BratzlerDW , DellingerEP , OlsenKM , PerlTM , AuwaerterPG , BolonMK , et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. American Journal of Health‐System Pharmacy2013;70(3):195–283. ">Bratzler 2013</a>; <a href="./references#CD004637-bbs2-0153" title="DellingerEP , GrossPA , BarrettTL , KrausePJ , MartoneWJ , McGowanJE , et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Clinical Infectious Diseases1994;18:422‐7. ">Dellinger 1994</a>; <a href="./references#CD004637-bbs2-0171" title="NelsonG , AltmanAD , NickA , MeyerLA , RamirezPT , AchtariC , et al. Guidelines for pre‐ and intra‐operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations ‐ PART I. Gynecologic Oncology2016;140(2):313‐22. ">Nelson 2016</a>; <a href="./references#CD004637-bbs2-0172" title="Royal College of Obstetricians and Gynaecologists. Effective procedures in gynaecology suitable for audit, 1999. www.rcog.org.uk (accessed 27 May 2003). ">RCOG 1999</a>; <a href="./references#CD004637-bbs2-0175" title="Scottish Intercollegiate Guidelines Network. Antibiotic prophylaxis in surgery. http://www.sign.ac.uk/pdf/sign104.pdf 2008, updated April 2014. ">SIGN 2008</a>; <a href="./references#CD004637-bbs2-0180" title="VanEykN , VanSchalkwykJ , Infectious Disease Committee. Anitbiotic prophylaxis in gynaecologic procedures. Journal of Obstetrics and Gynaecology Canada2012;34(4):382‐91. ">Van Eyk N, van Schalkwyk J 2012</a>), although in reality, application of such guidelines is variable (<a href="./references#CD004637-bbs2-0160" title="GoreckiP , ScheinM , RucinskiJC , WiseL . Antibiotic administration in patients undergoing common surgical procedures in a community teaching hospital: the chaos continues. World Journal of Surgery1999;23:429‐33. ">Gorecki 1999</a>). </p> <p>Although various antibiotic regimens and routes of delivery have been used, the most frequent current practice consists of a single dose of antibiotic given intravenously within two hours of the surgical incision, to facilitate optimum serum antibiotic levels during the operation (<a href="./references#CD004637-bbs2-0149" title="ClassenDC , EvansRS , PestotnikSL , HornSD , MenloveRL , BurkeJP . The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. New England Journal of Medicine1992;326(5):281‐6. ">Classen 1992</a>; <a href="./references#CD004637-bbs2-0154" title="DiPiroJT , VallnerJJ , BowdenTA , ClarkB , SisleyJF . Intraoperative serum concentrations of cefazolin and cefoxitin administered preoperatively at different times. Clinical Pharmacy1984;3(1):64‐7. ">DiPiro 1984</a>; <a href="./references#CD004637-bbs2-0171" title="NelsonG , AltmanAD , NickA , MeyerLA , RamirezPT , AchtariC , et al. Guidelines for pre‐ and intra‐operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations ‐ PART I. Gynecologic Oncology2016;140(2):313‐22. ">Nelson 2016</a>). A single dose has been reported to be as effective as multiple doses, although some researchers have suggested repeat dosing if surgery is long or blood loss is high (<a href="./references#CD004637-bbs2-0155" title="DiPiroJT , CheungRP , BowdenTA , MansbergerJA . Single dose systemic antibiotic prophylaxis of surgical wound infections. American Journal of Surgery1986;152(5):552‐9. ">DiPiro 1986</a>; <a href="./references#CD004637-bbs2-0178" title="TanosV , RojanskyN . Prophylactic antibiotics in abdominal hysterectomy. Journal of the American College of Surgeons1994;179:593‐600. ">Tanos 1994</a>). If prophylaxis is continued postoperatively, it is recommended that the duration of therapy should not exceed 24 hours (<a href="./references#CD004637-bbs2-0153" title="DellingerEP , GrossPA , BarrettTL , KrausePJ , MartoneWJ , McGowanJE , et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Clinical Infectious Diseases1994;18:422‐7. ">Dellinger 1994</a>). </p> <p>The type of antibiotic most commonly used is active against a wide range of bacteria (broad spectrum); this type includes amoxicillin/clavulanic acid (Augmentin) or a cephalosporin. Cephalosporins are grouped into generations according to their antimicrobial properties, with the oldest type referred to as "first generation". Subsequent generations of these drugs have progressively widened their antibacterial coverage against Gram‐negative organisms while showing a concurrent reduction in effectiveness against Gram‐positive organisms; moreover, wide use of very broad‐spectrum antibiotics greatly increases the risk of emergence of drug‐resistant bacteria (<a href="./references#CD004637-bbs2-0145" title="British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary, 2002. 4th Edition. http://www.bnf.org/ [accessed May 2003]. ">BNF 2002</a>). It is generally recommended that first‐ or second‐generation cephalosporins should be used for prophylaxis, as they appear to be equally effective for this purpose, less expensive than other treatments, and less likely to favour drug resistance (<a href="./references#CD004637-bbs2-0159" title="FukatsuK , SaitoH , MatsudaT , IkedaS , FurukawaS , MutoT . Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin‐resistant Staphylococcus aureus and on the incidence of wound infection. Archives of Surgery1997;132(12):1320‐5. ">Fukatsu 1997</a>; <a href="./references#CD004637-bbs2-0178" title="TanosV , RojanskyN . Prophylactic antibiotics in abdominal hysterectomy. Journal of the American College of Surgeons1994;179:593‐600. ">Tanos 1994</a>; <a href="./references#CD004637-bbs2-0181" title="WeedHG . Antimicrobial prophylaxis in the surgical patient. The Medical Clinics of North America2003;87:59‐75. ">Weed 2003</a>). </p> </section> <section id="CD004637-sec-0026"> <h3 class="title" id="CD004637-sec-0026">How the intervention might work</h3> <p>Prophylaxis works by briefly bolstering tissue defence mechanisms to promote rapid restoration of normal immune responses after the trauma of surgery. </p> </section> <section id="CD004637-sec-0027"> <h3 class="title" id="CD004637-sec-0027">Why it is important to do this review</h3> <p>A very large body of evidence on prophylactic antibiotics for hysterectomy involves hundreds of clinical trials. However, review authors have not systematically assessed this evidence in recent times. Existing meta‐analyses conducted some years back focused mainly on abdominal hysterectomy. No meta‐analysis has focused on trials involving other routes of hysterectomy. </p> <p>Several Cochrane reviews of prophylactic antibiotics for elective surgery have reported mixed findings. Two of these examined the topic of caesarean section (<a href="./references#CD004637-bbs2-0162" title="GyteGML , DouL , VazquezJC . Different classes of antibiotics given to women routinely for preventing infection at caesarean section. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD008726.pub2] ">Gyte 2014</a>; <a href="./references#CD004637-bbs2-0170" title="NabhanAF , AllamNE , Hamed Abdel‐Aziz SalamaM . Routes of administration of antibiotic prophylaxis for preventing infection after caesarean section. Cochrane Database of Systematic Reviews2016, Issue 6. [DOI: 10.1002/14651858.CD011876.pub2] ">Nabhan 2016</a>). <a href="./references#CD004637-bbs2-0162" title="GyteGML , DouL , VazquezJC . Different classes of antibiotics given to women routinely for preventing infection at caesarean section. Cochrane Database of Systematic Reviews2014, Issue 11. [DOI: 10.1002/14651858.CD008726.pub2] ">Gyte 2014</a> evaluated different classes of prophylactic antibiotics for women undergoing caesarean section and found that cephalosporins and penicillins had similar efficacy for preventing immediate postoperative infection. Investigators provided no data on late infection, nor on outcomes for the baby. <a href="./references#CD004637-bbs2-0170" title="NabhanAF , AllamNE , Hamed Abdel‐Aziz SalamaM . Routes of administration of antibiotic prophylaxis for preventing infection after caesarean section. Cochrane Database of Systematic Reviews2016, Issue 6. [DOI: 10.1002/14651858.CD011876.pub2] ">Nabhan 2016</a> compared routes of administration of prophylactic antibiotics and concluded that data show no clear difference between irrigation and intravenous routes in rates of post‐caesarean endometritis. A review on elective endoscopic retrograde cholangiopancreatography (<a href="./references#CD004637-bbs2-0146" title="BrandM , BizosD , O'FarrellPJR . Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD007345.pub2] ">Brand 2010</a>) reported that antibiotic prophylaxis appeared to reduce rates of bacteraemia, cholangitis, and septicaemia. A review of different regimens of antibiotic prophylaxis for people undergoing orthognathic surgery (<a href="./references#CD004637-bbs2-0148" title="Brignardello‐PetersenR , Carrasco‐LabraA , ArayaI , YanineN , Cordova JaraL , VillanuevaJ . Antibiotic prophylaxis for preventing infectious complications in orthognathic surgery. Cochrane Database of Systematic Reviews2015, Issue 1. [DOI: 10.1002/14651858.CD010266.pub2] ">Brignardello‐Petersen 2015</a>) found that long‐term antibiotic prophylaxis decreased the risk of skin and skin structure infection compared with short‐term prophylaxis, but comparisons between short‐term prophylaxis and a single preoperative dose were inconclusive. Reviews of antibiotic prophylaxis for elective open inguinal hernia repair (<a href="./references#CD004637-bbs2-0174" title="Sanchez‐ManuelFJ , Lozano‐GarcíaJ , Seco‐GilJL . Antibiotic prophylaxis for hernia repair. Cochrane Database of Systematic Reviews2012, Issue 2. [DOI: 10.1002/14651858.CD003769.pub4] ">Sanchez‐Manuel 2012</a>) or for elective laparoscopic cholecystectomy (<a href="./references#CD004637-bbs2-0173" title="SanabriaA , DominguezLC , ValdiviesoE , GomezG . Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy. Cochrane Database of Systematic Reviews2010, Issue 12. [DOI: 10.1002/14651858.CD005265.pub2] ">Sanabria 2010</a>) provided no clear evidence of benefit for the intervention group. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004637-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004637-sec-0028"></div> <p>To determine the effectiveness and safety of antibiotic prophylaxis in women undergoing elective hysterectomy. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004637-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004637-sec-0029"></div> <section id="CD004637-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004637-sec-0031"> <h4 class="title">Types of studies</h4> <p>Randomised, controlled trials (RCTs) of women having an elective total or subtotal hysterectomy by any route and comparing prophylactic antibiotics versus placebo or versus a different type, route, or timing of antibiotic. Trials were at least double‐blinded (i.e. with participants and clinicians blinded). We did not include quasi‐randomised trials (e.g. trials that allocated treatment by date of birth, day of the week, medical record number, month of the year, or the order in which participants were enrolled in the study). </p> <p>We excluded from the review studies that did not analyse at least 80% of women randomised for at least one outcome. When trials analysed at least 80% of participants for some outcomes but analysed less than 80% of participants for other outcomes, we included only those outcomes analysed for at least 80% of participants. The rationale for excluding trials with high numbers of withdrawals is that attrition was unlikely to be equally distributed between trial arms: Women who did not develop infection were more likely to be lost to follow‐up than those who did develop infection. </p> </section> <section id="CD004637-sec-0032"> <h4 class="title">Types of participants</h4> <p>Women of any age without serious comorbidity (such as cancer) undergoing an elective total or subtotal abdominal, vaginal, laparoscopic, or laparoscopically assisted hysterectomy, with or without oophorectomy, for a benign gynaecological condition such as fibroids, endometriosis, uterovaginal prolapse, or heavy menstrual bleeding. </p> </section> <section id="CD004637-sec-0033"> <h4 class="title">Types of interventions</h4> <p>Prophylactic antibiotics versus placebo or a different type or regimen of antibiotics.</p> <p>The term "prophylactic" was defined as follows. Prophylactic: antibiotic(s) given when an individual had no signs or symptoms of infection, when no antibiotics had been taken within the previous 48 hours, and when the first dose was given up to 12 hours preoperatively and the last dose was given not more than 24 hours postoperatively. </p> <section id="CD004637-sec-0034"> <h5 class="title">Types of antibiotics</h5> <p>Antibiotics were classified into the following types.</p> <p> <ol id="CD004637-list-0011"> <li> <p>Cephalosporins.</p> <ol id="CD004637-list-0012"> <li> <p>First‐generation (e.g. cefazolin, cephradine, cephazolin, cephalexin, cefadroxil).</p> </li> <li> <p>Second‐generation (e.g. cefoxitin, cefuroxime, cephamandole, cefaclor, cefprozil, loracarbef). </p> </li> <li> <p>Third‐generation (e.g. cefotaxime, cefotetan, ceftazidime, ceftriaxone, cefixime, cefpodoxime proxetil, ceftibuten, cefdinir, cephoperazone, ceftizoxime). </p> </li> <li> <p>Fourth‐generation (e.g. cefepime).</p> </li> </ol> </li> <li> <p>Penicillins (e.g. penicillin, amoxicillin).</p> </li> <li> <p>Macrolides (e.g. erythromycin, clarithromycin, azithromycin).</p> </li> <li> <p>Fluoroquinolones (e.g. ciprofloxacin, levofloxacin, oxfloxacin).</p> </li> <li> <p>Sulfonamides (e.g. co‐trimoxazole, trimethoprim).</p> </li> <li> <p>Tetracyclines (e.g. tetracycline, doxycycline).</p> </li> <li> <p>Aminogylocosides (e.g. gentamycin, tobramycin).</p> </li> <li> <p>Glycopeptides (e.g. vancomycin).</p> </li> <li> <p>Antiprotozoals (e.g. metronidazole, anitroimidazole).</p> </li> <li> <p>Combination drugs.</p> <ol id="CD004637-list-0013"> <li> <p>Augmentin (amoxicillin and clavulanic acid).</p> </li> <li> <p>Other combinations of drugs (will be considered individually).</p> </li> </ol> </li> </ol> </p> <p>Antibiotic regimens include the following.</p> <p> <ol id="CD004637-list-0014"> <li> <p>Route: Any systemic regimen was included, irrespective of the route of administration (e.g. intravenous, intramuscular, oral, rectal). </p> </li> <li> <p>Number of doses (e.g. single vs repeated doses).</p> </li> </ol> </p> </section> </section> <section id="CD004637-sec-0035"> <h4 class="title">Types of outcome measures</h4> <p>We considered trials if they reported any of the following clinical outcomes.</p> <section id="CD004637-sec-0036"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD004637-list-0015"> <li> <p>Infection: measured as the proportion of women who within eight weeks of surgery developed one of the following as defined by the study. </p> <ol id="CD004637-list-0016"> <li> <p>Total postoperative infection.</p> </li> <li> <p>Abdominal wound infection (e.g. wound cellulitis, abscess, dehiscence).</p> </li> <li> <p>Pelvic infection (including vaginal cuff (vault) infection, pelvic inflammatory disease, pelvic abscess, infected haematoma). </p> </li> <li> <p>Urinary tract infection.</p> </li> <li> <p>Other serious infection or infectious complication, such as septicaemia, septic shock, distant infection (e.g. pneumonia). </p> </li> </ol> </li> <li> <p>Postoperative fever of &gt; 38° on at least two occasions more than four hours apart, excluding the day of surgery. </p> </li> <li> <p>Total adverse effects: morbidity (e.g. allergic reaction, diarrhoea, bacterial resistance, or as defined by the study) and mortality (infection‐related and all‐cause). </p> </li> </ol> </p> <p>We classified primary outcomes as early (before discharge from hospital or within seven days of surgery), late (at follow‐up: within eight weeks of surgery), or total (early + late). </p> </section> <section id="CD004637-sec-0037"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD004637-list-0017"> <li> <p>Need for therapeutic antibiotics ‐ early (before discharge from hospital or within seven days of surgery), late (at follow‐up: within eight weeks of surgery), or total (early + late). </p> </li> <li> <p>Length of hospital stay.</p> </li> <li> <p>Quality of life.</p> </li> </ol> </p> </section> </section> </section> <section id="CD004637-sec-0038"> <h3 class="title">Search methods for identification of studies</h3> <p>In consultation with the Gynaecology and Fertility Group Information Specialist, we searched the following databases for all published and unpublished RCTs. </p> <section id="CD004637-sec-0039"> <h4 class="title">Electronic searches</h4> <p>We searched the following electronic databases, trial registers, and websites up to 29 November 2016. </p> <p> <ol id="CD004637-list-0018"> <li> <p>Gynaecology and Fertility Group (CGF) Specialised Register of Controlled Trials.</p> </li> <li> <p>Cochrane Central Register of Studies Online (CRSO).</p> </li> <li> <p>MEDLINE.</p> </li> <li> <p>Embase.</p> </li> <li> <p>PsycINFO.</p> </li> <li> <p>Cumulative Index to Nursing Allied Health and Literature (CINAHL).</p> <ol id="CD004637-list-0019"> <li> <p>We combined the MEDLINE search with the Cochrane highly sensitive search strategy for identifying randomised trials, which appears in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (Version 5.0.2, Chapter 6, 6.4.11). We combined Embase, PsycINFO, and CINAHL searches using trial filters developed by the Scottish Intercollegiate Guidelines Network (SIGN) (http://www.sign.ac.uk/methodology/filters.html#random). </p> </li> </ol> </li> <li> <p>Other electronic sources of trials included:</p> <ol id="CD004637-list-0020"> <li> <p>trial registers for ongoing and registered trials;</p> </li> <li> <p>http://www.clinicaltrials.gov (a service of the US National Institutes of Health);</p> </li> <li> <p>http://www.who.int/trialsearch/Default.aspx (World Health Organization International Clinical Trials Registry Platform search portal) (Note: it is now mandatory for Cochrane reviews to include searches of trial registers); </p> </li> <li> <p>DARE (Database of Abstracts of Reviews of Effects) in the Cochrane Library (http://onlinelibrary.wiley.com/o/cochrane/cochrane_cldare_articles_fs.html) (for reference lists from relevant non‐Cochrane reviews); </p> </li> <li> <p>Web of Knowledge (http://wokinfo.com/ ‐ another source of trials and conference abstracts);</p> </li> <li> <p>OpenGrey (http://www.opengrey.eu/ ‐ for unpublished literature from Europe);</p> </li> <li> <p>Latin American Caribbean Health Sciences Literature (LILACS database) (http://regional.bvsalud.org/php/index.php?lang=en ‐ for trials from the Portuguese‐ and Spanish‐speaking world); and </p> </li> <li> <p>PubMed and Google Scholar (for recent trials not yet indexed in MEDLINE).</p> </li> </ol> </li> </ol> </p> <p>For details of search strategies, see <a href="./appendices#CD004637-sec-0478">Appendix 1,</a><a href="./appendices#CD004637-sec-0479">Appendix 2,</a><a href="./appendices#CD004637-sec-0480">Appendix 3,</a><a href="./appendices#CD004637-sec-0481">Appendix 4,</a><a href="./appendices#CD004637-sec-0482">Appendix 5,</a> and <a href="./appendices#CD004637-sec-0483">Appendix 6</a>. </p> </section> <section id="CD004637-sec-0040"> <h4 class="title">Searching other resources</h4> <p>We handsearched the reference lists of articles retrieved by the search and contacted experts in the field to request additional data. We also handsearched relevant journals and conference abstracts not included in the CGF register, in liaison with the Information Specialist from the CGF Group. </p> </section> </section> <section id="CD004637-sec-0041"> <h3 class="title" id="CD004637-sec-0041">Data collection and analysis</h3> <section id="CD004637-sec-0042"> <h4 class="title">Selection of studies</h4> <p>After an initial screen of titles and abstracts retrieved by the search, we retrieved the full texts of all potentially eligible studies. At least two review authors (of VJ, JM, and RA) independently examined these full‐text articles for compliance with the inclusion criteria and selected studies that were eligible for inclusion in the review. We contacted study investigators as required to clarify study eligibility. We resolved disagreements regarding study eligibility by discussion or by consultation with a third review author. We documented the selection process using a PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) flow chart. </p> </section> <section id="CD004637-sec-0043"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted data from eligible studies using a data extraction form that they had designed and pilot‐tested. We resolved disagreements by discussion or by consultation with a third review author. Data extracted included study characteristics and outcome data. When studies had multiple publications, review authors collated multiple reports of the same study, so that each study rather than each report was the unit of interest in the review, and assigned such studies a single study ID with multiple references. </p> <p>We contacted study investigators to request additional data on methods and/or results, as required. </p> </section> <section id="CD004637-sec-0044"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently examined included studies for risk of bias using the Cochrane "Risk of bias" assessment tool (<a href="./references#CD004637-bbs2-0164" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>) to assess selection (random sequence generation and allocation concealment); performance (blinding of participants and personnel); detection (blinding of outcome assessors); attrition (incomplete outcome data); reporting (selective reporting); and other bias such as differences in demographic characteristics of participants. We took care to search for within‐trial selective reporting, as seen in trials failing to report obvious outcomes, or reporting them in insufficient detail to allow inclusion. We sought published protocols and compared outcomes between the protocol and the final published study. </p> <p>We resolved disagreements by discussion or by consultation with a third review author. We described all judgements fully and presented conclusions in the "Risk of bias" table; we incorporated these into the interpretation of review findings by performing sensitivity analyses (see below). </p> </section> <section id="CD004637-sec-0045"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data (e.g. infection rates), we used numbers of events in control and intervention groups of each study to calculate risk ratios (RRs). For continuous data (e.g. length of hospital stay), when studies reported exactly the same outcomes, we calculated mean differences (MDs) between treatment groups. We reversed the direction of effect of individual studies, if required, to ensure consistency across trials. We intended to treat ordinal data (e.g. quality of life scores) as continuous data if any included studies reported ordinal data. We presented 95% confidence intervals (CIs) for all outcomes. We compared the magnitude and direction of effects reported by studies versus how they were presented in the review, while taking account of legitimate differences<i>.</i> </p> </section> <section id="CD004637-sec-0046"> <h4 class="title">Unit of analysis issues</h4> <p>The primary analysis was per woman randomised.</p> </section> <section id="CD004637-sec-0047"> <h4 class="title">Dealing with missing data</h4> <p>We analysed the data on an intention‐to‐treat basis as far as possible and attempted to obtain missing data from the original trialists. When these were unobtainable, we analysed only available data. </p> <p>When studies reported sufficient detail for calculation of mean differences but no information on associated standard deviation (SD), we assumed the outcome to have a standard deviation equal to the highest SD from other studies within the same analysis. </p> </section> <section id="CD004637-sec-0048"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered whether clinical and methodological characteristics of included studies were sufficiently similar for meta‐analysis to provide a clinically meaningful summary. We assessed statistical heterogeneity by using the I<sup>2</sup> measurement. We took an I<sup>2</sup> measurement greater than 50% to indicate substantial heterogeneity (<a href="./references#CD004637-bbs2-0163" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>; <a href="./references#CD004637-bbs2-0164" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>)<i>.</i> </p> </section> <section id="CD004637-sec-0049"> <h4 class="title">Assessment of reporting biases</h4> <p>In view of the difficulty of detecting and correcting for publication bias and other reporting biases, review authors aimed to minimise their potential impact by ensuring a comprehensive search for eligible studies and by staying alert for duplication of data. When we included 10 or more studies in an analysis, we used a funnel plot to explore the possibility of small‐study effects (the tendency for estimates of the intervention effect to be more beneficial in smaller studies). </p> </section> <section id="CD004637-sec-0050"> <h4 class="title">Data synthesis</h4> <p>When studies were sufficiently similar, we combined the data using a fixed‐effect model. </p> <p>We graphically displayed an increase in risk of a particular outcome within meta‐analyses to the right of the centre‐line, and a decrease in risk of a particular outcome to the left of the centre‐line. </p> <p>We made the following comparisons.</p> <p> <ol id="CD004637-list-0021"> <li> <p>Any antibiotic versus placebo.</p> </li> <li> <p>Specific antibiotics versus placebo.</p> </li> <li> <p>Head‐to‐head comparisons of antibiotics.</p> </li> <li> <p>Comparisons of antibiotic regimens.</p> </li> </ol> </p> <p>We subgrouped all analyses by surgical route: vaginal or abdominal. We did not pool these subgroups. </p> </section> <section id="CD004637-sec-0051"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We subgrouped our main analysis according to the surgical route used (vaginal or abdominal). We did not undertake other prespecified subgroup analyses. </p> <p>When we detected substantial heterogeneity (I<sup>2</sup> &gt; 50%), we explored possible explanations by performing sensitivity analyses. We took any statistical heterogeneity into account when interpreting results, especially if we noted any variation in the direction of effect estimates. </p> </section> <section id="CD004637-sec-0052"> <h4 class="title">Sensitivity analysis</h4> <p>When heterogeneity was substantial (I<sup>2</sup> &gt; 50%), we conducted sensitivity analysis by choosing a statistical model (fixed‐effect vs random‐effects) and an effect estimate (risk ratio vs odds ratio), regardless of the number of trials included in an analysis. We planned to explore other clinical or methodological differences between studies only if data showed variation in the direction of effect. </p> <section id="CD004637-sec-0053"> <h5 class="title">Overall quality of the body of evidence: "Summary of findings" table</h5> <p>We prepared two separate "Summary of findings" tables for vaginal hysterectomy and abdominal hysterectomy based on the review's main comparison, that is, any antibiotics versus placebo. We used GRADEPRO (<a href="./references#CD004637-bbs2-0161" title="GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed prior to November 2016. Hamilton, Ontario: GRADE Working Group, McMaster University, 2014. ">GRADEPro GDT 2014</a>) and Cochrane methods (<a href="./references#CD004637-bbs2-0164" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>) and used these tables to evaluate the overall quality of the body of evidence for main review outcomes (total postoperative infections, abdominal wound infection, urinary tract infection, pelvic infection, other serious infection, postoperative fever, and total adverse effects) by applying GRADE criteria (study limitations (i.e. risk of bias), consistency of effect, imprecision, indirectness, and publication bias). Two review authors working independently made judgements about evidence quality (high, moderate, low, or very low) and resolved disagreements by discussion. We justified, documented, and incorporated our judgements into reporting of results for each outcome. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004637-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004637-sec-0054"></div> <section id="CD004637-sec-0055"> <h3 class="title">Description of studies</h3> <section id="CD004637-sec-0056"> <h4 class="title">Results of the search</h4> <p>The search produced a total of 940 titles and abstracts after duplicates were removed; we considered 149 full‐text articles for further assessment. Thirty‐seven trials in 42 reports met the eligibility criteria for inclusion, and we excluded 107 full‐text articles. See <a href="./references#CD004637-sec-0493" title="">Characteristics of included studies</a> and <a href="./references#CD004637-sec-0494" title="">Characteristics of excluded studies</a> tables. The PRISMA flow chart in <a href="#CD004637-fig-0001">Figure 1</a> illustrates the flow of literature throughout the search and assessment process. </p> <div class="figure" id="CD004637-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA flow chart." data-id="CD004637-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA flow chart.</p> </div> </div> </div> </section> <section id="CD004637-sec-0057"> <h4 class="title">Included studies</h4> <section id="CD004637-sec-0058"> <h5 class="title">Study design and setting</h5> <p>We included 37 studies in this review (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). </p> <p>The most recent study was <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>, which was already 14 years old at the time of our search. </p> <p>All included studies were parallel, double‐blinded, randomised controlled trials (RCTs). Twenty‐nine studies were two‐arm RCTs (<a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). Eight studies were three‐arm RCTs (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>). </p> <p>Seventeen studies were conducted in the United States (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>); five studies were conducted in the United Kingdom (<a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>); two were conducted in Canada (<a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>); and three in the Netherlands (<a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>). Two studies each were conducted in Australia (<a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>) and India (Chandigarth) (<a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>); one study each was conducted in Belgium (<a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>), Israel (<a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>), Sweden (<a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>), and Thailand (<a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>). The remaining two studies did not provide information on the countries in which they were conducted (<a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>). </p> <p>Six of the included studies were conducted at more than one centre: 14 centres (<a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>), four centres (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>), three centres (<a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>), and two centres (<a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>); five studies did not report the number of centres (<a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>); and each of the remaining 26 studies was conducted at a single centre (<a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). </p> </section> <section id="CD004637-sec-0059"> <h5 class="title">Participants</h5> <p>The 37 included studies enrolled a total of 6079 women. Seventeen studies randomised or analysed a total of 100 or fewer women (<a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>); eight studies randomised or analysed a total of 101 to 200 women (<a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>); five studies randomised or analysed a total of 201 to 300 women (<a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>); five studies randomised or analysed a total of 301 to 400 women (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>); one study randomised a total of 403 women (<a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>); and another randomised a total of 557 women (<a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>). </p> <p>A common inclusion criterion was that women had to be scheduled for elective abdominal hysterectomy, vaginal hysterectomy, or both types of hysterectomy for a benign condition. Thirteeen studies included women scheduled for abdominal hysterectomy (<a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>); 14 studies included women scheduled for elective vaginal hysterectomy (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>); nine studies included women scheduled for either abdominal or vaginal hysterectomy (<a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>); and one study did not report the type of hysterectomy for which women were scheduled (<a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>). </p> <p>No included studies focused on antibiotic prophylaxis in participants undergoing laparoscopically performed hysterectomy. </p> <p>Common exclusion criteria were emergency hysterectomy; pregnancy‐related hysterectomy; hypersensitivity to antibiotics such as cephalosporin, penicillin, amoxicillin, etc.; and use of antibiotics within two to seven days before surgery. </p> </section> <section id="CD004637-sec-0060"> <h5 class="title">Interventions</h5> <p>Included studies compared different classes of antibiotics with placebo or with each other. Included studies identified the following treatment groups. </p> <p> <ol id="CD004637-list-0022"> <li> <p>Any antibiotic versus placebo (<a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). </p> </li> <li> <p>Cephalosporin versus placebo (<a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>). </p> </li> <li> <p>Penicillin versus placebo (<a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>). </p> </li> <li> <p>Antiprotozoal versus placebo (<a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). </p> </li> <li> <p>Sulphonamides versus placebo (<a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>). </p> </li> <li> <p>Cephalosporin plus antiprotozoal versus placebo (<a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>). </p> </li> <li> <p>Penicillin plus antiprotozoal versus placebo (<a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>). </p> </li> <li> <p>Lincosamide versus placebo (<a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>). </p> </li> <li> <p>Cephalosporin versus penicillin (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>). </p> </li> <li> <p>Cephalosporin versus tetracycline (<a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>). </p> </li> <li> <p>Cephalosporin versus antiprotozoal (<a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>). </p> </li> <li> <p>Antiprotozoal versus lincosamide (<a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>). </p> </li> <li> <p>Cephalosporin plus antiprotozoal versus cephalosporin only (<a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>). </p> </li> <li> <p>Cephalosporin plus antiprotozoal versus antiprotozoal only (<a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>). </p> </li> <li> <p>Penicillin plus antiprotozoal versus penicillin only (<a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>). </p> </li> <li> <p>Cephalosporin early administration versus usual timing (both single dose) (<a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>). </p> </li> <li> <p>Cephalosporin one dose versus two doses (<a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>). </p> </li> <li> <p>Cephalosporin one dose versus three doses (<a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>). </p> </li> <li> <p>Cephalosporin one dose versus multiple doses (<a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>). </p> </li> <li> <p>Cephalosporin one gram versus two grams (<a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>). </p> </li> </ol> </p> <p>Included studies administered antibiotics through the following routes.</p> <p> <ol id="CD004637-list-0023"> <li> <p>Intravenous (IV) (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). </p> </li> <li> <p>Intramuscular (IM) (<a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>). </p> </li> <li> <p>IV and IM (<a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>). </p> </li> <li> <p>Oral (<a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>). </p> </li> <li> <p>IV and rectal (<a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>). </p> </li> </ol> </p> <p>One of the included studies did not state the route used for administration of antibiotics (<a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>). </p> <p>Investigators administered antibiotics as a single dose, as multiple doses, or as single versus multiple doses in the following studies. </p> <p> <ol id="CD004637-list-0024"> <li> <p>Single dose (<a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>). </p> </li> <li> <p>Multiple doses (<a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). </p> </li> <li> <p>Single dose versus multiple doses (<a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>). </p> </li> </ol> </p> <p>Timing and duration of administration varied in the included studies. However, none of the included studies administered the first dose of antibiotics more than 12 hours before surgery and the last dose more than 24 hours after surgery. </p> </section> <section id="CD004637-sec-0061"> <h5 class="title">Outcomes</h5> <p>Primary outcome measures of this review were presence of postoperative infection (total postoperative infections, abdominal wound infection, pelvic infection, urinary tract infection (UTI), other serious infection (such as pneumonia, septicaemia, septic shock), and postoperative fever), total adverse effects such as morbidity (e.g. diarrhoea, allergic reactions), and mortality. Thirty‐six included studies reported data on at least one of the review's primary outcome measures (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>); and one of the included studies did not report data on any of the review's primary outcomes (<a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>). Twenty‐five included studies reported data on adverse effects, most in narrative form (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). Common adverse effects included allergy reactions and diarrhoea. None of the included studies reported any incident of mortality. </p> <p>Secondary outcome measures included any requirement for therapeutic antibiotics, length of hospital stay, and quality of life following surgery. Twenty‐seven included studies reported on at least one of the secondary outcome measures (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). Secondary outcome measures commonly reported were need for therapeutic antibiotics and length of hospital stay; no studies provided data on quality of life. The remaining 10 studies did not report on any of the secondary outcome measures (<a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>). </p> </section> </section> <section id="CD004637-sec-0062"> <h4 class="title">Excluded studies</h4> <p>Review authors determined that 107 studies were not eligible for inclusion in this review. Common reasons for exclusion were administration of antibiotics more than 12 hours before surgery or for more than 24 hours after surgery and non‐blinding of participants and personnel. For further details on reasons for exclusion of studies, see <a href="./references#CD004637-sec-0494" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD004637-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD004637-fig-0002">Figure 2</a> and <a href="#CD004637-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD004637-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004637-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD004637-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004637-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD004637-sec-0064"> <h4 class="title">Allocation</h4> <section id="CD004637-sec-0065"> <h5 class="title">Random sequence generation</h5> <p>We considered processes used in sequence generation to be adequate in 10 of the included studies because they involved the use of computers (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>) or random number tables (<a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>). We therefore rated these studies as having low risk of bias with respect to random sequence generation. The remaining 27 studies provided insufficient information to permit conclusive judgements on the process involved in sequence generation; thus we rated them as having unclear risk of bias. </p> </section> <section id="CD004637-sec-0066"> <h5 class="title">Allocation concealment</h5> <p>We rated 17 studies as having low risk of bias with respect to allocation concealment (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>). We considered the processes involved in concealing allocations in these studies to be adequate; these included remote or central allocation through the hospital pharmacy and use of sealed opaque envelopes. We assessed the remaining 20 studies as having unclear risk because information was insufficient to allow conclusive judgements with respect to allocation concealment. </p> </section> </section> <section id="CD004637-sec-0067"> <h4 class="title">Blinding</h4> <p>We considered that blinding was likely to influence findings for both primary and secondary review outcomes. Although we considered all included studies to be adequate with regard to blinding of both participants and physicians, most did not provide adequate information on how participants were evaluated postoperatively. Only 16 studies reported sufficient information on outcome assessment and/or participant follow‐up; we thus rated these studies as having low risk with respect to performance and detection bias (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>). The remaining 21 studies did not provide sufficient information on whether outcome assessors were blinded; we therefore rated these studies as having unclear risk with respect to performance and detection bias (<a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). </p> </section> <section id="CD004637-sec-0068"> <h4 class="title">Incomplete outcome data</h4> <p>We judged 16 studies as having low risk with respect to incomplete outcome data or attrition bias (<a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). Proportions of withdrawals/losses to follow‐up and reasons for withdrawal in these studies were fairly well balanced or similar across treatment groups, or outcome data were analysed on an intention‐to‐treat (ITT) basis by including all randomised women in data analyses. Nineteen studies provided insufficient information on the number of withdrawals/losses to follow‐up and/or on reasons for withdrawal, and data were not analysed on the basis of ITT (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>). We thus rated these studies as having unclear risk with respect to attrition bias. We rated the remaining two studies as having high risk of bias: In one of these studies, proportions of withdrawals were not balanced between groups and data were not analysed on the basis of ITT (<a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>); in the other study, proportions of withdrawals and reasons for withdrawal were not balanced across treatment groups (<a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>). </p> </section> <section id="CD004637-sec-0069"> <h4 class="title">Selective reporting</h4> <p>Protocols were not available for any of the included studies, and review authors could not determine whether outcomes were selectively reported. Therefore, the process of detecting selective reporting bias in included studies involved careful assessment of methods sections to determine which outcomes were prespecified and whether data were reported on all prespecified outcomes. Thirteen studies provided data on all outcomes prespecified in the methods sections; we rated these as having low risk with respect to selective reporting (within‐trial selective reporting) (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). Twenty‐three studies provided insufficient information to allow conclusive judgements with respect to selective reporting; therefore, we rated these studies as having unclear risk of selective reporting bias (<a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>). We rated the only remaining study as having high risk of selective reporting because evidence showed selective reporting, with no data reported on some of the outcomes prespecified in the methods section (<a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>). </p> </section> <section id="CD004637-sec-0070"> <h4 class="title">Other potential sources of bias</h4> <p>We assessed other potential sources of bias with respect to whether data showed significant differences between treatment groups in terms of baseline demographic characteristics of participants, such as age and body mass index (BMI). In 28 studies, baseline demographic characteristics were similar between treatment groups; thus we rated these studies as having low risk with respect to other potential sources of bias (<a href="./references#CD004637-bbs2-0002" title="BoodtPJ , SnijdersWP , JanknegtR . Single‐dose prophylaxis in hysterectomies. An interim analysis. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):280‐3. ">Boodt 1990</a>; <a href="./references#CD004637-bbs2-0003" title="ChongsomchaiC , LumbiganonP , AnansuwanchaiJ , OunchaiJ . Prophylactic antibiotics in abdominal hysterectomy. XVI FIGO World Congress of O &amp; G, 2000 Sept, Washington DC. Washington DC, 2000. ChongsomchaiC , LumbiganonP , ThinkhamropJ , OunchaiJ , VudhikamraksaN . Placebo‐controlled, double‐blind, randomized study of prophylactic antibiotics in elective abdominal hysterectomy. Journal of Hospital Infection2002;52(4):302‐6. ">Chongsomchai 2002</a>; <a href="./references#CD004637-bbs2-0004" title="CrosthwaiteAH , HurseAB , McDonaldIA , MilesHM , PavillardER . Single dose tinidazole prophylaxis in hysterectomy. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology1985;25(1):55‐8. ">Crosthwaite 1985</a>; <a href="./references#CD004637-bbs2-0006" title="DharKK , DhallGI , AyyagariA . Single dose tinidazole prophylaxis in vaginal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):117‐20. ">Dhar 1993</a>; <a href="./references#CD004637-bbs2-0007" title="DharKK , DhallGI , AyyagariA . Tinidazole prophylaxis in elective abdominal hysterectomy. International Journal of Gynaecology &amp; Obstetrics1993;42(2):121‐5. ">Dhar 1993a</a>; <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a>; <a href="./references#CD004637-bbs2-0009" title="EgarterC , FitzR , BrehmR , HussleinP . Prophylactic perioperative use of clindamycin and metronidazole in vaginal hysterectomy without pelvic floor repair. Archives of Gynecology &amp; Obstetrics1988;244(1):53‐7. ">Egarter 1988</a>; <a href="./references#CD004637-bbs2-0010" title="EronLJ , GordonSF , HarveyLI , SitesJG . A trial using early preoperative administration of cefonicid for antimicrobial prophylaxis with hysterectomies. Annals of Pharmacotherapy1989;23(9):655‐8. ">Eron 1989</a>; <a href="./references#CD004637-bbs2-0012" title="GallSA , HillG . Cefoperazone as a prophylactic agent in abdominal hysterectomy. Reviews of Infectious Diseases1983;5(Suppl 1):s200‐1. ">Gall 1983</a>; <a href="./references#CD004637-bbs2-0013" title="HagerWD , SweetRL , CharlesD , LarsenB . Comparative study of mezlocillin versus cefotaxime single‐dose prophylaxis in patients undergoing vaginal hysterectomy. Current Therapeutic Research, Clinical &amp; Experimental1989;45(1):63‐9. ">Hager 1989</a>; <a href="./references#CD004637-bbs2-0015" title="HemsellDL , CunninghamFG , KappusS , NoblesB . Cefoxitin for prophylaxis in premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1980;56(5):629‐34. ">Hemsell 1980</a>; <a href="./references#CD004637-bbs2-0016" title="HemsellDL , ReischJ , NoblesB , HemsellPG . Prevention of major infection after elective abdominal hysterectomy: individual determination required. American Journal of Obstetrics &amp; Gynecology1983;147(5):520‐8. ">Hemsell 1983</a>; <a href="./references#CD004637-bbs2-0017" title="HemsellDL , HeardML , NoblesBJ , HemsellPG . Single‐dose cefoxitin prophylaxis for premenopausal women undergoing vaginal hysterectomy. Obstetrics &amp; Gynecology1984;63(3):285‐90. ">Hemsell 1984</a>; <a href="./references#CD004637-bbs2-0020" title="HemsellDL , BawdonRE , HemsellPG , NoblesBJ , JohnsonER , HeardMC . Single‐dose cephalosporin for prevention of major pelvic infection after vaginal hysterectomy: cefazolin versus cefoxitin versus cefotaxime. American Journal of Obstetrics &amp; Gynecology1987;156(5):1201‐5. ">Hemsell 1987</a>; <a href="./references#CD004637-bbs2-0022" title="HenrikssonL , Colling‐SaltinAS , FrickG , KullanderS , SandholmLE , UrsingJ , et al. Metronidazole prophylaxis to prevent infections after total abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica1998;77(1):116‐9. ">Henriksson 1998</a>; <a href="./references#CD004637-bbs2-0023" title="HolmanJF , McGowanJE , ThompsonJD . Perioperative antibiotics in major elective gynecologic surgery. Southern Medical Journal1978;71(4):417‐20. ">Holman 1978</a>; <a href="./references#CD004637-bbs2-0024" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for Women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. HouangETW , HowellCR , ChapmanM . Ampicillin combined with sulbactam or metronidazole for single‐dose chemoprophylaxis in major gynaecological surgery. Journal of Antimicrobial Chemotherapy1984;14(5):529‐35. [MEDLINE: PBS Workform: MDG form for journal articles] ">Houang 1984</a>; <a href="./references#CD004637-bbs2-0025" title="HouangET . The trials of antibiotic prophylaxis at Chelsea Hospital for women. Journal of Obstetrics &amp; Gynaecology1984;5(Suppl 1):S20‐2. ">Houang 1984a</a>; <a href="./references#CD004637-bbs2-0026" title="JaffeR , AltarasM , FejginM , Ben‐AderetN . Prophylactic single‐dose co‐trimoxazole for prevention of urinary tract infection after abdominal hysterectomy. Chemotherapy1985;31(6):476‐9. ">Jaffe 1985</a>; <a href="./references#CD004637-bbs2-0028" title="KauerFM , WijmaJ , MansonWL . Vaginal hysterectomy: cefuroxime, metronidazole or both?. Pharmaceutisch Weekblad Scientific Edition1990;12(6A):284‐8. ">Kauer 1990</a>; <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>; <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a>; <a href="./references#CD004637-bbs2-0031" title="MathewsDDA , ArgawalV , GordonAM , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during vaginal hysterectomy and repair. British Journal of Obstetrics &amp; Gynaecology1979;86(9):737‐40. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1979</a>; <a href="./references#CD004637-bbs2-0032" title="MendelsonJ , PortnoyJ , DeSaint VictorJR , GelfandMM . Effect of single and multidose cephradine prophylaxis on infectious morbidity of vaginal hysterectomy. Obstetrics &amp; Gynecology1979;53(1):31‐5. ">Mendelson 1979</a>; <a href="./references#CD004637-bbs2-0033" title="PolkBF , TagerIB , ShapiroM , Goren‐WhiteB , GoldsteinP , SchoenbaumSC . Randomised clinical trial of perioperative cefazolin in preventing infection after hysterectomy. Lancet1980;1(8166):437‐40. ">Polk 1980</a>; <a href="./references#CD004637-bbs2-0035" title="SmithARB , StanbridgeTN , MorewoodGA , CooperJ . Double blind trial with a single intramuscular dose of co‐trimoxazole before total abdominal hysterectomy. Journal of Obstetrics &amp; Gynaecology1984;5(1):49‐52. ">Smith 1984</a>; <a href="./references#CD004637-bbs2-0036" title="StageAH , GloverDD , VaughanJE . Low‐dose cephradine prophylaxis in obstetric and gynecologic surgery. Journal of Reproductive Medicine1982;27(3):113‐9. ">Stage 1982</a>; <a href="./references#CD004637-bbs2-0037" title="TiTY , VinceletteJ , AokiF , et al. Randomized clinical trial of prophylactic metronidazole in vaginal hysterectomy. Clinical &amp; Investigative Medicine (Medecine Clinique et Experimentale)1981;4(2). VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Canadian Medical Association Journal1982;127(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , OgilvieRI , RichardsGK , SeymourRJ . Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal hysterectomy. Clinical &amp; Investigative Medicine1981;4(2):119‐23. VinceletteJ , FinkelsteinF , AokiFY , TiTY , OgilvieRI , RichardGK , et al. Double‐blind trial of perioperative intravenous metronidazole prophylaxis for abdominal and vaginal hysterectomy. Surgery1983;93(1II):185‐9. ">Vincelette 1983</a>). The remaining nine studies provided insufficient information to allow conclusive judgements with respect to whether significant differences in baseline demographic characteristics were evident between treatment groups; we thus rated these studies as having unclear risk with respect to other sources of bias (<a href="./references#CD004637-bbs2-0001" title="BenignoBB , EvrardJ , FaroS , FordLC , LaCroixG , LawrenceWD , et al. A comparison of piperacillin, cephalothin and cefoxitin in the prevention of postoperative infections in patients undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1986;163(5):421‐7. ">Benigno 1986</a>; <a href="./references#CD004637-bbs2-0005" title="DaviE , AusinJ , EscofetC , et al. Cefoxitin versus placebo in the prophylaxis of postoperative infection in abdominal hysterectomy [abstract]. Archives of Gynecology1985;237(Suppl). ">Davi 1985</a>; <a href="./references#CD004637-bbs2-0011" title="FaroS , PastorekJG , AldridgeKE , NicaudS , CunninghamG . Randomized double‐blind comparison of mezlocillin versus cefoxitin prophylaxis for vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1988;166(5):431‐5. ">Faro 1988</a>; <a href="./references#CD004637-bbs2-0014" title="HedicanREJr , SartoGE . Use of prophylactic antibiotic and vaginal cuff inflammation. Journal of the Iowa Medical Society1976;66(9):373‐4, 378. ">Hedican 1976</a>; <a href="./references#CD004637-bbs2-0018" title="HemsellDL , HemsellPG , HeardML , NoblesBJ . Preoperative cefoxitin prophylaxis for elective abdominal hysterectomy. American Journal of Obstetrics &amp; Gynecology1985;153(2):225‐6. ">Hemsell 1985</a>; <a href="./references#CD004637-bbs2-0019" title="HemsellDL , HemsellPG , NoblesBJ . Doxycycline and cefamandole prophylaxis for premenopausal women undergoing vaginal hysterectomy. Surgery Gynecology &amp; Obstetrics1985;161(5):462‐4. ">Hemsell 1985a</a>; <a href="./references#CD004637-bbs2-0021" title="HemsellDL , JohnsonER , HeardMC , HemsellPG , NoblesBJ , BawdonRE . Single‐dose piperacillin versus triple‐dose cefoxitin prophylaxis at vaginal and abdominal hysterectomy. Southern Medical Journal1989;82(4):438‐42. ">Hemsell 1989</a>; <a href="./references#CD004637-bbs2-0027" title="JanssensD , PeetersN , SauwaertE , CatterselB . Tinidazole in the prevention of post‐operative wound infection after hysterectomy. Journal of Antimicrobial Chemotherapy1982;10(Suppl. A):87‐94. ">Janssens 1982</a>; <a href="./references#CD004637-bbs2-0034" title="SchepersJP , MerkusF . Cefoxitin sodium: double‐blind, placebo‐controlled prophylactic study in premenopausal patients undergoing abdominal hysterectomy. Clinical Pharmacology &amp; Therapeutics1981;29(2):230‐90. ">Schepers 1981</a>). </p> </section> </section> <section id="CD004637-sec-0071"> <h3 class="title" id="CD004637-sec-0071">Effects of interventions</h3> <p>See: <a href="./full#CD004637-tbl-0001"><b>Summary of findings for the main comparison</b> Antibiotics compared with placebo for prophylaxis in elective vaginal hysterectomy</a>; <a href="./full#CD004637-tbl-0002"><b>Summary of findings 2</b> Antibiotics compared with placebo for prophylaxis in elective abdominal hysterectomy</a>; <a href="./full#CD004637-tbl-0003"><b>Summary of findings 3</b> Head‐to‐head comparisons of antibiotics for prophylaxis in elective vaginal hysterectomy</a>; <a href="./full#CD004637-tbl-0004"><b>Summary of findings 4</b> Head‐to‐head comparisons of antibiotics for prophylaxis in elective abdominal hysterectomy</a> </p> <section id="CD004637-sec-0072"> <h4 class="title">1. Any antibiotics versus placebo</h4> <section id="CD004637-sec-0073"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0074"> <h6 class="title">1.1 Total postoperative infections ‐ early and late</h6> <p>See <a href="./references#CD004637-fig-0018" title="">Analysis 1.1</a>; <a href="#CD004637-fig-0004">Figure 4</a> </p> <div class="figure" id="CD004637-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.1 Total postoperative infections ‐ early and late. </p> </div> </div> </div> <section id="CD004637-sec-0075"> <p><b>1.1.1 Vaginal hysterectomy</b></p> <p>The rate of postoperative infection (early or late) was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.28, 95% CI 0.19 to 0.40; four RCTs, N = 293; I<sup>2</sup> = 85%; low‐quality evidence; <a href="./references#CD004637-fig-0018" title="">Analysis 1.1</a>). Evidence suggests that if the average risk of infection with placebo is assumed to be 62%, the risk following antibiotic prophylaxis would be between 12% and 25%. Although heterogeneity for this comparison was substantial (I<sup>2</sup> = 85%), we did not downgrade the quality of evidence for inconsistency because the direction of effect was consistent and all inconsistency was attributable to <a href="./references#CD004637-bbs2-0029" title="LedgerWJ , SweetRL , HeadingtonJT . Prophylactic cephaloridine in the prevention of postoperative pelvic infections in premenopausal women undergoing vaginal hysterectomy. American Journal of Obstetrics &amp; Gynecology1973;115(6):766‐74. ">Ledger 1973</a>, which measured only early postoperative infection rates (to hospital discharge). The other three studies in this comparison measured both early and late infections. </p> <p>On sensitivity analysis, observed evidence of a difference in the incidence of total postoperative infections between the two groups remained whether odds ratio (OR) (OR 0.13, 95% CI 0.08 to 0.23) or a random‐effects (RE) model (RR 0.19, 95% CI 0.06 to 0.67) was used. </p> </section> <section id="CD004637-sec-0076"> <p><b>1.1.2 Abdominal hysterectomy</b></p> <p>The rate of postoperative infection was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.38, 95% CI 0.21 to 0.67; one RCT, N = 158; low‐quality evidence; <a href="./references#CD004637-fig-0018" title="">Analysis 1.1</a>). Evidence suggests that if the average risk of infection with placebo is assumed to be 39%, risk following antibiotic prophylaxis would be between 8% and 26%. </p> </section> </section> <section id="CD004637-sec-0077"> <h6 class="title">1.2 Abdominal wound infection</h6> <section id="CD004637-sec-0078"> <p><b>1.2.1 Abdominal hysterectomy</b></p> <p>The rate of abdominal wound infection in women who received prophylactic antibiotics was lower than in those given placebo (RR 0.51, 95% CI 0.36 to 0.73; 11 RCTs, N = 2247; I<sup>2</sup> = 6%; moderate‐quality evidence; <a href="./references#CD004637-fig-0019" title="">Analysis 1.2</a>). Evidence suggests that if the average risk of infection with placebo is assumed to be 7%, risk following antibiotic prophylaxis would be between 2% and 5%. </p> </section> </section> <section id="CD004637-sec-0079"> <h6 class="title">1.3 Urinary tract infection</h6> <section id="CD004637-sec-0080"> <p><b>1.3.1 Vaginal hysterectomy</b></p> <p>The rate of urinary tract infection (UTI) in women who received prophylactic antibiotics was lower than in those given placebo (RR 0.58, 95% CI 0.43 to 0.77; eight RCTs, N = 1473; I<sup>2</sup> = 44%; moderate‐quality evidence; <a href="./references#CD004637-fig-0020" title="">Analysis 1.3</a>). Evidence suggests that if the average risk of infection with placebo is assumed to be 13%, risk following antibiotic prophylaxis would be between 6% and 10%. </p> </section> <section id="CD004637-sec-0081"> <p><b>1.3.2 Abdominal hysterectomy</b></p> <p>The rate of UTI was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.41, 95% CI 0.31 to 0.53; 11 RCTs, N = 2705; I<sup>2</sup> = 28%; moderate‐quality evidence; <a href="./references#CD004637-fig-0020" title="">Analysis 1.3</a>). Evidence suggests that if the average risk of infection with placebo is assumed to be 13%, risk following antibiotic prophylaxis would be between 4% and 7%. </p> </section> </section> <section id="CD004637-sec-0082"> <h6 class="title">1.4 Pelvic infection</h6> <section id="CD004637-sec-0083"> <p><b>1.4.1 Vaginal hysterectomy</b></p> <p>The rate of pelvic infection in women who received prophylactic antibiotics was lower than in those given placebo (RR 0.28, 95% CI 0.20 to 0.39; 11 RCTs, N = 1693; I<sup>2</sup> = 57%; moderate‐quality evidence; <a href="./references#CD004637-fig-0021" title="">Analysis 1.4</a>). Evidence suggests that if the average risk of infection with placebo is assumed to be 13%, risk following antibiotic prophylaxis would be between 3% and 5%. Heterogeneity for this comparison was substantial (I<sup>2</sup> = 57%), but we did not downgrade the quality of the evidence for inconsistency, as the direction of effect was consistent. Evidence of a difference in reported cases of pelvic infection persisted whether sensitivity analysis was based on OR (OR 0.17, 95% CI 0.11 to 0.27) or on an RE model (RR 0.22, 95% CI 0.11 to 0.46). </p> </section> <section id="CD004637-sec-0084"> <p><b>1.4.2 Abdominal hysterectomy</b></p> <p>The rate of pelvic infection in women who received prophylactic antibiotics was lower than in those given placebo (RR 0.50, 95% CI 0.35 to 0.71; 11 RCTs, N = 1883; I<sup>2</sup> = 11%; moderate‐quality evidence; <a href="./references#CD004637-fig-0021" title="">Analysis 1.4</a>). Evidence suggests that if the average risk of infection with placebo is assumed to be 8%, risk following antibiotic prophylaxis would be between 3% and 6%. </p> </section> </section> <section id="CD004637-sec-0085"> <h6 class="title">1.5 Other serious infection</h6> <section id="CD004637-sec-0086"> <p><b>1.5.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in the rate of other serious infection (RR 0.20, 95% CI 0.01 to 4.10; one RCT, N = 146; very low‐quality evidence; <a href="./references#CD004637-fig-0022" title="">Analysis 1.5</a>). Evidence suggests that if the average risk of infection with placebo is assumed to be 3%, risk following antibiotic prophylaxis would be between 0% and 11%. </p> </section> <section id="CD004637-sec-0087"> <p><b>1.5.2 Abdominal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups in the rate of other serious infection (RR 0.44, 95% CI 0.12 to 1.69; two RCTs, N = 476; I<sup>2</sup> = 29%; very low‐quality evidence; <a href="./references#CD004637-fig-0022" title="">Analysis 1.5</a>). Evidence suggests that if the risk of other serious infection with placebo is assumed to be 3%, risk following antibiotic prophylaxis would be between 0% and 5%. </p> </section> </section> <section id="CD004637-sec-0088"> <h6 class="title">1.6. Postoperative fever</h6> <section id="CD004637-sec-0089"> <p><b>1.6.1 Vaginal hysterectomy</b></p> <p>The rate of postoperative fever in women who received prophylactic antibiotics was lower than in those given placebo (RR 0.43, 95% CI 0.34 to 0.54; nine RCTs, N = 1562; I<sup>2</sup> = 47%; moderate‐quality evidence; <a href="./references#CD004637-fig-0023" title="">Analysis 1.6</a>). Evidence suggests that if the average risk of postoperative fever with placebo is assumed to be 22%, risk following antibiotic prophylaxis would be between 7% and 12%. </p> </section> <section id="CD004637-sec-0090"> <p><b>1.6.2 Abdominal hysterectomy</b></p> <p>The rate of postoperative fever in women who received prophylactic antibiotics was lower than in those given placebo (RR 0.59, 95% CI 0.50 to 0.70; 11 RCTs, N = 2394; I<sup>2</sup> = 55%; moderate‐quality evidence; <a href="./references#CD004637-fig-0023" title="">Analysis 1.6</a>; <a href="#CD004637-fig-0005">Figure 5</a>). Evidence suggests that if the average risk of postoperative fever with placebo is assumed to be 24%, risk following antibiotic prophylaxis would be between 12% and 17%. Heterogeneity for this comparison was substantial (I<sup>2</sup> = 55%), but we did not downgrade the quality of the evidence for inconsistency, as the direction of effect was consistent. Evidence of a difference in reported cases of postoperative fever persisted whether sensitivity analysis was based on OR (OR 0.50, 95% CI 0.40 to 0.62) or on an RE model (RR 0.55, 95% CI 0.42 to 0.72). </p> <div class="figure" id="CD004637-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.6 Postoperative fever." data-id="CD004637-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.6 Postoperative fever. </p> </div> </div> </div> </section> </section> <section id="CD004637-sec-0091"> <h6 class="title">1.7 Total adverse effects</h6> <p>See <a href="./references#CD004637-fig-0024" title="">Analysis 1.7</a>; <a href="#CD004637-fig-0006">Figure 6</a> </p> <div class="figure" id="CD004637-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.7 Total adverse effects." data-id="CD004637-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.7 Total adverse effects. </p> </div> </div> </div> <section id="CD004637-sec-0092"> <p><b>1.7.1 Vaginal hysterectomy</b></p> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0093"> <p><b>1.7.2 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in the rate of total adverse effects (RR 1.80, 95% CI 0.62 to 5.18; two RCTs, N = 430; I<sup>2</sup> = 0%; very low‐quality evidence; <a href="./references#CD004637-fig-0024" title="">Analysis 1.7</a>). Evidence suggests that if the average risk of total adverse effects with placebo is assumed to be 2%, risk following antibiotic prophylaxis would be between 1% and 12%. </p> </section> </section> </section> <section id="CD004637-sec-0094"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0095"> <h6 class="title">1.8 Need for therapeutic antibiotics</h6> <section id="CD004637-sec-0096"> <p><b>1.8.1 Vaginal hysterectomy</b></p> <p>The rate of need for therapeutic antibiotics was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.51, 95% CI 0.37 to 0.68; six RCTs, N = 1309; I<sup>2</sup> = 30%; <a href="./references#CD004637-fig-0025" title="">Analysis 1.8</a>). </p> </section> <section id="CD004637-sec-0097"> <p><b>1.8.2 Abdominal hysterectomy</b></p> <p>The rate of need for therapeutic antibiotics was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.74, 95% CI 0.59 to 0.93; six RCTs, N = 1359; I<sup>2</sup> = 34%; <a href="./references#CD004637-fig-0025" title="">Analysis 1.8</a>). </p> </section> </section> <section id="CD004637-sec-0098"> <h6 class="title">1.9 Length of hospital stay</h6> <section id="CD004637-sec-0099"> <p><b>1.9.1 Vaginal hysterectomy</b></p> <p>Mean length of hospital stay was shorter in women who received prophylactic antibiotics than in those given placebo (MD ‐1.35 days, 95% CI ‐1.78 to ‐0.92; four RCTs, N = 853; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0026" title="">Analysis 1.9</a>). </p> </section> <section id="CD004637-sec-0100"> <p><b>1.9.2 Abdominal hysterectomy</b></p> <p>Mean length of hospital stay was shorter in women who received prophylactic antibiotics than in those given placebo (MD ‐0.59 days, 95% CI ‐0.76 to ‐0.43; seven RCTs, N = 1510; I<sup>2</sup> = 87%; <a href="./references#CD004637-fig-0026" title="">Analysis 1.9</a>). We explored the presence of significant heterogeneity. </p> </section> </section> </section> </section> <section id="CD004637-sec-0101"> <h4 class="title">2. Cephalosporin versus placebo</h4> <section id="CD004637-sec-0102"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0103"> <h6 class="title">2.1 Total postoperative infections ‐ early and late</h6> <section id="CD004637-sec-0104"> <p><b>2.1.1 Vaginal hysterectomy</b></p> <p>The total postoperative infection rate was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.29, 95% CI 0.20 to 0.42; three RCTs, N = 265; I<sup>2</sup> = 89%; <a href="./references#CD004637-fig-0027" title="">Analysis 2.1</a>; <a href="#CD004637-fig-0007">Figure 7</a>). Although heterogeneity among studies was substantial, the directions of effect estimates for individual studies were consistent. In addition, we examined the presence of heterogeneity using sensitivity analysis. The observed difference in outcomes between the two groups remained whether sensitivity analysis was based on OR (OR 0.14, 95% CI 0.08 to 0.24) or on an RE model (RR 0.19, 95% CI 0.04 to 0.88), and more cases of total postoperative infection were reported in women in the placebo group in both analyses. </p> <div class="figure" id="CD004637-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Cephalosporin versus placebo, outcome: 2.1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Cephalosporin versus placebo, outcome: 2.1 Total postoperative infections ‐ early and late. </p> </div> </div> </div> </section> </section> <section id="CD004637-sec-0105"> <h6 class="title">2.2 Abdominal wound infection</h6> <section id="CD004637-sec-0106"> <p><b>2.2.1 Abdominal hysterectomy</b></p> <p>The rate of abdominal wound infection was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.41, 95% CI 0.25 to 0.66; seven RCTs, N = 1528; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0028" title="">Analysis 2.2</a>). </p> </section> </section> <section id="CD004637-sec-0107"> <h6 class="title">2.3 Urinary tract infection</h6> <section id="CD004637-sec-0108"> <p><b>2.3.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in the rate of UTI (RR 0.71, 95% CI 0.46 to 1.08; five RCTs, N = 499; I<sup>2</sup> = 31%; <a href="./references#CD004637-fig-0029" title="">Analysis 2.3</a>). </p> </section> <section id="CD004637-sec-0109"> <p><b>2.3.2 Abdominal hysterectomy</b></p> <p>The rate of UTI was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.42, 95% CI 0.31 to 0.58; six RCTs, N = 1668; I<sup>2</sup> = 25%; <a href="./references#CD004637-fig-0029" title="">Analysis 2.3</a>). </p> </section> </section> <section id="CD004637-sec-0110"> <h6 class="title">2.4 Pelvic infection</h6> <section id="CD004637-sec-0111"> <p><b>2.4.1 Vaginal hysterectomy</b></p> <p>The rate of pelvic infection was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.15, 95% CI 0.09 to 0.28; six RCTs, N = 1281; I<sup>2</sup> = 8%; <a href="./references#CD004637-fig-0030" title="">Analysis 2.4</a>). </p> </section> <section id="CD004637-sec-0112"> <p><b>2.4.2 Abdominal hysterectomy</b></p> <p>The rate of pelvic infection was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.60, 95% CI 0.39 to 0.93; seven RCTs, N = 1528; I<sup>2</sup> = 3%; <a href="./references#CD004637-fig-0030" title="">Analysis 2.4</a>). </p> </section> </section> <section id="CD004637-sec-0113"> <h6 class="title">2.5 Other serious infection</h6> <section id="CD004637-sec-0114"> <p><b>2.5.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in the rate of other serious infection (RR 0.20, 95% CI 0.01 to 4.12; one RCT, N = 206; <a href="./references#CD004637-fig-0031" title="">Analysis 2.5</a>). </p> </section> <section id="CD004637-sec-0115"> <p><b>2.5.2 Abdominal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups in the rate of other serious infection (RR 0.33, 95% CI 0.04 to 3.16; one RCT, N = 220; <a href="./references#CD004637-fig-0031" title="">Analysis 2.5</a>). </p> </section> </section> <section id="CD004637-sec-0116"> <h6 class="title">2.6 Postoperative fever</h6> <section id="CD004637-sec-0117"> <p><b>2.6.1 Vaginal hysterectomy</b></p> <p>The rate of postoperative fever was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.37, 95% CI 0.25 to 0.54; five RCTs, N = 1028; I<sup>2</sup> = 71%; <a href="./references#CD004637-fig-0032" title="">Analysis 2.6</a>; <a href="#CD004637-fig-0008">Figure 8</a>). Direction of effect estimates in all five studies were consistent. We investigated the presence of significant heterogeneity using sensitivity analysis. The observed difference in outcomes between the two groups persisted whether sensitivity analysis was based on OR (OR 0.29, 95% CI 0.18 to 0.47) or on an RE model (RR 0.34, 95% CI 0.15 to 0.78), and more women in the placebo group were given the diagnosis of postoperative fever. </p> <div class="figure" id="CD004637-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Cephalosporin versus placebo, outcome: 2.6 Postoperative fever." data-id="CD004637-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Cephalosporin versus placebo, outcome: 2.6 Postoperative fever. </p> </div> </div> </div> </section> <section id="CD004637-sec-0118"> <p><b>2.6.2 Abdominal hysterectomy</b></p> <p>The rate of postoperative fever was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.62, 95% CI 0.49 to 0.77; six RCTs, N = 1463; I<sup>2</sup> = 43%; <a href="./references#CD004637-fig-0032" title="">Analysis 2.6</a>). </p> </section> </section> <section id="CD004637-sec-0119"> <h6 class="title">2.7 Total adverse effects</h6> <section id="CD004637-sec-0120"> <p><b>2.7.1 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in the rate of adverse effects (RR 1.00, 95% CI 0.06 to 15.83; one RCT, N = 284; <a href="./references#CD004637-fig-0033" title="">Analysis 2.7</a>). </p> </section> </section> </section> <section id="CD004637-sec-0121"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0122"> <h6 class="title">2.8 Need for therapeutic antibiotics</h6> <section id="CD004637-sec-0123"> <p><b>2.8.1 Vaginal hysterectomy</b></p> <p>The rate of need for therapeutic antibiotics in women who received prophylactic antibiotics was lower than in those given placebo (RR 0.55, 95% CI 0.37 to 0.81; three RCTs, N = 863; I<sup>2</sup> = 36%; <a href="./references#CD004637-fig-0034" title="">Analysis 2.8</a>). </p> </section> <section id="CD004637-sec-0124"> <p><b>2.8.2 Abdominal hysterectomy</b></p> <p>We found no conclusive evidence of a difference between groups in the number of women requiring therapeutic antibiotics, although data suggest benefit for the antibiotic prophylaxis group (RR 0.79, 95% CI 0.61 to 1.01; four RCTs, N = 1138; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0034" title="">Analysis 2.8</a>). </p> </section> </section> <section id="CD004637-sec-0125"> <h6 class="title">2.9 Length of hospital stay</h6> <section id="CD004637-sec-0126"> <p><b>2.9.1 Vaginal hysterectomy</b></p> <p>Mean length of hospital stay was shorter in women who received prophylactic antibiotics than in those given placebo (MD ‐1.30 days, 95% CI ‐1.88 to ‐0.72; two RCTs, N = 657; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0035" title="">Analysis 2.9</a>). </p> </section> <section id="CD004637-sec-0127"> <p><b>2.9.2 Abdominal hysterectomy</b></p> <p>Mean length of hospital stay was shorter in women who received prophylactic antibiotics than in those given placebo (MD ‐0.43 days, 95% CI ‐0.67 to ‐0.19; four RCTs, N = 818; I<sup>2</sup> = 63%; <a href="./references#CD004637-fig-0035" title="">Analysis 2.9</a>). Four studies showed consistency in direction of effect estimates. In addition, we found evidence that a difference in length of hospital stay between the two groups persisted when we subjected the evidence to sensitivity analysis based on an RE model (MD ‐0.54, 95% CI ‐1.04 to ‐0.05), and that women in the placebo group stayed longer in hospital than those in the cephalosporin group. </p> </section> </section> </section> </section> <section id="CD004637-sec-0128"> <h4 class="title">3. Penicillin versus placebo</h4> <section id="CD004637-sec-0129"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0130"> <h6 class="title">3.1 Total postoperative infections ‐ early and late</h6> <section id="CD004637-sec-0131"> <p><b>3.1.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in the incidence of total postoperative infections (early and late) (RR 0.20, 95% CI 0.03 to 1.42; one RCT, N = 20; <a href="./references#CD004637-fig-0036" title="">Analysis 3.1</a>). </p> </section> <section id="CD004637-sec-0132"> <p><b>3.1.2 Abdominal hysterectomy</b></p> <p>The total infection rate was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.30, 95% CI 0.13 to 0.70; one RCT, N = 100; <a href="./references#CD004637-fig-0036" title="">Analysis 3.1</a>). </p> </section> </section> <section id="CD004637-sec-0133"> <h6 class="title">3.2 Abdominal wound infection</h6> <section id="CD004637-sec-0134"> <p><b>3.2.1 Abdominal hysterectomy</b></p> <p>The rate of abdominal wound infection was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.16, 95% CI 0.05 to 0.53; two RCTs, N = 320; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0037" title="">Analysis 3.2</a>). </p> </section> </section> <section id="CD004637-sec-0135"> <h6 class="title">3.3 Urinary tract infection</h6> <section id="CD004637-sec-0136"> <p><b>3.3.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups in the rate of UTI (RR 0.50, 95% CI 0.05 to 4.67; one RCT, N = 20; <a href="./references#CD004637-fig-0038" title="">Analysis 3.3</a>). </p> </section> <section id="CD004637-sec-0137"> <p><b>3.3.2 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in the rate of UTI (RR 0.60, 95% CI 0.21 to 1.76; two RCTs, N = 320; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0038" title="">Analysis 3.3</a>). </p> </section> </section> <section id="CD004637-sec-0138"> <h6 class="title">3.4 Pelvic infection</h6> <section id="CD004637-sec-0139"> <p><b>3.4.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in the rate of pelvic infection (RR 0.14, 95% CI 0.01 to 2.45; one RCT, N = 20; <a href="./references#CD004637-fig-0039" title="">Analysis 3.4</a>). </p> </section> <section id="CD004637-sec-0140"> <p><b>3.4.2 Abdominal hysterectomy</b></p> <p>The rate of pelvic infection was lower in women who received prophylactic antibiotics than in those given placebo (RR 1.33, 95% CI 0.31 to 5.82; one RCT, N = 220; <a href="./references#CD004637-fig-0039" title="">Analysis 3.4</a>). </p> </section> </section> <section id="CD004637-sec-0141"> <h6 class="title">3.5 Other serious infection</h6> <section id="CD004637-sec-0142"> <p><b>3.5.1 Abdominal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups in the rate of other serious infection (RR 0.14, 95% CI 0.01 to 2.73; one RCT, N = 220; <a href="./references#CD004637-fig-0040" title="">Analysis 3.5</a>). </p> </section> </section> <section id="CD004637-sec-0143"> <h6 class="title">3.6 Postoperative fever</h6> <section id="CD004637-sec-0144"> <p><b>3.6.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in the rate of postoperative fever (RR 0.14, 95% CI 0.01 to 2.45; one RCT, N = 20; <a href="./references#CD004637-fig-0041" title="">Analysis 3.6</a>; <a href="#CD004637-fig-0009">Figure 9</a>). </p> <div class="figure" id="CD004637-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 3 Penicillin versus placebo, outcome: 3.6 Postoperative fever." data-id="CD004637-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 3 Penicillin versus placebo, outcome: 3.6 Postoperative fever. </p> </div> </div> </div> </section> <section id="CD004637-sec-0145"> <p><b>3.6.2 Abdominal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups in the rate of postoperative fever (RR 0.65, 95% CI 0.35 to 1.20; two RCTs, N = 320; I<sup>2</sup> = 82%; <a href="./references#CD004637-fig-0041" title="">Analysis 3.6</a>). Heterogeneity for this comparison was substantial (I<sup>2</sup> = 82%) with inconsistency in the direction of effects for the two studies. Evidence of no difference in reported cases of postoperative fever persisted whether sensitivity analysis was based on OR (OR 0.61, 95% CI 0.31 to 1.22) or on an RE model (RR 0.38, 95% CI 0.03 to 4.51). </p> </section> </section> <section id="CD004637-sec-0146"> <h6 class="title">3.7 Total adverse effects</h6> <p>Investigators provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0147"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0148"> <h6 class="title">3.8 Need for therapeutic antibiotics</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0149"> <h6 class="title">3.9 Length of hospital stay</h6> <p>Investigators provided no data for this outcome.</p> </section> </section> </section> <section id="CD004637-sec-0150"> <h4 class="title">4. Antiprotozoal versus placebo</h4> <section id="CD004637-sec-0151"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0152"> <h6 class="title">4.1 Total postoperative infections ‐ early and late</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0153"> <h6 class="title">4.2 Abdominal wound infection</h6> <section id="CD004637-sec-0154"> <p><b>4.2.1 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in rates of abdominal wound infection (RR 0.71, 95% CI 0.32 to 1.57; two RCTs, N = 462; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0042" title="">Analysis 4.1</a>). </p> </section> </section> <section id="CD004637-sec-0155"> <h6 class="title">4.3 Urinary tract infection</h6> <section id="CD004637-sec-0156"> <p><b>4.3.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups in rates of UTI (RR 1.25, 95% CI 0.51 to 3.04; one RCT, N = 226; I<sup>2</sup> = 75%; <a href="./references#CD004637-fig-0043" title="">Analysis 4.2</a>). </p> </section> <section id="CD004637-sec-0157"> <p><b>4.3.2 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in rates of UTI (RR 1.00, 95% CI 0.34 to 2.96; one RCT, N = 146; <a href="./references#CD004637-fig-0043" title="">Analysis 4.2</a>). </p> </section> </section> <section id="CD004637-sec-0158"> <h6 class="title">4.4 Pelvic infection</h6> <section id="CD004637-sec-0159"> <p><b>4.4.1 Vaginal hysterectomy</b></p> <p>The rate of pelvic infection was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.36, 95% CI 0.17 to 0.75; four RCTs, N = 375; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0044" title="">Analysis 4.3</a>). </p> </section> <section id="CD004637-sec-0160"> <p><b>4.4.2 Abdominal hysterectomy</b></p> <p>The rate of pelvic infection was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.42, 95% CI 0.22 to 0.83; four RCTs, N = 662; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0044" title="">Analysis 4.3</a>). </p> </section> </section> <section id="CD004637-sec-0161"> <h6 class="title">4.5 Other serious infection</h6> <section id="CD004637-sec-0162"> <p><b>4.5.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups in rates of other serious infection (RR 0.25, 95% CI 0.03 to 2.21; two RCTs, N = 246; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0045" title="">Analysis 4.4</a>). </p> </section> <section id="CD004637-sec-0163"> <p><b>4.5.2 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in rates of other serious infection (RR 1.00, 95% CI 0.14 to 6.91; one RCT, N = 146; <a href="./references#CD004637-fig-0045" title="">Analysis 4.4</a>). </p> </section> </section> <section id="CD004637-sec-0164"> <h6 class="title">4.6 Postoperative fever</h6> <section id="CD004637-sec-0165"> <p><b>4.6.1 Vaginal hysterectomy</b></p> <p>The rate of postoperative fever was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.45, 95% CI 0.21 to 0.97; two RCTs, N = 130; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0046" title="">Analysis 4.5</a>; <a href="#CD004637-fig-0010">Figure 10</a>). </p> <div class="figure" id="CD004637-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 4 Antiprotozoal versus placebo, outcome: 4.5 Postoperative fever." data-id="CD004637-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG10.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 4 Antiprotozoal versus placebo, outcome: 4.5 Postoperative fever. </p> </div> </div> </div> </section> <section id="CD004637-sec-0166"> <p><b>4.6.2 Abdominal hysterectomy</b></p> <p>The rate of postoperative fever was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.39, 95% CI 0.18 to 0.85; one RCT, N = 100; <a href="./references#CD004637-fig-0046" title="">Analysis 4.5</a>). </p> </section> </section> <section id="CD004637-sec-0167"> <h6 class="title">4.7 Total adverse effects</h6> <section id="CD004637-sec-0168"> <p><b>4.7.1 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed differences between groups in rates of adverse effects (RR 2.00, 95% CI 0.63 to 6.35; one RCT, N = 146; <a href="./references#CD004637-fig-0047" title="">Analysis 4.6</a>). </p> </section> </section> </section> <section id="CD004637-sec-0169"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0170"> <h6 class="title">4.8 Need for therapeutic antibiotics</h6> <section id="CD004637-sec-0171"> <p><b>4.8.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups in the need for therapeutic antibiotics (RR 0.58, 95% CI 0.29 to 1.15; two RCTs, N = 196; I<sup>2</sup> = 67%; <a href="./references#CD004637-fig-0048" title="">Analysis 4.7</a>). Findings did not change whether sensitivity analysis was based on OR (OR 0.52, 95% CI 0.24 to 1.17) or on an RE model (RR 0.55, 95% CI 0.15 to 1.95). </p> </section> <section id="CD004637-sec-0172"> <p><b>4.8.2 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in the need for therapeutic antibiotics (RR 0.62, 95% CI 0.36 to 1.06; two RCTs, N = 246; I<sup>2</sup> = 78%; <a href="./references#CD004637-fig-0048" title="">Analysis 4.7</a>). Findings did not change whether sensitivity analysis was based on OR (OR 0.56, 95% CI 0.30 to 1.07) or on an RE model (RR 0.55, 95% CI 0.15 to 2.02). </p> </section> </section> <section id="CD004637-sec-0173"> <h6 class="title">4.9 Length of hospital stay</h6> <section id="CD004637-sec-0174"> <p><b>4.9.1 Vaginal hysterectomy</b></p> <p>Mean length of hospital stay was shorter in women who received prophylactic antibiotics than in those given placebo (MD ‐0.86 days, 95% CI ‐1.22 to ‐0.49; three RCTs, N = 276; I<sup>2</sup> = 63%; <a href="./references#CD004637-fig-0049" title="">Analysis 4.8</a>). Direction of effect estimates were consistent in the three studies. Evidence of a difference in outcome between the two groups persisted when subjected to sensitivity analysis based on an RE model (MD ‐0.97, 95% CI ‐1.72 to ‐0.23), with women in the placebo group staying longer in hospital than those in the antiprotozoal group. </p> </section> <section id="CD004637-sec-0175"> <p><b>4.9.2 Abdominal hysterectomy</b></p> <p>Mean length of hospital stay was shorter in women who received prophylactic antibiotics than in those given placebo (MD ‐1.33 days, 95% CI ‐1.68 to ‐0.97; three RCTs; N = 358; I<sup>2</sup> = 89%; <a href="./references#CD004637-fig-0049" title="">Analysis 4.8</a>). Direction of effect estimates of individual studies were not consistent. We investigated the presence of significant heterogeneity and found no evidence of a difference in outcome between the two groups when an RE model (MD ‐0.93, 95% CI ‐2.12 to 0.26) was used. </p> </section> </section> </section> </section> <section id="CD004637-sec-0176"> <h4 class="title">5. Sulphonamides versus placebo</h4> <section id="CD004637-sec-0177"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0178"> <h6 class="title">5.1 Total postoperative infections ‐ early and late</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0179"> <h6 class="title">5.2 Abdominal wound infection</h6> <section id="CD004637-sec-0180"> <p><b>5.2.1 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in rates of abdominal wound infection (RR 1.23, 95% CI 0.35 to 4.35; two RCTs, N = 119; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0050" title="">Analysis 5.1</a>). </p> </section> </section> <section id="CD004637-sec-0181"> <h6 class="title">5.3 Urinary tract infection</h6> <section id="CD004637-sec-0182"> <p><b>5.3.1 Vaginal hysterectomy</b></p> <p>The rate of UTI was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.36, 95% CI 0.15 to 0.84; one RCT, N = 50; <a href="./references#CD004637-fig-0051" title="">Analysis 5.2</a>). </p> </section> <section id="CD004637-sec-0183"> <p><b>5.3.2 Abdominal hysterectomy</b></p> <p>The rate of UTI was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.18, 95% CI 0.06 to 0.50; two RCTs, N = 157; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0051" title="">Analysis 5.2</a>). </p> </section> </section> <section id="CD004637-sec-0184"> <h6 class="title">5.4 Pelvic infection</h6> <section id="CD004637-sec-0185"> <p><b>5.4.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups in rates of pelvic infection (RR 0.14, 95% CI 0.01 to 2.63; one RCT, N = 50; <a href="./references#CD004637-fig-0052" title="">Analysis 5.3</a>). </p> </section> <section id="CD004637-sec-0186"> <p><b>5.4.2 Abdominal hysterectomy</b></p> <p>The rate of pelvic infection was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.11, 95% CI 0.01 to 0.84; two RCTs, N = 119; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0052" title="">Analysis 5.3</a>). </p> </section> </section> <section id="CD004637-sec-0187"> <h6 class="title">5.5 Other serious infection</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0188"> <h6 class="title">5.6 Postoperative fever</h6> <section id="CD004637-sec-0189"> <p><b>5.6.1 Vaginal hysterectomy</b></p> <p>The rate of postoperative fever was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.50, 95% CI 0.26 to 0.95; one RCT, N = 50; <a href="./references#CD004637-fig-0053" title="">Analysis 5.4</a>). </p> </section> <section id="CD004637-sec-0190"> <p><b>5.6.2 Abdominal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups in the numbers of women with a diagnosis of postoperative fever (RR 0.63, 95% CI 0.38 to 1.04; two RCTs, N = 157; I<sup>2</sup> = 69%; <a href="./references#CD004637-fig-0053" title="">Analysis 5.4</a>). Direction of effect estimates were consistent across studies. We examined the presence of significant heterogeneity using sensitivity analysis; whether sensitivity analysis was based on OR (OR 0.51, 95% CI 0.25 to 1.05) or an RE model (RR 0.63, 95% CI 0.24 to 1.62) did not substantially influence the findings. </p> </section> </section> <section id="CD004637-sec-0191"> <h6 class="title">5.7 Total adverse effects</h6> <p>Investigators provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0192"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0193"> <h6 class="title">5.8 Need for therapeutic antibiotics</h6> <section id="CD004637-sec-0194"> <p><b>5.8.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups in the need for therapeutic antibiotics as the study that reported on this outcome did not find any evidence of a difference <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a> (RR 0.33, 95% CI 0.10 to 1.09; one RCT, N = 50). </p> </section> <section id="CD004637-sec-0195"> <p><b>5.8.2 Abdominal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups in the need for therapeutic antibiotics as the study that reported on this outcome did not find any evidence of a difference <a href="./references#CD004637-bbs2-0030" title="MathewsDDR , CooperJ . A double‐blind trial of single‐dose chemoprophylaxis with co‐trimoxazole during total abdominal hysterectomy. British Journal of Obstetrics &amp; Gynaecology1977;84(12):894‐7. [MEDLINE: PBS Workform: MDG form for journal articles] ">Mathews 1977</a> (RR 0.97, 95% CI 0.15 to 6.41; one RCT, N = 59). </p> </section> </section> <section id="CD004637-sec-0196"> <h6 class="title">5.9 Length of hospital stay</h6> <p>Investigators provided no data for this outcome.</p> </section> </section> </section> <section id="CD004637-sec-0197"> <h4 class="title">6. Cephalosporin plus antiprotozoal versus placebo</h4> <section id="CD004637-sec-0198"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0199"> <h6 class="title">6.1 Total postoperative infections ‐ early and late</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0200"> <h6 class="title">6.2 Abdominal wound infection</h6> <section id="CD004637-sec-0201"> <p><b>6.2.1 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 1.00, 95% CI 0.14 to 7.03; two RCTs, N = 406; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0055" title="">Analysis 6.1</a>). </p> </section> </section> <section id="CD004637-sec-0202"> <h6 class="title">6.3 Urinary tract infection</h6> <section id="CD004637-sec-0203"> <p><b>6.3.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.50, 95% CI 0.24 to 1.04; one RCT, N = 406; <a href="./references#CD004637-fig-0056" title="">Analysis 6.2</a>). </p> </section> <section id="CD004637-sec-0204"> <p><b>6.3.2 Abdominal hysterectomy</b></p> <p>The rate of urinary tract infection was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.27, 95% CI 0.08 to 0.96; one RCT, N = 406; <a href="./references#CD004637-fig-0056" title="">Analysis 6.2</a>). </p> </section> </section> <section id="CD004637-sec-0205"> <h6 class="title">6.4 Pelvic infection</h6> <section id="CD004637-sec-0206"> <p><b>6.4.1 Vaginal hysterectomy</b></p> <p>The rate of pelvic infection was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.05, 95% CI 0.01 to 0.37; one RCT, N = 406; <a href="./references#CD004637-fig-0057" title="">Analysis 6.3</a>). </p> </section> </section> <section id="CD004637-sec-0207"> <h6 class="title">6.5 Other serious infection</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0208"> <h6 class="title">6.6 Postoperative fever</h6> <section id="CD004637-sec-0209"> <p><b>6.6.1 Vaginal hysterectomy</b></p> <p>The rate of postoperative fever was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.50, 95% CI 0.34 to 0.73; one RCT, N = 406; <a href="./references#CD004637-fig-0058" title="">Analysis 6.4</a>). </p> </section> <section id="CD004637-sec-0210"> <p><b>6.6.2 Abdominal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.79, 95% CI 0.58 to 1.09; one RCT, N = 406; <a href="./references#CD004637-fig-0058" title="">Analysis 6.4</a>). </p> </section> </section> <section id="CD004637-sec-0211"> <h6 class="title">6.7 Total adverse effects</h6> <p>Investigators provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0212"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0213"> <h6 class="title">6.8 Need for therapeutic antibiotics</h6> <section id="CD004637-sec-0214"> <p><b>6.8.1 Vaginal hysterectomy</b></p> <p>The rate of need for therapeutic antibiotics was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.36, 95% CI 0.19 to 0.68; one RCT, N = 406; <a href="./references#CD004637-fig-0059" title="">Analysis 6.5</a>). </p> </section> <section id="CD004637-sec-0215"> <p><b>6.8.2 Abdominal hysterectomy</b></p> <p>The rate of need for therapeutic antibiotics was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.38, 95% CI 0.15 to 0.94; one RCT, N = 406; <a href="./references#CD004637-fig-0059" title="">Analysis 6.5</a>). </p> </section> </section> <section id="CD004637-sec-0216"> <h6 class="title">6.9 Length of hospital stay</h6> <section id="CD004637-sec-0217"> <p><b>6.9.1 Abdominal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (MD ‐0.30 days, 95% CI ‐0.60 to ‐0.00; one RCT, N = 406; <a href="./references#CD004637-fig-0060" title="">Analysis 6.6</a>). </p> </section> </section> </section> </section> <section id="CD004637-sec-0218"> <h4 class="title">7. Penicillin plus antiprotozoal versus placebo</h4> <section id="CD004637-sec-0219"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0220"> <h6 class="title">7.1 Total postoperative infections ‐ early and late</h6> <section id="CD004637-sec-0221"> <p><b>7.1.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.25, 95% CI 0.04 to 1.73; one RCT, n 18; <a href="./references#CD004637-fig-0061" title="">Analysis 7.1</a>). </p> </section> <section id="CD004637-sec-0222"> <p><b>7.1.2 Abdominal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.44, 95% CI 0.23 to 0.86; one RCT, N = 107; <a href="./references#CD004637-fig-0061" title="">Analysis 7.1</a>). </p> </section> </section> <section id="CD004637-sec-0223"> <h6 class="title">7.2 Abdominal wound infection</h6> <section id="CD004637-sec-0224"> <p><b>7.2.1 Abdominal hysterectomy</b></p> <p>The rate of abdominal wound infection was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.14, 95% CI 0.03 to 0.60; one RCT, N = 107; <a href="./references#CD004637-fig-0062" title="">Analysis 7.2</a>). </p> </section> </section> <section id="CD004637-sec-0225"> <h6 class="title">7.3 Urinary tract infection</h6> <section id="CD004637-sec-0226"> <p><b>7.3.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.63, 95% CI 0.07 to 5.72; one RCT, n = 18; <a href="./references#CD004637-fig-0063" title="">Analysis 7.3</a>). </p> </section> <section id="CD004637-sec-0227"> <p><b>7.3.2 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.97, 95% CI 0.38 to 2.47; one RCT, N = 107; <a href="./references#CD004637-fig-0063" title="">Analysis 7.3</a>). </p> </section> </section> <section id="CD004637-sec-0228"> <h6 class="title">7.4 Pelvic infection</h6> <section id="CD004637-sec-0229"> <p><b>7.4.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.17, 95% CI 0.01 to 2.96; one RCT, N = 18; <a href="./references#CD004637-fig-0064" title="">Analysis 7.4</a>). </p> </section> </section> <section id="CD004637-sec-0230"> <h6 class="title">7.5 Other serious infection</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0231"> <h6 class="title">7.6 Postoperative fever</h6> <section id="CD004637-sec-0232"> <p><b>7.6.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.17, 95% CI 0.01 to 2.96; one RCT, N = 18; <a href="./references#CD004637-fig-0065" title="">Analysis 7.5</a>). </p> </section> <section id="CD004637-sec-0233"> <p><b>7.6.2 Abdominal hysterectomy</b></p> <p>The rate of postoperative fever was lower in women who received prophylactic antibiotics than in those given placebo (RR 0.08, 95% CI 0.01 to 0.64; one RCT, N = 107; <a href="./references#CD004637-fig-0065" title="">Analysis 7.5</a>). </p> </section> </section> <section id="CD004637-sec-0234"> <h6 class="title">7.7 Total adverse effects</h6> <p>Researchers provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0235"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0236"> <h6 class="title">7.8 Need for therapeutic antibiotics</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0237"> <h6 class="title">7.9 Length of hospital stay</h6> <p>Researchers provided no data for this outcome.</p> </section> </section> </section> <section id="CD004637-sec-0238"> <h4 class="title">8. Lincosamide versus placebo</h4> <section id="CD004637-sec-0239"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0240"> <h6 class="title">8.1 Total postoperative infections ‐ early and late</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0241"> <h6 class="title">8.2 Abdominal wound infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0242"> <h6 class="title">8.3 Urinary tract infection</h6> <section id="CD004637-sec-0243"> <p><b>8.3.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups (RR 0.71, 95% CI 0.25 to 2.06; one RCT, N = 80; <a href="./references#CD004637-fig-0066" title="">Analysis 8.1</a>). </p> </section> </section> <section id="CD004637-sec-0244"> <h6 class="title">8.4 Pelvic infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0245"> <h6 class="title">8.5 Other serious infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0246"> <h6 class="title">8.6 Postoperative fever</h6> <section id="CD004637-sec-0247"> <p><b>8.6.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 1.00, 95% CI 0.06 to 15.44; one RCT, N = 80; <a href="./references#CD004637-fig-0067" title="">Analysis 8.2</a>). </p> </section> </section> <section id="CD004637-sec-0248"> <h6 class="title">8.7 Total adverse effects</h6> <p>Researchers provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0249"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0250"> <h6 class="title">8.8 Need for therapeutic antibiotics</h6> <p>Researchers provided no data for this outcome<b>.</b> </p> </section> <section id="CD004637-sec-0251"> <h6 class="title">8.9 Length of hospital stay</h6> <section id="CD004637-sec-0252"> <p><b>8.9.1 Vaginal hysterectomy</b></p> <p>Evidence showed a difference in length of hospital stay between the two treatment groups, with women in the placebo group staying longer in hospital than those in the lincosamide group (MD ‐0.40, 95% CI ‐0.77 to ‐0.03; one RCT, N = 80; <a href="./references#CD004637-fig-0068" title="">Analysis 8.3</a>). </p> </section> </section> </section> </section> <section id="CD004637-sec-0253"> <h4 class="title">9. Cephalosporin versus penicillin</h4> <section id="CD004637-sec-0254"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0255"> <h6 class="title">9.1 Total postoperative infections ‐ early and late</h6> <section id="CD004637-sec-0256"> <p><b>9.1.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 1.04, 95% CI 0.55 to 2.00; two RCTs, N = 470; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0069" title="">Analysis 9.1</a>; <a href="#CD004637-fig-0011">Figure 11</a>). </p> <div class="figure" id="CD004637-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 9 Cephalosporin versus penicillin, outcome: 9.1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG11.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 9 Cephalosporin versus penicillin, outcome: 9.1 Total postoperative infections ‐ early and late. </p> </div> </div> </div> </section> </section> <section id="CD004637-sec-0257"> <h6 class="title">9.2 Abdominal wound infection</h6> <section id="CD004637-sec-0258"> <p><b>9.2.1 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.33, 95% CI 0.01 to 8.09; one RCT, N = 220; <a href="./references#CD004637-fig-0070" title="">Analysis 9.2</a>). </p> </section> </section> <section id="CD004637-sec-0259"> <h6 class="title">9.3 Urinary tract infection</h6> <section id="CD004637-sec-0260"> <p><b>9.3.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.20, 95% CI 0.01 to 3.98; one RCT, N = 95; <a href="./references#CD004637-fig-0071" title="">Analysis 9.3</a>). </p> </section> <section id="CD004637-sec-0261"> <p><b>9.3.2 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 1.00, 95% CI 0.06 to 15.79; one RCT, N = 220; <a href="./references#CD004637-fig-0071" title="">Analysis 9.3</a>). </p> </section> </section> <section id="CD004637-sec-0262"> <h6 class="title">9.4 Pelvic infection</h6> <section id="CD004637-sec-0263"> <p><b>9.4.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.88, 95% CI 0.47 to 1.64; three RCTs, N = 565; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0072" title="">Analysis 9.4</a>). </p> </section> <section id="CD004637-sec-0264"> <p><b>9.4.2 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.50, 95% CI 0.09 to 2.67; one RCT, N = 220; <a href="./references#CD004637-fig-0072" title="">Analysis 9.4</a>). </p> </section> </section> <section id="CD004637-sec-0265"> <h6 class="title">9.5 Other serious infection</h6> <section id="CD004637-sec-0266"> <p><b>9.5.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 2.90, 95% CI 0.12 to 69.68; one RCT, N = 114; <a href="./references#CD004637-fig-0073" title="">Analysis 9.5</a>). </p> </section> <section id="CD004637-sec-0267"> <p><b>9.5.2 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 3.00, 95% CI 0.12 to 72.85; one RCT, N = 220; <a href="./references#CD004637-fig-0073" title="">Analysis 9.5</a>). </p> </section> </section> <section id="CD004637-sec-0268"> <h6 class="title">9.6 Postoperative fever</h6> <section id="CD004637-sec-0269"> <p><b>9.6.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.82, 95% CI 0.58 to 1.15; three RCTs, N = 565; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0074" title="">Analysis 9.6</a>). </p> </section> <section id="CD004637-sec-0270"> <p><b>9.6.2 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.86, 95% CI 0.42 to 1.77; one RCT, N = 220; <a href="./references#CD004637-fig-0074" title="">Analysis 9.6</a>; <a href="#CD004637-fig-0012">Figure 12</a>). </p> <div class="figure" id="CD004637-fig-0012"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 12</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 9 Cephalosporin versus penicillin, outcome: 9.6 Postoperative fever." data-id="CD004637-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG12.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 9 Cephalosporin versus penicillin, outcome: 9.6 Postoperative fever. </p> </div> </div> </div> </section> </section> <section id="CD004637-sec-0271"> <h6 class="title">9.7 Total adverse effects</h6> <section id="CD004637-sec-0272"> <p><b>9.7.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.95, 95% CI 0.79 to 1.14; two RCTs, N = 451; I<sup>2</sup> = 85%; <a href="./references#CD004637-fig-0075" title="">Analysis 9.7</a>; <a href="#CD004637-fig-0013">Figure 13</a>). </p> <div class="figure" id="CD004637-fig-0013"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 13</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 9 Cephalosporin versus penicillin, outcome: 9.7 Total adverse effects." data-id="CD004637-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG13.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 9 Cephalosporin versus penicillin, outcome: 9.7 Total adverse effects. </p> </div> </div> </div> </section> </section> </section> <section id="CD004637-sec-0273"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0274"> <h6 class="title">9.8 Need for therapeutic antibiotics</h6> <section id="CD004637-sec-0275"> <p><b>9.8.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 1.32, 95% CI 0.88 to 1.97; two RCTs, N = 470; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0076" title="">Analysis 9.8</a>). </p> </section> </section> <section id="CD004637-sec-0276"> <h6 class="title">9.9 Length of hospital stay</h6> <section id="CD004637-sec-0277"> <p><b>9.9.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (MD ‐0.47, 95% CI ‐0.97 to 0.04; two RCTs, N = 209; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0077" title="">Analysis 9.9</a>). </p> </section> </section> </section> </section> <section id="CD004637-sec-0278"> <h4 class="title">10 Cephalosporin versus tetracycline</h4> <section id="CD004637-sec-0279"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0280"> <h6 class="title">10.1 Total postoperative infections ‐ early and late</h6> <section id="CD004637-sec-0281"> <p><b>10.1.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.59, 95% CI 0.20 to 1.78; one RCT, N = 51; <a href="./references#CD004637-fig-0078" title="">Analysis 10.1</a>). </p> </section> </section> <section id="CD004637-sec-0282"> <h6 class="title">10.2 Abdominal wound infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0283"> <h6 class="title">10.3 Urinary tract infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0284"> <h6 class="title">10.4 Pelvic infection</h6> <section id="CD004637-sec-0285"> <p><b>10.4.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.83, 95% CI 0.25 to 2.75; one RCT, N = 51; <a href="./references#CD004637-fig-0079" title="">Analysis 10.2</a>). </p> </section> </section> <section id="CD004637-sec-0286"> <h6 class="title">10.5 Other serious infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0287"> <h6 class="title">10.6 Postoperative fever</h6> <section id="CD004637-sec-0288"> <p><b>10.6.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.69, 95% CI 0.13 to 3.81; one RCT, N = 51; <a href="./references#CD004637-fig-0080" title="">Analysis 10.3</a>). </p> </section> </section> <section id="CD004637-sec-0289"> <h6 class="title">10.7 Total adverse effects</h6> <p>Researchers provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0290"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0291"> <h6 class="title">10.8 Need for therapeutic antibiotics</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0292"> <h6 class="title">10.9 Length of hospital stay</h6> <section id="CD004637-sec-0293"> <p><b>10.9.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (MD ‐0.20 days, 95% CI ‐1.11 to 0.71; one RCT, N = 51; <a href="./references#CD004637-fig-0081" title="">Analysis 10.4</a>). </p> </section> </section> </section> </section> <section id="CD004637-sec-0294"> <h4 class="title">11. Cephalosporin versus antiprotozoal</h4> <section id="CD004637-sec-0295"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0296"> <h6 class="title">11.1 Total postoperative infections ‐ early and late</h6> <section id="CD004637-sec-0297"> <p><b>11.1.1 Vaginal hysterectomy</b></p> <p>The rate of postoperative infection was lower in the cephalosporin group (RR 0.04, 95% CI 0.00 to 0.67; one RCT, N = 78; <a href="./references#CD004637-fig-0082" title="">Analysis 11.1</a>). </p> </section> </section> <section id="CD004637-sec-0298"> <h6 class="title">11.2 Abdominal wound infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0299"> <h6 class="title">11.3 Urinary tract infection</h6> <section id="CD004637-sec-0300"> <p><b>11.3.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.05, 95% CI 0.00 to 0.81; one RCT, N = 78; <a href="./references#CD004637-fig-0083" title="">Analysis 11.2</a>). </p> </section> </section> <section id="CD004637-sec-0301"> <h6 class="title">11.4 Pelvic infection</h6> <section id="CD004637-sec-0302"> <p><b>11.4.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.17, 95% CI 0.01 to 4.03; one RCT, N = 78; <a href="./references#CD004637-fig-0084" title="">Analysis 11.3</a>). </p> </section> </section> <section id="CD004637-sec-0303"> <h6 class="title">11.5 Other serious infection</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0304"> <h6 class="title">11.6 Postoperative fever</h6> <section id="CD004637-sec-0305"> <p><b>11.6.1 Vaginal hysterectomy</b></p> <p>The rate of postoperative fever was lower in women who received cephalosporin than in those given antiprotozoal (RR 0.06, 95% CI 0.01 to 0.42; one RCT, N = 78; <a href="./references#CD004637-fig-0085" title="">Analysis 11.4</a>). </p> </section> </section> <section id="CD004637-sec-0306"> <h6 class="title">11.7 Total adverse effects</h6> <p>Investigators provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0307"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0308"> <h6 class="title">11.8 Need for therapeutic antibiotics</h6> <section id="CD004637-sec-0309"> <p><b>11.8.1 Vaginal hysterectomy</b></p> <p>The rate of need for therapeutic antibiotics was lower in women who received cephalosporin than in those given antiprotozoal (RR 0.03, 95% CI 0.00 to 0.44; one RCT, N = 78; <a href="./references#CD004637-fig-0086" title="">Analysis 11.5</a>). </p> </section> </section> <section id="CD004637-sec-0310"> <h6 class="title">11.9 Length of hospital stay</h6> <section id="CD004637-sec-0311"> <p><b>11.9.1 Vaginal hysterectomy</b></p> <p>Mean length of hospital stay was shorter in women who received cephalosporin than in those given antiprotozoal (MD ‐1.90 days, 95% CI ‐3.32 to ‐0.48; one RCT, N = 78; <a href="./references#CD004637-fig-0087" title="">Analysis 11.6</a>). </p> </section> </section> </section> </section> <section id="CD004637-sec-0312"> <h4 class="title">12. Antiprotozoal versus lincosamide</h4> <section id="CD004637-sec-0313"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0314"> <h6 class="title">12.1 Total postoperative infections ‐ early and late</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0315"> <h6 class="title">12.2 Abdominal wound infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0316"> <h6 class="title">12.3 Urinary tract infection</h6> <section id="CD004637-sec-0317"> <p><b>12.3.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 4.00, 95% CI 0.47 to 34.24; one RCT, N = 80; <a href="./references#CD004637-fig-0088" title="">Analysis 12.1</a>). </p> </section> </section> <section id="CD004637-sec-0318"> <h6 class="title">12.4 Pelvic infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0319"> <h6 class="title">12.5 Other serious infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0320"> <h6 class="title">12.6 Postoperative fever</h6> <section id="CD004637-sec-0321"> <p><b>12.6.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.33, 95% CI 0.01 to 7.95; one RCT, N = 80; <a href="./references#CD004637-fig-0089" title="">Analysis 12.2</a>). </p> </section> </section> <section id="CD004637-sec-0322"> <h6 class="title">12.7 Total adverse effects</h6> <p>Researchers provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0323"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0324"> <h6 class="title">12.8 Need for therapeutic antibiotics</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0325"> <h6 class="title">12.9 Length of hospital stay</h6> <section id="CD004637-sec-0326"> <p><b>12.9.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (MD ‐0.20 days, 95% CI ‐0.60 to 0.20; one RCT, N = 80; <a href="./references#CD004637-fig-0090" title="">Analysis 12.3</a>). </p> </section> </section> </section> </section> <section id="CD004637-sec-0327"> <h4 class="title">13. Cephalosporin plus antiprotozoal versus cephalosporin</h4> <section id="CD004637-sec-0328"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0329"> <h6 class="title">13.1 Total postoperative infections ‐ early and late</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0330"> <h6 class="title">13.2 Abdominal wound infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0331"> <h6 class="title">13.3 Urinary tract infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0332"> <h6 class="title">13.4 Pelvic infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0333"> <h6 class="title">13.5 Other serious infections</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0334"> <h6 class="title">13.6 Postoperative fever</h6> <section id="CD004637-sec-0335"> <p><b>13.6.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.50, 95% CI 0.03 to 7.68; one RCT, N = 78; <a href="./references#CD004637-fig-0091" title="">Analysis 13.1</a>). </p> </section> </section> <section id="CD004637-sec-0336"> <h6 class="title">13.7 Total adverse effects</h6> <p>Researchers provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0337"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0338"> <h6 class="title">13.8 Need for therapeutic antibiotics</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0339"> <h6 class="title">13.9 Length of hospital stay</h6> <section id="CD004637-sec-0340"> <p><b>13.9.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (MD 0.30 days, 95% CI ‐0.43 to 1.03; one RCT, N = 78; <a href="./references#CD004637-fig-0092" title="">Analysis 13.2</a>). </p> </section> </section> </section> </section> <section id="CD004637-sec-0341"> <h4 class="title">14. Cephalosporin plus antiprotozoal versus antiprotozoal only</h4> <section id="CD004637-sec-0342"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0343"> <h6 class="title">14.1 Total postoperative infections ‐ early and late</h6> <section id="CD004637-sec-0344"> <p><b>14.1.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups (RR 0.04, 95% CI 0.00 to 0.67; one RCT, N = 78; <a href="./references#CD004637-fig-0093" title="">Analysis 14.1</a>). </p> </section> </section> <section id="CD004637-sec-0345"> <h6 class="title">14.2 Abdominal wound infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0346"> <h6 class="title">14.3 Urinary tract infection</h6> <section id="CD004637-sec-0347"> <p><b>14.3.1 Vaginal hysterectomy</b></p> <p>The rate of UTI was lower in women who received cephalosporin plus antiprotozoal than in those given antiprotozoal only (RR 0.05, 95% CI 0.00 to 0.81; one RCT, N = 78; <a href="./references#CD004637-fig-0094" title="">Analysis 14.2</a>). </p> </section> </section> <section id="CD004637-sec-0348"> <h6 class="title">14.4 Pelvic infection</h6> <section id="CD004637-sec-0349"> <p><b>14.4.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.17, 95% CI 0.01 to 4.03; one RCT, N = 78; <a href="./references#CD004637-fig-0095" title="">Analysis 14.3</a>). </p> </section> </section> <section id="CD004637-sec-0350"> <h6 class="title">14.5 Other serious infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0351"> <h6 class="title">14.6 Postoperative fever</h6> <section id="CD004637-sec-0352"> <p><b>14.6.1 Vaginal hysterectomy</b></p> <p>The rate of postoperative fever was lower in women who received cephalosporin plus antiprotozoal than in those given antiprotozoal only (RR 0.06, 95% CI 0.01 to 0.42; one RCT, N = 78; <a href="./references#CD004637-fig-0096" title="">Analysis 14.4</a>). </p> </section> </section> <section id="CD004637-sec-0353"> <h6 class="title">14.7 Total adverse effects</h6> <p>Investigators provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0354"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0355"> <h6 class="title">14.8 Need for therapeutic antibiotics</h6> <section id="CD004637-sec-0356"> <p><b>14.8.1 Vaginal hysterectomy</b></p> <p>The rate of need for therapeutic antibiotics was lower in women who received cephalosporin plus antiprotozoal than in those given antiprotozoal only (RR 0.03, 95% CI 0.00 to 0.44; one RCT, N = 78; <a href="./references#CD004637-fig-0097" title="">Analysis 14.5</a>). </p> </section> </section> <section id="CD004637-sec-0357"> <h6 class="title">14.9 Length of hospital stay</h6> <section id="CD004637-sec-0358"> <p><b>14.9.1 Vaginal hysterectomy</b></p> <p>Length of hospital stay was shorter in women who received cephalosporin plus antiprotozoal than in those given antiprotozoal only (MD ‐1.60 days, 95% CI ‐3.11 to ‐0.09; one RCT, N = 78; <a href="./references#CD004637-fig-0098" title="">Analysis 14.6</a>). </p> </section> </section> </section> </section> <section id="CD004637-sec-0359"> <h4 class="title">15. Penicillin plus antiprotozoal versus penicillin only</h4> <section id="CD004637-sec-0360"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0361"> <h6 class="title">15.1 Total postoperative infections ‐ early and late</h6> <section id="CD004637-sec-0362"> <p><b>15.1.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 1.25, 95% CI 0.09 to 17.02; one RCT, N = 18; <a href="./references#CD004637-fig-0099" title="">Analysis 15.1</a>). </p> </section> <section id="CD004637-sec-0363"> <p><b>15.1.2 Abdominal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 1.47, 95% CI 0.57 to 3.75; one RCT, N = 109; <a href="./references#CD004637-fig-0099" title="">Analysis 15.1</a>). </p> </section> </section> <section id="CD004637-sec-0364"> <h6 class="title">15.2 Abdominal wound infection</h6> <section id="CD004637-sec-0365"> <p><b>15.2.1 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.94, 95% CI 0.25 to 3.59; two RCT, N = 155; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0100" title="">Analysis 15.2</a>). </p> </section> </section> <section id="CD004637-sec-0366"> <h6 class="title">15.3 Urinary tract infection</h6> <section id="CD004637-sec-0367"> <p><b>15.3.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 1.25, 95% CI 0.09 to 17.02; one RCT, N = 18; <a href="./references#CD004637-fig-0101" title="">Analysis 15.3</a>). </p> </section> <section id="CD004637-sec-0368"> <p><b>15.3.2 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 2.00, 95% CI 0.80 to 4.97; two RCTs, N = 155; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0101" title="">Analysis 15.3</a>). </p> </section> </section> <section id="CD004637-sec-0369"> <h6 class="title">15.4 Pelvic infection</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0370"> <h6 class="title">15.5 Other serious infection</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0371"> <h6 class="title">15.6 Postoperative fever</h6> <section id="CD004637-sec-0372"> <p><b>15.6.1 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.96, 95% CI 0.20 to 4.50; two RCTs, N = 155; I<sup>2</sup> = 0%; <a href="./references#CD004637-fig-0102" title="">Analysis 15.4</a>). </p> </section> </section> <section id="CD004637-sec-0373"> <h6 class="title">15.7 Total adverse effects</h6> <p>Investigators provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0374"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0375"> <h6 class="title">15.8 Need for therapeutic antibiotics</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0376"> <h6 class="title">15.9 Length of hospital stay</h6> <p>Investigators provided no data for this outcome.</p> </section> </section> </section> <section id="CD004637-sec-0377"> <h4 class="title">16. Cephalosporin early administration versus usual timing (both single dose)</h4> <section id="CD004637-sec-0378"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0379"> <h6 class="title">16.1 Total postoperative infections ‐ early and late</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0380"> <h6 class="title">16.2 Abdominal wound infection</h6> <section id="CD004637-sec-0381"> <p><b>16.2.1 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.50, 95% CI 0.03 to 7.90; one RCT, n = 252; <a href="./references#CD004637-fig-0104" title="">Analysis 16.1</a>). </p> </section> </section> <section id="CD004637-sec-0382"> <h6 class="title">16.3 Urinary tract infection</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0383"> <h6 class="title">16.4 Pelvic infection</h6> <section id="CD004637-sec-0384"> <p><b>16.4.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 1.50, 95% CI 0.16 to 14.20; one RCT, N = 252; <a href="./references#CD004637-fig-0105" title="">Analysis 16.2</a>). </p> </section> <section id="CD004637-sec-0385"> <p><b>16.4.2 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 1.50, 95% CI 0.16 to 14.20; one RCT, N = 252; <a href="./references#CD004637-fig-0105" title="">Analysis 16.2</a>). </p> </section> </section> <section id="CD004637-sec-0386"> <h6 class="title">16.5 Other serious infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0387"> <h6 class="title">16.6 Postoperative fever</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0388"> <h6 class="title">16.7 Total adverse effects</h6> <p>Researchers provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0389"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0390"> <h6 class="title">16.8 Need for therapeutic antibiotics</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0391"> <h6 class="title">16.9 Length of hospital stay</h6> <p>Researchers provided no data for this outcome.</p> </section> </section> </section> <section id="CD004637-sec-0392"> <h4 class="title">17. Cephalosporin one dose versus two doses</h4> <section id="CD004637-sec-0393"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0394"> <h6 class="title">17.1 Total postoperative infections ‐ early and late</h6> <section id="CD004637-sec-0395"> <p><b>17.1.1 Abdominal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.67, 95% CI 0.14 to 3.18; one RCT, N = 150; <a href="./references#CD004637-fig-0106" title="">Analysis 17.1</a>). </p> </section> </section> <section id="CD004637-sec-0396"> <h6 class="title">17.2 Abdominal wound infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0397"> <h6 class="title">17.3 Urinary tract infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0398"> <h6 class="title">17.4 Pelvic infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0399"> <h6 class="title">17.5 Other serious infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0400"> <h6 class="title">17.6 Postoperative fever</h6> <section id="CD004637-sec-0401"> <p><b>17.6.1 Abdominal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 2.00, 95% CI 0.97 to 4.13; one RCT, N = 150; <a href="./references#CD004637-fig-0107" title="">Analysis 17.2</a>). </p> </section> </section> <section id="CD004637-sec-0402"> <h6 class="title">17.7 Total adverse effects</h6> <p>Researchers provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0403"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0404"> <h6 class="title">17.8 Need for therapeutic antibiotics</h6> <section id="CD004637-sec-0405"> <p><b>17.8.1 Abdominal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 9.90, 95% CI 0.48 to 202.43; one RCT, N = 150; <a href="./references#CD004637-fig-0108" title="">Analysis 17.3</a>). </p> </section> </section> <section id="CD004637-sec-0406"> <h6 class="title">17.9 Length of hospital stay</h6> <p>Researchers provided no data for this outcome.</p> </section> </section> </section> <section id="CD004637-sec-0407"> <h4 class="title">18. Cephalosporin one dose versus three doses</h4> <section id="CD004637-sec-0408"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0409"> <h6 class="title">18.1 Total postoperative infections ‐ early and late</h6> <section id="CD004637-sec-0410"> <p><b>18.1.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 0.50, 95% CI 0.05 to 5.36; one RCT, N = 116; <a href="./references#CD004637-fig-0109" title="">Analysis 18.1</a>). </p> </section> </section> <section id="CD004637-sec-0411"> <h6 class="title">18.2 Abdominal wound infection</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0412"> <h6 class="title">18.3 Urinary tract infection</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0413"> <h6 class="title">18.4 Pelvic infection</h6> <section id="CD004637-sec-0414"> <p><b>18.4.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.50, 95% CI 0.05 to 5.36; one RCT, N = 116; <a href="./references#CD004637-fig-0110" title="">Analysis 18.2</a>). </p> </section> </section> <section id="CD004637-sec-0415"> <h6 class="title">18.5 Other serious infection</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0416"> <h6 class="title">18.6 Postoperative fever</h6> <section id="CD004637-sec-0417"> <p><b>18.6.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 0.91, 95% CI 0.42 to 1.97; one RCT, N = 116; <a href="./references#CD004637-fig-0111" title="">Analysis 18.3</a>). </p> </section> </section> <section id="CD004637-sec-0418"> <h6 class="title">18.7 Total adverse effects</h6> <p>Investigators provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0419"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0420"> <h6 class="title">18.8 Need for therapeutic antibiotics</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0421"> <h6 class="title">18.9 Length of hospital stay</h6> <p>It is unclear whether data showed a difference between groups for this outcome (MD ‐0.30 days, 95% CI ‐0.72 to 0.12; one RCT, N = 116; <a href="./references#CD004637-fig-0112" title="">Analysis 18.4</a>). </p> </section> </section> </section> <section id="CD004637-sec-0422"> <h4 class="title">19. Cephalosporin one dose versus multiple doses</h4> <section id="CD004637-sec-0423"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0424"> <h6 class="title">19.1 Total postoperative infections ‐ early and late</h6> <section id="CD004637-sec-0425"> <p><b>19.1.1 Vaginal hysterectomy</b></p> <p>We found no clear evidence of a difference between groups (RR 5.00, 95% CI 0.25 to 98.52; one RCT, N = 44; <a href="./references#CD004637-fig-0113" title="">Analysis 19.1</a>). </p> </section> </section> <section id="CD004637-sec-0426"> <h6 class="title">19.2 Abdominal wound infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0427"> <h6 class="title">19.3 Urinary tract infection</h6> <section id="CD004637-sec-0428"> <p><b>19.3.1 Vaginal hysterectomy</b></p> <p>We found no clear evidence of a difference between groups (RR 3.00, 95% CI 0.13 to 69.87; one RCT, N = 44; <a href="./references#CD004637-fig-0114" title="">Analysis 19.2</a>). </p> </section> </section> <section id="CD004637-sec-0429"> <h6 class="title">19.4 Pelvic infection</h6> <section id="CD004637-sec-0430"> <p><b>19.4.1 Vaginal hysterectomy</b></p> <p>We found no clear evidence of a difference between groups (RR 3.00, 95% CI 0.13 to 69.87; one RCT, N = 44; <a href="./references#CD004637-fig-0115" title="">Analysis 19.3</a>). </p> </section> </section> <section id="CD004637-sec-0431"> <h6 class="title">19.5 Other serious infection</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0432"> <h6 class="title">19.6 Postoperative fever</h6> <section id="CD004637-sec-0433"> <p><b>19.6.1 Vaginal hysterectomy</b></p> <p>We found no clear evidence of a difference between groups for this outcome (RR 5.00, 95% CI 0.25 to 98.52; one RCT, N = 44; <a href="./references#CD004637-fig-0116" title="">Analysis 19.4</a>). </p> </section> </section> <section id="CD004637-sec-0434"> <h6 class="title">19.7 Total adverse effects</h6> <p>Researchers provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0435"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0436"> <h6 class="title">19.8 Need for therapeutic antibiotics</h6> <p>Researchers provided no data for this outcome.</p> </section> <section id="CD004637-sec-0437"> <h6 class="title">19.9 Length of hospital stay</h6> <p>Researchers provided no data for this outcome.</p> </section> </section> </section> <section id="CD004637-sec-0438"> <h4 class="title">20 Cephalosporin one gram versus two grams</h4> <section id="CD004637-sec-0439"> <h5 class="title">Primary outcomes</h5> <section id="CD004637-sec-0440"> <h6 class="title">20.1 Total postoperative infections ‐ early and late</h6> <section id="CD004637-sec-0441"> <p><b>20.1.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 1.49, 95% CI 0.25 to 8.74; one RCT, N = 237; <a href="./references#CD004637-fig-0117" title="">Analysis 20.1</a>). </p> </section> </section> <section id="CD004637-sec-0442"> <h6 class="title">20.2 Abdominal wound infection</h6> <p>Investigators reported no data for this outcome.</p> </section> <section id="CD004637-sec-0443"> <h6 class="title">20.3 Urinary tract infection</h6> <p>Investigators reported no data for this outcome.</p> </section> <section id="CD004637-sec-0444"> <h6 class="title">20.4 Pelvic infection</h6> <section id="CD004637-sec-0445"> <p><b>20.4.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 1.49, 95% CI 0.25 to 8.74; one RCT, N = 237; <a href="./references#CD004637-fig-0118" title="">Analysis 20.2</a>). </p> </section> </section> <section id="CD004637-sec-0446"> <h6 class="title">20.5 Other serious infection</h6> <p>Investigators provided no data for this outcome.</p> </section> <section id="CD004637-sec-0447"> <h6 class="title">20.6 Postoperative fever</h6> <section id="CD004637-sec-0448"> <p><b>20.6.1 Vaginal hysterectomy</b></p> <p>It is unclear whether results showed a difference between groups for this outcome (RR 1.49, 95% CI 0.43 to 5.14; one RCT, N = 237; <a href="./references#CD004637-fig-0119" title="">Analysis 20.3</a>). </p> </section> </section> <section id="CD004637-sec-0449"> <h6 class="title">20.7 Total adverse effects</h6> <p>Investigators provided no data for this outcome.</p> </section> </section> <section id="CD004637-sec-0450"> <h5 class="title">Secondary outcomes</h5> <section id="CD004637-sec-0451"> <h6 class="title">20.8 Need for therapeutic antibiotics</h6> <section id="CD004637-sec-0452"> <p><b>20.8.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (RR 1.49, 95% CI 0.25 to 8.74; one RCT, N = 237; <a href="./references#CD004637-fig-0120" title="">Analysis 20.4</a>). </p> </section> </section> <section id="CD004637-sec-0453"> <h6 class="title">20.9 Length of hospital stay</h6> <section id="CD004637-sec-0454"> <p><b>20.9.1 Vaginal hysterectomy</b></p> <p>It is unclear whether data showed a difference between groups for this outcome (MD ‐0.10 days, 95% CI ‐0.60 to 0.40; one RCT, N = 237; <a href="./references#CD004637-fig-0121" title="">Analysis 20.5</a>). </p> </section> </section> </section> </section> <section id="CD004637-sec-0455"> <h4 class="title">Funnel plots</h4> <p>We examined the presence of publication or reporting bias by analysing funnel plots in five subgroups: 1.2.1 (<a href="#CD004637-fig-0014">Figure 14</a>); 1.3.2 (<a href="#CD004637-fig-0015">Figure 15</a>); 1.4.1 and 1.4.2 (<a href="#CD004637-fig-0016">Figure 16</a>); and 1.6.2 (<a href="#CD004637-fig-0017">Figure 17</a>). We found evidence suggesting a tendency towards publication bias; smaller studies were likely to report beneficial effects with the use of antibiotic prophylaxis. </p> <div class="figure" id="CD004637-fig-0014"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 14</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.2 Abdominal wound infection." data-id="CD004637-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG14.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.2 Abdominal wound infection. </p> </div> </div> </div> <div class="figure" id="CD004637-fig-0015"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 15</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.3 Urinary tract infection." data-id="CD004637-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG15.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.3 Urinary tract infection. </p> </div> </div> </div> <div class="figure" id="CD004637-fig-0016"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 16</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.4 Pelvic infection." data-id="CD004637-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG16.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.4 Pelvic infection.</p> </div> </div> </div> <div class="figure" id="CD004637-fig-0017"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 17</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.6 Postoperative fever." data-id="CD004637-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG17.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.6 Postoperative fever. </p> </div> </div> </div> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004637-sec-0456" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004637-sec-0456"></div> <section id="CD004637-sec-0457"> <h3 class="title" id="CD004637-sec-0457">Summary of main results</h3> <p>This is the first Cochrane review to assess the effectiveness and safety of antibiotic prophylaxis for elective hysterectomy for benign disease, and to determine which, if any, prophylactic regimen is most suitable. Thirty‐seven studies met the eligibility criteria for inclusion; they compared various antibiotics with placebo and with one another in 20 comparisons involving a total of 6079 participants. Primary outcomes reported were infection (total postoperative infections ‐ early and late, abdominal wound infection, urinary tract infection, pelvic infection, other serious infection, and postoperative fever) and total adverse effects. Secondary outcomes reported were need for therapeutic antibiotics and length of hospital stay. </p> <p>We subsumed the various comparisons under four broad groups as follows.</p> <section id="CD004637-sec-0458"> <h4 class="title">1. Any antibiotics versus placebo</h4> <p>Antibiotics in this case included cephalosporin, penicillin, antiprotozoal, sulphonamide, and lincosamide. Researchers compared these individually or in combination with placebo in two subgroups. </p> <section id="CD004637-sec-0459"> <h5 class="title">Vaginal hysterectomy</h5> <p>We found evidence of a difference in the incidence of postoperative infection between women who received prophylactic antibiotics and those given placebo. Researchers reported fewer cases of total postoperative infection, urinary tract infection (UTI), pelvic infection, and postoperative fever in women who were given prophylactic antibiotics of any class compared with those who received placebo. However, we found no evidence of a difference between groups in the proportions of women who developed other serious infection. </p> <p>On safety, we found no available data that would allow us to properly evaluate the adverse effects associated with each group. </p> <p>With regard to need for therapeutic antibiotics, fewer women in the antibiotic groups required therapeutic antibiotics postoperatively compared with those in the placebo group. Similarly, women who received prophylactic antibiotics spent fewer days in hospital than those given placebo. </p> </section> <section id="CD004637-sec-0460"> <h5 class="title">Abdominal hysterectomy</h5> <p>As in the vaginal hysterectomy subgroup, we found evidence of a difference between groups in the proportions of women given a diagnosis of postoperative infection. Lower proportions of women who received prophylactic antibiotics received a diagnosis of total postoperative infection, abdominal wound infection, UTI, pelvic infection, and postoperative fever compared with those given placebo. However, we found no evidence of a difference between groups in reported cases of other serious infection. </p> <p>With regard to safety, we found evidence of a difference between groups in the incidence of total adverse effects, with fewer cases of adverse effects reported in women who received antibiotics compared with those given placebo. </p> <p>On the need for therapeutic antibiotics, fewer women in the antibiotic group required therapeutic antibiotics compared with those in the placebo group. Similarly, women who received prophylactic antibiotics spent shorter days in hospital than those given placebo. </p> </section> </section> <section id="CD004637-sec-0461"> <h4 class="title">2. Head‐to‐head comparisons between antibiotics</h4> <p>We identified four different head‐to‐head comparisons: cephalosporin versus penicillin, cephalosporin versus tetracycline, cephalosporin versus antiprotozoal, and antiprotozoal versus lincosamide. Investigators compared participants in two subgroups as follows. </p> <section id="CD004637-sec-0462"> <h5 class="title">Vaginal hysterectomy</h5> <p>Investigators performed all four comparisons in this subgroup. We found no evidence of a difference between groups in reported cases of total postoperative infection, abdominal wound infection, UTI, pelvic infection, other serious infection, and postoperative fever with cephalosporin versus penicillin, cephalosporin versus tetracycline, and antiprotozoal versus lincosamide, when data were available. However, researchers reported fewer cases of total postoperative infection and postoperative fever in women who received cephalosporin compared with those given antiprotozoal. </p> <p>Only one comparison (cephalosporin vs penicillin) yielded data on adverse effects, and no evidence showed differences in total adverse effects between the two groups. </p> <p>With regard to the need for therapeutic antibiotics and length of hospital stay, we found no evidence of a difference between groups in the proportions of women requiring therapeutic antibiotics or in the numbers of days spent in hospital with cephalosporin versus penicillin, cephalosporin versus tetracycline, and antiprotozoal versus lincosamide. However, we found evidence of a difference in the two outcomes between cephalosporin and antiprotozoal groups: Fewer women in the cephalosporin group required therapeutic antibiotics, and women in this group spent fewer days in hospital, compared with those in the antiprotozoal group. </p> </section> <section id="CD004637-sec-0463"> <h5 class="title">Abdominal hysterectomy</h5> <p>Researchers performed only one of the comparisons (cephalosporin vs penicillin) in this subgroup. We found no evidence of a difference in reported cases of infection (total postoperative infection, abdominal wound infection, UTI, pelvic infection, other serious infection, and postoperative fever) between the two groups. Investigators provided no data on adverse effects, need for therapeutic antibiotics, and length of hospital stay. </p> </section> </section> <section id="CD004637-sec-0464"> <h4 class="title">3. Combined antibiotics versus single antibiotic</h4> <p>We identified three different comparisons: cephalosporin plus antiprotozoal versus cephalosporin, cephalosporin plus antiprotozoal versus antiprotozoal, and penicillin plus antiprotozoal versus penicillin. Researchers performed these comparisons in two subgroups as follows. </p> <section id="CD004637-sec-0465"> <h5 class="title">Vaginal hysterectomy</h5> <p>Investigators performed all three comparisons in this subgroup but did not provide data for most outcomes, including adverse effects. When data were available, we found no evidence of a difference in outcomes between the two groups for two of the comparisons (cephalosporin plus antiprotozoal vs cephalosporin only and penicillin plus antiprotozoal vs penicillin only). However, fewer women who received cephalosporin combined with antiprotozoal received a diagnosis of total postoperative infection, UTI, or postoperative fever compared with those who received antiprotozoal only. </p> </section> <section id="CD004637-sec-0466"> <h5 class="title">Abdominal hysterectomy</h5> <p>Researchers performed only one comparison (penicillin plus antiprotozoal vs penicillin only) in this subgroup. They provided no data on some outcomes, including adverse effects. When data were available, we found no evidence of a difference in outcomes between the two groups. </p> </section> </section> <section id="CD004637-sec-0467"> <h4 class="title">4. Cephalosporins in different dose regimens</h4> <p>Investigators addressed comparisons subsumed under this broad heading most often in single small trials and did not provide data on most of the outcome measures, including total adverse effects. When outcome data were reported, we found no evidence of a difference between groups in the incidence of postoperative infection, the need for therapeutic antibiotics, and length of hospital stay for each of these comparisons. </p> </section> </section> <section id="CD004637-sec-0468"> <h3 class="title" id="CD004637-sec-0468">Overall completeness and applicability of evidence</h3> <p>Overall, the data demonstrate that prophylactic antibiotics are more effective than placebo in preventing postoperative infection, reducing the requirement for therapeutic antibiotics, and shortening length of hospital stay in women undergoing elective vaginal or abdominal hysterectomy. However, few studies reported data on adverse effects associated with the use of antibiotic prophylaxis; therefore, we were unable to determine whether prophylactic antibiotics are associated with significant adverse effects. However, as prophylaxis is usually given as a single shot, the adverse effect rate might truly be low. </p> <p>Similarly, few studies compared antibiotics head‐to‐head; thus we were unable to determine which specific antibiotic is most effective, or whether individual antibiotics are similar with respect to effectiveness and safety. </p> <p>We identified few studies evaluating antibiotics in different combinations, dose regimens, and routes of administration. Thus we could not determine whether it is possible to sustain the effectiveness of antibiotics while reducing adverse effects by combining lower doses of two different antibiotics, or by using certain dose regimens or routes of administration. </p> <p>None of the included studies investigated laparoscopic hysterectomy (total or subtotal laparoscopic hysterectomy or laparoscopically assisted vaginal hysterectomy). Thus the findings of this review are not applicable to this type of hysterectomy, which has been performed increasingly over the past decade. </p> <p>One should interpret the results on "length of hospital stay" and "urinary tract infections" with caution, as some studies reporting these outcomes were conducted decades ago. Meanwhile, hospital stay has decreased tremendously over the past few decades owing to improved knowledge of postoperative care and doctors' adaptation of the principles of "early recovery after surgery" (ERAS®). These include striving postoperatively for early mobilisation, normalisation of oral intake, and early removal of urinary catheters, thus decreasing length of hospital stay, risk of nosocomial infection, and risk of UTI. For example, it is very rare nowadays for healthy patients who undergo uncomplicated vaginal hysterectomy to be admitted to a hospital for longer than three days, whereas the studies in <a href="./references#CD004637-fig-0026" title="">Analysis 1.9</a> show mean hospitalisation duration of 8.3 to 11.9 days. </p> </section> <section id="CD004637-sec-0469"> <h3 class="title" id="CD004637-sec-0469">Quality of the evidence</h3> <p>Most studies considered for this review were of poor quality in relation to risk of bias. We excluded many studies owing to unclear design, lack of double‐blinding, or non‐blinding. Among the included studies, very few clearly described their methods of sequence generation and allocation concealment. For most comparisons, effect estimates were associated with imprecision due to small sample sizes and wide confidence intervals. </p> <p>We assessed the quality of evidence for the review's main comparison (any antibiotics vs placebo for vaginal and abdominal hysterectomy). The quality of evidence for our primary outcome ranged from very low to moderate. The main limitations in the body of evidence were risk of bias (due to poor reporting of sequence generation and allocation concealment), serious imprecision (associated with small sample size and low event rates, leading to wide confidence intervals), and inadequate reporting of adverse effects. </p> <p>We rated the quality of evidence for head‐to head comparisons of antibiotics and for dose comparisons as very low owing to imprecision related to wide confidence intervals and low event rates, and to risk of bias associated with poor reporting of study methods. </p> <p>We examined the presence of publication or reporting bias in a funnel plot for five subgroups in one of the comparisons (any antibiotics vs placebo) and found evidence suggesting a tendency towards publication or reporting bias, with smaller studies likely to report beneficial effects with antibiotic prophylaxis. However, we did not consider that evidence of publication bias was strong enough to necessitate downgrading the quality of evidence. </p> </section> <section id="CD004637-sec-0470"> <h3 class="title" id="CD004637-sec-0470">Potential biases in the review process</h3> <p>Although we undertook a comprehensive search to ensure that we identified potentially eligible studies, it is possible that some eligible studies might have been left out in the course of the search and selection process. </p> </section> <section id="CD004637-sec-0471"> <h3 class="title" id="CD004637-sec-0471">Agreements and disagreements with other studies or reviews</h3> <p>Clinical guidelines (<a href="./references#CD004637-bbs2-0144" title="ACOG (American College of Obstetricians and Gynecologists). Antibiotic prophylaxis for gynecologic procedures. Obstetrics &amp; Gynecology2009;reaffirmed 2016(113):1180‐9. ">ACOG 2009</a>; <a href="./references#CD004637-bbs2-0152" title="DeffieuxX , deRochambeauB , ChêneG , GauthierT , HuetS4 , LamblinG , et al: French College of Obstetrics and Gynaecology (CNGOF). Hysterectomy for benign pathology: guidelines for clinical practice [Hystérectomie pour pathologie bénigne: recommandations pour la pratique clinique]. Journal de Gynécologie Obstétrique et Biologie de la Reproduction2015;44(10):1219‐27. ">Deffieux 2015</a>; <a href="./references#CD004637-bbs2-0175" title="Scottish Intercollegiate Guidelines Network. Antibiotic prophylaxis in surgery. http://www.sign.ac.uk/pdf/sign104.pdf 2008, updated April 2014. ">SIGN 2008</a>) and narrative reviews (<a href="./references#CD004637-bbs2-0150" title="CliffordV , DaleyA . Antibiotic prophylaxis in obstetric and gynaecological procedures: a review. Australian and New Zealand Journal of Obstetrics and Gynaecology2012;52(5):412‐9. ">Clifford 2012</a>; <a href="./references#CD004637-bbs2-0165" title="HodgesKR , DavisBR , SwaimLS . Prevention and management of hysterectomy complications. Clinical Obstetrics and Gynecology2014;57(1):43‐57. ">Hodges 2014</a>; <a href="./references#CD004637-bbs2-0177" title="SteinerHL , StrandEA . Surgical‐site infection in gynecologic surgery: pathophysiology and prevention. American Journal of Obstetrics and Gynecology2017;S0002‐9378(17):30254‐5. doi: 10.1016/j.ajog.2017.02.014. [Epub ahead of print]. ">Steiner 2017</a>) recommend antibiotic prophylaxis for women undergoing hysterectomy, and pragmatically opt to advise cephalosporins as a first choice. However, the evidence base for first‐line cephalosporins is limited by the lack of recent trials. Moreover, no randomised controlled trials (RCTs) at all examined the topic of antibiotic prophylaxis for laparoscopic hysterectomy. </p> <p>Much of the evidence is very old: For example, <a href="./references#CD004637-bbs2-0150" title="CliffordV , DaleyA . Antibiotic prophylaxis in obstetric and gynaecological procedures: a review. Australian and New Zealand Journal of Obstetrics and Gynaecology2012;52(5):412‐9. ">Clifford 2012</a> is a narrative review that refers to old studies such as <a href="./references#CD004637-bbs2-0008" title="DuffP . Antibiotic prophylaxis for abdominal hysterectomy. Obstetrics &amp; Gynecology1982;60(1):25‐9. ">Duff 1982</a> and <a href="./references#CD004637-bbs2-0178" title="TanosV , RojanskyN . Prophylactic antibiotics in abdominal hysterectomy. Journal of the American College of Surgeons1994;179:593‐600. ">Tanos 1994</a> to recommend prophylactic antibiotics for hysterectomy, and <a href="./references#CD004637-bbs2-0075" title="LarssonPG , CarlssonB . Does pre‐ and postoperative metronidazole treatment lower vaginal cuff infection rate after abdominal hysterectomy among women with bacterial vaginosis?. Infectious Diseases in Obstetrics &amp; Gynecology2002;10(3):133‐40. ">Larsson 2002</a> to recommend preoperative treatment of bacterial vaginosis. We excluded both <a href="./references#CD004637-bbs2-0075" title="LarssonPG , CarlssonB . Does pre‐ and postoperative metronidazole treatment lower vaginal cuff infection rate after abdominal hysterectomy among women with bacterial vaginosis?. Infectious Diseases in Obstetrics &amp; Gynecology2002;10(3):133‐40. ">Larsson 2002</a> and <a href="./references#CD004637-bbs2-0178" title="TanosV , RojanskyN . Prophylactic antibiotics in abdominal hysterectomy. Journal of the American College of Surgeons1994;179:593‐600. ">Tanos 1994</a> from the current review because investigators utilised extended seven‐day prophylaxis as well as an historical comparison group (respectively). </p> <p>A more recent review (<a href="./references#CD004637-bbs2-0169" title="MorrillMY , SchimpfMO , AbedH , CarberryC , MarguliesRU , WhiteAB , et al. Society of Gynecologic Surgeons Systematic Review Group. Antibiotic prophylaxis for selected gynecologic surgeries. International Journal of Gynaecology and Obstetrics2013;120(1):10‐5. ">Morrill 2013</a>) investigated antibiotic prophylaxis in selected gynaecological surgeries, including hysteroscopic and cervical surgery, while <i>excluding</i> hysterectomy (<a href="./references#CD004637-bbs2-0169" title="MorrillMY , SchimpfMO , AbedH , CarberryC , MarguliesRU , WhiteAB , et al. Society of Gynecologic Surgeons Systematic Review Group. Antibiotic prophylaxis for selected gynecologic surgeries. International Journal of Gynaecology and Obstetrics2013;120(1):10‐5. ">Morrill 2013</a>). Review authors concluded that evidence provides a strong case for prophylactic antibiotics for abdominal gynaecological surgery but acknowledged lack of evidence for their use in vaginal surgery. For laparoscopic surgery, we found no advantage of prophylactic antibiotics, but high‐quality evidence was lacking and results were hampered by heterogeneity of the population; women underwent widely varying surgeries, from diagnostic laparoscopy to ovarian cystectomy or extended endometriosis surgery. </p> <p>A large retrospective cohort of 21,358 hysterectomies performed in the United States (<a href="./references#CD004637-bbs2-0179" title="UppalS , HarrisJ , Al‐NiaimiA , SwensonCW , PearlmanMD , ReynoldsRK , et al. Prophylactic antibiotic choice and risk of surgical site infection after hysterectomy. Obstetrics and Gynecology2016;127(2):321‐9. ">Upall 2016</a>) investigated associations between a composite outcome of "any surgical site infection" and classes of antibiotics administered preoperatively. Investigators found that women receiving beta‐lactam antibiotic regimens (i.e. first‐ or second‐generation cephalosporins, ampicillin plus sulbactam, or ertapenem) had lower risk of surgical site infection than women given a beta‐lactam alternative (i.e. clindamycin combination, gentamycin combination, metronidazole combination) or a non‐standard regimen (i.e. clindamycin, gentamycin, or aztreonam, or another antibiotic alone). We found comparable benefit for cephalosporins but only for vaginal hysterectomy when compared with antiprotozoal alone. </p> <p>Several published systematic reviews and meta‐analyses of the use of antibiotics in hysterectomy have reported mainly on the same set of included RCTs. </p> <p><a href="./references#CD004637-bbs2-0182" title="Wttewaall‐EvelaarEW . Meta‐analysis of randomized controlled trials of antibiotic prophylaxis in abdominal hysterectomy. Pharmaceutisch Weekblad Scientific1990;12(6A):296‐9. ">Wttewaall‐Evelaar 1990</a> meta‐analysed 17 randomised blinded placebo‐controlled trials of prophylaxis for elective abdominal hysterectomy, all published between 1986 and 1988. In most cases, the antibiotics used were cephalosporins. Review authors concluded that prophylaxis significantly reduced levels of infection (p &lt; 0.001; no odds ratio reported), and that additional placebo‐controlled trials were not warranted. <a href="./references#CD004637-bbs2-0168" title="MittendorfR , AronsonMP , BerryRE , WilliamsMA , KipelnickB , KlicksteinA , et al. Avoiding serious infections associated with abdominal hysterectomy: a meta‐analysis of antibiotic prophylaxis. American Journal of Obstetrics and Gynecology1993;169:1119‐24. ">Mittendorf 1993</a> meta‐analysed 31 English‐language RCTs published from 1972 to 1986, and concluded that antibiotic prophylaxis reduced the rate of serious infection after abdominal hysterectomy from 21.1% to 9% (P = 0.00001; no odds ratio reported in text). Trials that used different routes of administration and differing prophylaxis regimens, varying from a single dose to five days' duration, were pooled. <a href="./references#CD004637-bbs2-0178" title="TanosV , RojanskyN . Prophylactic antibiotics in abdominal hysterectomy. Journal of the American College of Surgeons1994;179:593‐600. ">Tanos 1994</a> meta‐analysed 17 "controlled or comparative" trials conducted between 1978 and 1990 to investigate single or one‐day prophylactic regimens of intravenous or intramuscular cephalosporins for abdominal hysterectomy. It is unclear whether all of the included trials were randomised, and some trials included oncology patients among their participants. Again, results clearly favoured the use of prophylaxis (odds ratio (OR) 0.35, 95% confidence interval (CI) 0.3 to 0.4). </p> <p>Two of these meta‐analyses combined results from studies that included very different participants or interventions. The other (<a href="./references#CD004637-bbs2-0182" title="Wttewaall‐EvelaarEW . Meta‐analysis of randomized controlled trials of antibiotic prophylaxis in abdominal hysterectomy. Pharmaceutisch Weekblad Scientific1990;12(6A):296‐9. ">Wttewaall‐Evelaar 1990</a>) was more rigorous but did not include any of the numerous studies carried out since 1986. </p> <p>More recently, a systematic review by Costa and Krauss‐Silva meta‐analysed double‐blinded, placebo‐controlled trials on the use of antibiotic prophylaxis for elective, non‐radical abdominal hysterectomy (<a href="./references#CD004637-bbs2-0151" title="CostaRJ , Krauss‐SilvaL . Systematic review and meta‐analysis of antibiotic prophylaxis in abdominal hysterectomy [Revisão sistemática e meta‐análiseda antibioticoprofilaxiana histerectomia abdominal]. Cadernos de Saúde Pública2004;20(Suppl 2):S175‐89. ">Costa 2004</a>). Review authors meta‐analysed a total of 16 studies published between 1977 and 2003, but it is important to note that the most recent study was published in 1998, and the 15 remaining RCTs were published in 1988 or earlier. Review authors concluded that use of antibiotic prophylaxis is effective for prevention of postoperative infection (risk ratio (RR) 0.49, 95% CI 0.41 to 0.59). They concluded that no evidence showed benefit for multiple‐ versus single‐dose prophylaxis. </p> <p>We identified no RCTs on the use of antibiotics in laparoscopic hysterectomy for inclusion in this review. A recent review by Lachiewicz on laparoscopic hysterectomy recommends use of antibiotics, with dose adjusted to body weight (increased dosage when patients weigh more than 120 kilograms), and use of antiprotozoals. The latter recommendation consists of using antiprotozoals routinely or after screening for bacterial vaginosis before surgery in which the vaginal‐abdominal barrier was breached (<a href="./references#CD004637-bbs2-0166" title="LachiewiczMP , MoultonLJ , JaiyeobaO . Infection prevention and evaluation of fever after laparoscopic hysterectomy. Journal of the Society of Laparoendscopic Surgeons2015;19(3):pii: e2015.00065. doi: 10.4293/JSLS.2015.00065.. ">Lachiewicz 2015</a>). However, arguments for these recommendations in laparoscopy derive from authority‐based guidelines or non‐randomised trials (<a href="./references#CD004637-bbs2-0147" title="BratzlerDW , DellingerEP , OlsenKM , PerlTM , AuwaerterPG , BolonMK , et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. American Journal of Health‐System Pharmacy2013;70(3):195–283. ">Bratzler 2013</a>; <a href="./references#CD004637-bbs2-0176" title="SoperDE . Bacterial vaginosis and postoperative infections. American Journal of Obstetrics and Gynecology1993;169(2 Pt 2):467‐9. ">Soper 1993</a>). </p> <p>Findings from the studies above are consistent with the findings of this review, which found evidence that antibiotic prophylaxis is effective in preventing postoperative infection in women undergoing elective vaginal or abdominal hysterectomy. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004637-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="PRISMA flow chart." data-id="CD004637-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA flow chart.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004637-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD004637-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.6 Postoperative fever." data-id="CD004637-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.6 Postoperative fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.7 Total adverse effects." data-id="CD004637-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.7 Total adverse effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Cephalosporin versus placebo, outcome: 2.1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Cephalosporin versus placebo, outcome: 2.1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Cephalosporin versus placebo, outcome: 2.6 Postoperative fever." data-id="CD004637-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Cephalosporin versus placebo, outcome: 2.6 Postoperative fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 3 Penicillin versus placebo, outcome: 3.6 Postoperative fever." data-id="CD004637-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Forest plot of comparison: 3 Penicillin versus placebo, outcome: 3.6 Postoperative fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG10.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 4 Antiprotozoal versus placebo, outcome: 4.5 Postoperative fever." data-id="CD004637-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Forest plot of comparison: 4 Antiprotozoal versus placebo, outcome: 4.5 Postoperative fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG11.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 9 Cephalosporin versus penicillin, outcome: 9.1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Forest plot of comparison: 9 Cephalosporin versus penicillin, outcome: 9.1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG12.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 9 Cephalosporin versus penicillin, outcome: 9.6 Postoperative fever." data-id="CD004637-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 12</div> <div class="figure-caption"> <p>Forest plot of comparison: 9 Cephalosporin versus penicillin, outcome: 9.6 Postoperative fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG13.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 9 Cephalosporin versus penicillin, outcome: 9.7 Total adverse effects." data-id="CD004637-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 13</div> <div class="figure-caption"> <p>Forest plot of comparison: 9 Cephalosporin versus penicillin, outcome: 9.7 Total adverse effects. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG14.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.2 Abdominal wound infection." data-id="CD004637-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 14</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.2 Abdominal wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG15.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.3 Urinary tract infection." data-id="CD004637-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 15</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.3 Urinary tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG16.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.4 Pelvic infection." data-id="CD004637-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 16</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.4 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-AFig-FIG17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-AFig-FIG17.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.6 Postoperative fever." data-id="CD004637-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 17</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any antibiotic versus placebo, outcome: 1.6 Postoperative fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-AFig-FIG17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic versus placebo, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic versus placebo, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic versus placebo, Outcome 2 Abdominal wound infection." data-id="CD004637-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic versus placebo, Outcome 2 Abdominal wound infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic versus placebo, Outcome 3 Urinary tract infection." data-id="CD004637-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic versus placebo, Outcome 3 Urinary tract infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic versus placebo, Outcome 4 Pelvic infection." data-id="CD004637-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic versus placebo, Outcome 4 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic versus placebo, Outcome 5 Other serious infections." data-id="CD004637-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic versus placebo, Outcome 5 Other serious infections.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-001-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic versus placebo, Outcome 6 Postoperative fever." data-id="CD004637-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic versus placebo, Outcome 6 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-001-07.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic versus placebo, Outcome 7 Total adverse effects." data-id="CD004637-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic versus placebo, Outcome 7 Total adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic versus placebo, Outcome 8 Need for therapeutic antibiotics." data-id="CD004637-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic versus placebo, Outcome 8 Need for therapeutic antibiotics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any antibiotic versus placebo, Outcome 9 Length of hospital stay." data-id="CD004637-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Any antibiotic versus placebo, Outcome 9 Length of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-002-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cephalosporin versus placebo, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Cephalosporin versus placebo, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cephalosporin versus placebo, Outcome 2 Abdominal wound infection." data-id="CD004637-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Cephalosporin versus placebo, Outcome 2 Abdominal wound infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cephalosporin versus placebo, Outcome 3 Urinary tract infection." data-id="CD004637-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Cephalosporin versus placebo, Outcome 3 Urinary tract infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cephalosporin versus placebo, Outcome 4 Pelvic infection." data-id="CD004637-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Cephalosporin versus placebo, Outcome 4 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cephalosporin versus placebo, Outcome 5 Other serious infections." data-id="CD004637-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Cephalosporin versus placebo, Outcome 5 Other serious infections.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-002-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cephalosporin versus placebo, Outcome 6 Postoperative fever." data-id="CD004637-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Cephalosporin versus placebo, Outcome 6 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cephalosporin versus placebo, Outcome 7 Total adverse effects." data-id="CD004637-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Cephalosporin versus placebo, Outcome 7 Total adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cephalosporin versus placebo, Outcome 8 Need for therapeutic antibiotics." data-id="CD004637-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Cephalosporin versus placebo, Outcome 8 Need for therapeutic antibiotics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Cephalosporin versus placebo, Outcome 9 Length of hospital stay." data-id="CD004637-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Cephalosporin versus placebo, Outcome 9 Length of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Penicillin versus placebo, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0036" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Penicillin versus placebo, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Penicillin versus placebo, Outcome 2 Abdominal wound infection." data-id="CD004637-fig-0037" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Penicillin versus placebo, Outcome 2 Abdominal wound infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Penicillin versus placebo, Outcome 3 Urinary tract infection." data-id="CD004637-fig-0038" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Penicillin versus placebo, Outcome 3 Urinary tract infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Penicillin versus placebo, Outcome 4 Pelvic infection." data-id="CD004637-fig-0039" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Penicillin versus placebo, Outcome 4 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Penicillin versus placebo, Outcome 5 Other serious infections." data-id="CD004637-fig-0040" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Penicillin versus placebo, Outcome 5 Other serious infections.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-003-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Penicillin versus placebo, Outcome 6 Postoperative fever." data-id="CD004637-fig-0041" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Penicillin versus placebo, Outcome 6 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antiprotozoal versus placebo, Outcome 1 Abdominal wound infection." data-id="CD004637-fig-0042" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Antiprotozoal versus placebo, Outcome 1 Abdominal wound infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antiprotozoal versus placebo, Outcome 2 Urinary tract infection." data-id="CD004637-fig-0043" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Antiprotozoal versus placebo, Outcome 2 Urinary tract infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antiprotozoal versus placebo, Outcome 3 Pelvic infection." data-id="CD004637-fig-0044" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Antiprotozoal versus placebo, Outcome 3 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antiprotozoal versus placebo, Outcome 4 Other serious infections." data-id="CD004637-fig-0045" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Antiprotozoal versus placebo, Outcome 4 Other serious infections.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-004-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antiprotozoal versus placebo, Outcome 5 Postoperative fever." data-id="CD004637-fig-0046" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Antiprotozoal versus placebo, Outcome 5 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antiprotozoal versus placebo, Outcome 6 Total adverse effects." data-id="CD004637-fig-0047" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Antiprotozoal versus placebo, Outcome 6 Total adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antiprotozoal versus placebo, Outcome 7 Need for therapeutic antibiotics." data-id="CD004637-fig-0048" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Antiprotozoal versus placebo, Outcome 7 Need for therapeutic antibiotics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Antiprotozoal versus placebo, Outcome 8 Length of hospital stay." data-id="CD004637-fig-0049" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Antiprotozoal versus placebo, Outcome 8 Length of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Sulphonamides versus placebo, Outcome 1 Abdominal wound infection." data-id="CD004637-fig-0050" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Sulphonamides versus placebo, Outcome 1 Abdominal wound infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Sulphonamides versus placebo, Outcome 2 Urinary tract infection." data-id="CD004637-fig-0051" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Sulphonamides versus placebo, Outcome 2 Urinary tract infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Sulphonamides versus placebo, Outcome 3 Pelvic infection." data-id="CD004637-fig-0052" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Sulphonamides versus placebo, Outcome 3 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Sulphonamides versus placebo, Outcome 4 Postoperative fever." data-id="CD004637-fig-0053" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Sulphonamides versus placebo, Outcome 4 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Sulphonamides versus placebo, Outcome 5 Length of hospital stay." data-id="CD004637-fig-0054" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Sulphonamides versus placebo, Outcome 5 Length of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Cephalosporin + antiprotozoal versus placebo, Outcome 1 Abdominal wound infection." data-id="CD004637-fig-0055" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Cephalosporin + antiprotozoal versus placebo, Outcome 1 Abdominal wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Cephalosporin + antiprotozoal versus placebo, Outcome 2 Urinary tract infection." data-id="CD004637-fig-0056" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Cephalosporin + antiprotozoal versus placebo, Outcome 2 Urinary tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Cephalosporin + antiprotozoal versus placebo, Outcome 3 Pelvic infection." data-id="CD004637-fig-0057" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Cephalosporin + antiprotozoal versus placebo, Outcome 3 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Cephalosporin + antiprotozoal versus placebo, Outcome 4 Postoperative fever." data-id="CD004637-fig-0058" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Cephalosporin + antiprotozoal versus placebo, Outcome 4 Postoperative fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Cephalosporin + antiprotozoal versus placebo, Outcome 5 Need for therapeutic antibiotics." data-id="CD004637-fig-0059" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Cephalosporin + antiprotozoal versus placebo, Outcome 5 Need for therapeutic antibiotics. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Cephalosporin + antiprotozoal versus placebo, Outcome 6 Length of hospital stay." data-id="CD004637-fig-0060" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Cephalosporin + antiprotozoal versus placebo, Outcome 6 Length of hospital stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Penicillin + antiprotozoal versus placebo, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0061" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Penicillin + antiprotozoal versus placebo, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Penicillin + antiprotozoal versus placebo, Outcome 2 Abdominal wound infection." data-id="CD004637-fig-0062" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Penicillin + antiprotozoal versus placebo, Outcome 2 Abdominal wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Penicillin + antiprotozoal versus placebo, Outcome 3 Urinary tract infection." data-id="CD004637-fig-0063" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Penicillin + antiprotozoal versus placebo, Outcome 3 Urinary tract infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Penicillin + antiprotozoal versus placebo, Outcome 4 Pelvic infection." data-id="CD004637-fig-0064" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Penicillin + antiprotozoal versus placebo, Outcome 4 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Penicillin + antiprotozoal versus placebo, Outcome 5 Postoperative fever." data-id="CD004637-fig-0065" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Penicillin + antiprotozoal versus placebo, Outcome 5 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Lincosamide versus placebo, Outcome 1 Urinary tract infection." data-id="CD004637-fig-0066" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Lincosamide versus placebo, Outcome 1 Urinary tract infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Lincosamide versus placebo, Outcome 2 Postoperative fever." data-id="CD004637-fig-0067" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Lincosamide versus placebo, Outcome 2 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Lincosamide versus placebo, Outcome 3 Length of hospital stay." data-id="CD004637-fig-0068" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Lincosamide versus placebo, Outcome 3 Length of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-009-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Cephalosporin versus penicillin, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0069" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Cephalosporin versus penicillin, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Cephalosporin versus penicillin, Outcome 2 Abdominal wound infection." data-id="CD004637-fig-0070" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Cephalosporin versus penicillin, Outcome 2 Abdominal wound infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Cephalosporin versus penicillin, Outcome 3 Urinary tract infection." data-id="CD004637-fig-0071" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Cephalosporin versus penicillin, Outcome 3 Urinary tract infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Cephalosporin versus penicillin, Outcome 4 Pelvic infection." data-id="CD004637-fig-0072" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Cephalosporin versus penicillin, Outcome 4 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Cephalosporin versus penicillin, Outcome 5 Other serious infections." data-id="CD004637-fig-0073" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 Cephalosporin versus penicillin, Outcome 5 Other serious infections.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-009-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Cephalosporin versus penicillin, Outcome 6 Postoperative fever." data-id="CD004637-fig-0074" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 Cephalosporin versus penicillin, Outcome 6 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-009-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-009-07.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Cephalosporin versus penicillin, Outcome 7 Total adverse effects." data-id="CD004637-fig-0075" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.7</div> <div class="figure-caption"> <p>Comparison 9 Cephalosporin versus penicillin, Outcome 7 Total adverse effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-009-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-009-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Cephalosporin versus penicillin, Outcome 8 Need for therapeutic antibiotics." data-id="CD004637-fig-0076" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.8</div> <div class="figure-caption"> <p>Comparison 9 Cephalosporin versus penicillin, Outcome 8 Need for therapeutic antibiotics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-009-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-009-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Cephalosporin versus penicillin, Outcome 9 Length of hospital stay." data-id="CD004637-fig-0077" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.9</div> <div class="figure-caption"> <p>Comparison 9 Cephalosporin versus penicillin, Outcome 9 Length of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-009-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Cephalosporin versus tetracycline, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0078" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Cephalosporin versus tetracycline, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Cephalosporin versus tetracycline, Outcome 2 Pelvic infection." data-id="CD004637-fig-0079" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Cephalosporin versus tetracycline, Outcome 2 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Cephalosporin versus tetracycline, Outcome 3 Postoperative fever." data-id="CD004637-fig-0080" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Cephalosporin versus tetracycline, Outcome 3 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-010-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-010-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Cephalosporin versus tetracycline, Outcome 4 Length of hospital stay." data-id="CD004637-fig-0081" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-010-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10 Cephalosporin versus tetracycline, Outcome 4 Length of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-010-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Cephalosporin versus antiprotozoal, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0082" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Cephalosporin versus antiprotozoal, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Cephalosporin versus antiprotozoal, Outcome 2 Urinary tract infection." data-id="CD004637-fig-0083" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Cephalosporin versus antiprotozoal, Outcome 2 Urinary tract infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Cephalosporin versus antiprotozoal, Outcome 3 Pelvic infection." data-id="CD004637-fig-0084" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Cephalosporin versus antiprotozoal, Outcome 3 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Cephalosporin versus antiprotozoal, Outcome 4 Postoperative fever." data-id="CD004637-fig-0085" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 Cephalosporin versus antiprotozoal, Outcome 4 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-011-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-011-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Cephalosporin versus antiprotozoal, Outcome 5 Need for therapeutic antibiotics." data-id="CD004637-fig-0086" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-011-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.5</div> <div class="figure-caption"> <p>Comparison 11 Cephalosporin versus antiprotozoal, Outcome 5 Need for therapeutic antibiotics.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-011-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-011-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-011-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Cephalosporin versus antiprotozoal, Outcome 6 Length of hospital stay." data-id="CD004637-fig-0087" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-011-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.6</div> <div class="figure-caption"> <p>Comparison 11 Cephalosporin versus antiprotozoal, Outcome 6 Length of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-011-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Antiprotozoal versus lincosamide, Outcome 1 Urinary tract infection." data-id="CD004637-fig-0088" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 Antiprotozoal versus lincosamide, Outcome 1 Urinary tract infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Antiprotozoal versus lincosamide, Outcome 2 Postoperative fever." data-id="CD004637-fig-0089" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 Antiprotozoal versus lincosamide, Outcome 2 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-012-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-012-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Antiprotozoal versus lincosamide, Outcome 3 Length of hospital stay." data-id="CD004637-fig-0090" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-012-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12 Antiprotozoal versus lincosamide, Outcome 3 Length of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-012-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Cephalosporin + antiprotozoal versus cephalosporin only, Outcome 1 Postoperative fever." data-id="CD004637-fig-0091" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 Cephalosporin + antiprotozoal versus cephalosporin only, Outcome 1 Postoperative fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-013-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-013-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Cephalosporin + antiprotozoal versus cephalosporin only, Outcome 2 Length of hospital stay." data-id="CD004637-fig-0092" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-013-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13 Cephalosporin + antiprotozoal versus cephalosporin only, Outcome 2 Length of hospital stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-013-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Cephalosporin + antiprotozoal versus antiprotozoal only, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0093" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 Cephalosporin + antiprotozoal versus antiprotozoal only, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-014-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-014-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Cephalosporin + antiprotozoal versus antiprotozoal only, Outcome 2 Urinary tract infection." data-id="CD004637-fig-0094" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-014-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14 Cephalosporin + antiprotozoal versus antiprotozoal only, Outcome 2 Urinary tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-014-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-014-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-014-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Cephalosporin + antiprotozoal versus antiprotozoal only, Outcome 3 Pelvic infection." data-id="CD004637-fig-0095" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-014-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.3</div> <div class="figure-caption"> <p>Comparison 14 Cephalosporin + antiprotozoal versus antiprotozoal only, Outcome 3 Pelvic infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-014-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-014-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-014-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Cephalosporin + antiprotozoal versus antiprotozoal only, Outcome 4 Postoperative fever." data-id="CD004637-fig-0096" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-014-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.4</div> <div class="figure-caption"> <p>Comparison 14 Cephalosporin + antiprotozoal versus antiprotozoal only, Outcome 4 Postoperative fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-014-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-014-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-014-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Cephalosporin + antiprotozoal versus antiprotozoal only, Outcome 5 Need for therapeutic antibiotics." data-id="CD004637-fig-0097" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-014-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.5</div> <div class="figure-caption"> <p>Comparison 14 Cephalosporin + antiprotozoal versus antiprotozoal only, Outcome 5 Need for therapeutic antibiotics. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-014-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-014-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-014-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Cephalosporin + antiprotozoal versus antiprotozoal only, Outcome 6 Length of hospital stay." data-id="CD004637-fig-0098" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-014-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.6</div> <div class="figure-caption"> <p>Comparison 14 Cephalosporin + antiprotozoal versus antiprotozoal only, Outcome 6 Length of hospital stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-014-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Penicillin + antiprotozoal versus penicillin only, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0099" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 Penicillin + antiprotozoal versus penicillin only, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Penicillin + antiprotozoal versus penicillin only, Outcome 2 Abdominal wound infection." data-id="CD004637-fig-0100" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 Penicillin + antiprotozoal versus penicillin only, Outcome 2 Abdominal wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-015-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-015-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Penicillin + antiprotozoal versus penicillin only, Outcome 3 Urinary tract infection." data-id="CD004637-fig-0101" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-015-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15 Penicillin + antiprotozoal versus penicillin only, Outcome 3 Urinary tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-015-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-015-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-015-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Penicillin + antiprotozoal versus penicillin only, Outcome 4 Postoperative fever." data-id="CD004637-fig-0102" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-015-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.4</div> <div class="figure-caption"> <p>Comparison 15 Penicillin + antiprotozoal versus penicillin only, Outcome 4 Postoperative fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-015-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-015-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-015-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Penicillin + antiprotozoal versus penicillin only, Outcome 5 Length of hospital stay." data-id="CD004637-fig-0103" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-015-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.5</div> <div class="figure-caption"> <p>Comparison 15 Penicillin + antiprotozoal versus penicillin only, Outcome 5 Length of hospital stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-015-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Cephalosporin: early administration versus usual timing (both single dose), Outcome 1 Abdominal wound infection." data-id="CD004637-fig-0104" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 Cephalosporin: early administration versus usual timing (both single dose), Outcome 1 Abdominal wound infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-016-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-016-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Cephalosporin: early administration versus usual timing (both single dose), Outcome 2 Pelvic infection." data-id="CD004637-fig-0105" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-016-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16 Cephalosporin: early administration versus usual timing (both single dose), Outcome 2 Pelvic infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-016-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-017-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-017-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Cephalosporin: one dose versus two doses, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0106" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-017-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 Cephalosporin: one dose versus two doses, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-017-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-017-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-017-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Cephalosporin: one dose versus two doses, Outcome 2 Postoperative fever." data-id="CD004637-fig-0107" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-017-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.2</div> <div class="figure-caption"> <p>Comparison 17 Cephalosporin: one dose versus two doses, Outcome 2 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-017-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-017-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-017-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Cephalosporin: one dose versus two doses, Outcome 3 Need for therapeutic antibiotics." data-id="CD004637-fig-0108" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-017-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.3</div> <div class="figure-caption"> <p>Comparison 17 Cephalosporin: one dose versus two doses, Outcome 3 Need for therapeutic antibiotics. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-017-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-018-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-018-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Cephalosporin: one dose versus three doses, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0109" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-018-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18 Cephalosporin: one dose versus three doses, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-018-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-018-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-018-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Cephalosporin: one dose versus three doses, Outcome 2 Pelvic infection." data-id="CD004637-fig-0110" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-018-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.2</div> <div class="figure-caption"> <p>Comparison 18 Cephalosporin: one dose versus three doses, Outcome 2 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-018-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-018-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-018-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Cephalosporin: one dose versus three doses, Outcome 3 Postoperative fever." data-id="CD004637-fig-0111" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-018-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.3</div> <div class="figure-caption"> <p>Comparison 18 Cephalosporin: one dose versus three doses, Outcome 3 Postoperative fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-018-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-018-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-018-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Cephalosporin: one dose versus three doses, Outcome 4 Length of hospital stay." data-id="CD004637-fig-0112" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-018-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.4</div> <div class="figure-caption"> <p>Comparison 18 Cephalosporin: one dose versus three doses, Outcome 4 Length of hospital stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-018-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-019-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-019-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Cephalosporin: one dose versus multiple doses, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0113" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-019-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.1</div> <div class="figure-caption"> <p>Comparison 19 Cephalosporin: one dose versus multiple doses, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-019-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-019-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-019-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Cephalosporin: one dose versus multiple doses, Outcome 2 Urinary tract infection." data-id="CD004637-fig-0114" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-019-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.2</div> <div class="figure-caption"> <p>Comparison 19 Cephalosporin: one dose versus multiple doses, Outcome 2 Urinary tract infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-019-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-019-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-019-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Cephalosporin: one dose versus multiple doses, Outcome 3 Pelvic infection." data-id="CD004637-fig-0115" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-019-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.3</div> <div class="figure-caption"> <p>Comparison 19 Cephalosporin: one dose versus multiple doses, Outcome 3 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-019-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-019-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-019-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Cephalosporin: one dose versus multiple doses, Outcome 4 Postoperative fever." data-id="CD004637-fig-0116" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-019-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.4</div> <div class="figure-caption"> <p>Comparison 19 Cephalosporin: one dose versus multiple doses, Outcome 4 Postoperative fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-019-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-020-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-020-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Cephalosporin one gram versus two grams, Outcome 1 Total postoperative infections ‐ early and late." data-id="CD004637-fig-0117" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-020-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.1</div> <div class="figure-caption"> <p>Comparison 20 Cephalosporin one gram versus two grams, Outcome 1 Total postoperative infections ‐ early and late. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-020-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-020-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-020-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Cephalosporin one gram versus two grams, Outcome 2 Pelvic infection." data-id="CD004637-fig-0118" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-020-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.2</div> <div class="figure-caption"> <p>Comparison 20 Cephalosporin one gram versus two grams, Outcome 2 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-020-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-020-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-020-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Cephalosporin one gram versus two grams, Outcome 3 Postoperative fever." data-id="CD004637-fig-0119" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-020-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.3</div> <div class="figure-caption"> <p>Comparison 20 Cephalosporin one gram versus two grams, Outcome 3 Postoperative fever.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-020-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-020-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-020-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Cephalosporin one gram versus two grams, Outcome 4 Need for therapeutic antibiotics." data-id="CD004637-fig-0120" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-020-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.4</div> <div class="figure-caption"> <p>Comparison 20 Cephalosporin one gram versus two grams, Outcome 4 Need for therapeutic antibiotics. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-020-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004637-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/urn:x-wiley:14651858:media:CD004637:CD004637-CMP-020-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_t/tCD004637-CMP-020-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Cephalosporin one gram versus two grams, Outcome 5 Length of hospital stay." data-id="CD004637-fig-0121" src="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-020-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.5</div> <div class="figure-caption"> <p>Comparison 20 Cephalosporin one gram versus two grams, Outcome 5 Length of hospital stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/media/CDSR/CD004637/image_n/nCD004637-CMP-020-05.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004637-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotics compared with placebo for prophylaxis in elective vaginal hysterectomy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antibiotics compared with placebo for prophylaxis in elective vaginal hysterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> women having elective vaginal hysterectomy<br/> <b>Settings:</b> hospital<br/> <b>Intervention:</b> antibiotics<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Total postoperative infections ‐ early and late</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.28</b> <br/> (0.19 to 0.4) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>293<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> low<sup>b,c,f</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>618 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>173 per 1000</b><br/> (117 to 247) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Urinary tract infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.58</b> <br/> (0.43 to 0.77) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1473<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>127 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>74 per 1000</b><br/> (55 to 98) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Pelvic infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.28</b> <br/> (0.20 to 0.39) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1693<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>134 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>38 per 1000</b><br/> (27 to 52) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Other serious infections</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.20</b> <br/> (0.01 to 4.10) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>146<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>b,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>5 per 1000</b><br/> (0 to 111) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Postoperative fever</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.43</b> <br/> (0.34 to 0.54) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1562<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>219 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>94 per 1000</b><br/> (74 to 118) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total adverse effects</b> ‐ not reported </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>This outcome was not reported</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and <b>relative effect</b> of the intervention (and its 95% CI)<br/> CI: confidence interval; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Median baseline risk of control group<br/> <sup>b</sup>Downgraded one level for serious risk of bias: sequence generation and allocation concealment assessed as "unclear" in some studies owing to poor reporting<br/> <sup>c</sup>Substantial heterogeneity for this comparison (I<sup>2</sup> = 85%). The quality of the evidence was not downgraded for inconsistency, as the direction of effect was consistent and all inconsistency was attributable to a study that measured only early postoperative infection rates (to hospital discharge), whereas the other three studies measured both early and late infection<br/> <sup>d</sup>Substantial heterogeneity for this comparison (I<sup>2</sup> = 57%), but the quality of the evidence was not downgraded for inconsistency, as the direction of effect was consistent<br/> <sup>e</sup>Downgraded two levels for very serious imprecision: small sample size and effect estimate with wide confidence interval </p> <p><sup>f</sup>Downgraded two levels for serious imprecision: small sample size </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotics compared with placebo for prophylaxis in elective vaginal hysterectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004637-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antibiotics compared with placebo for prophylaxis in elective abdominal hysterectomy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Antibiotics compared with placebo for prophylaxis in elective abdominal hysterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> women having elective abdominal hysterectomy<br/> <b>Settings:</b> hospital<br/> <b>Intervention:</b> antibiotics<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo </b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Total postoperative infections ‐ early and late</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.38</b> <br/> (0.21 to 0.67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>158<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>388 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>147 per 1000</b><br/> (82 to 260) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Abdominal wound infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.51</b> <br/> (0.36 to 0.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2247<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>65 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b><br/> (23 to 47) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Urinary tract infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.41</b> <br/> (0.31 to 0.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2705<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>132 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>54 per 1000</b><br/> (41 to 70) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Pelvic infection</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.50</b> <br/> (0.35 to 0.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1883<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>83 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b><br/> (29 to 59) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Other serious infections</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.44</b> <br/> (0.12 to 1.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>476<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>b,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b><br/> (3 to 46) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Postoperative fever</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.59</b> <br/> (0.50 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2394<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>242 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>143 per 1000</b><br/> (121 to 169) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Total adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.80</b> <br/> (0.62 to 5.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>430<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>b,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>23 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>41 per 1000</b><br/> (14 to 119) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and <b>relative effect</b> of the intervention (and its 95% CI)<br/> CI: confidence interval; RR: risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Median baseline risk of control group<br/> <sup>b</sup>Downgraded one level for serious risk of bias: sequence generation and/or allocation concealment assessed as "unclear" in some studies owing to poor reporting<br/> <sup>c</sup>Downgraded one level for serious imprecision: small sample size<br/> <sup>d</sup>Substantial heterogeneity for this comparison (I<sup>2</sup> = 51%), but the quality of the evidence was not downgraded for inconsistency, as the direction of effect was consistent<br/> <sup>e</sup>Downgraded two levels for very serious imprecision: small sample size and effect estimate with wide confidence interval </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antibiotics compared with placebo for prophylaxis in elective abdominal hysterectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004637-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Head‐to‐head comparisons of antibiotics for prophylaxis in elective vaginal hysterectomy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Antibiotics compared with alternative antibiotics for prophylaxis in elective vaginal hysterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Population:</b> women having elective vaginal hysterectomy<br/> <b>Settings:</b> hospital<br/> <b>Intervention:</b> antibiotics<br/> <b>Comparison:</b> alternative antibiotics </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Illustrative comparative risks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antibiotics vs alternative antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD004637-list-0001"> <li> <p><b>Total postoperative infections ‐ early and lat</b>e </p> </li> <li> <p><b>Urinary tract infection</b> </p> </li> <li> <p><b>Pelvic infection</b> </p> </li> <li> <p><b>Other serious infections</b> </p> </li> <li> <p><b>Postoperative fever</b> </p> </li> </ul> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>When data were available, no evidence showed a difference between any groups compared for any of our primary outcomes, except: </p> <p> <ul id="CD004637-list-0002"> <li> <p>fewer cases of total postoperative infection and postoperative fever in women who received cephalosporin than in those who received antiprotozoal </p> </li> <li> <p>fewer cases of total postoperative infection, UTI, or postoperative fever in women receiving cephalosporin with antiprotozoal than in those receiving antiprotozoal only </p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD004637-list-0003"> <li> <p>cephalosporin vs penicillin (2 RCTs, 470 women)</p> </li> <li> <p>cephalosporin vs tetracycline (1 RCT, 51 women)</p> </li> <li> <p>cephalosporin vs antiprotozoal (1 RCT, 78 women)</p> </li> <li> <p>antiprotozoal vs lincosamide (1 RCT, 80 women)</p> </li> <li> <p>cephalosporin plus antiprotozoal vs cephalosporin only (1 RCT, 78 women)</p> </li> <li> <p>cephalosporin plus antiprotozoal vs antiprotozoal only (1 RCT, 78 women)</p> </li> <li> <p>penicillin plus antiprotozoal vs penicillin only (1 RCT, 18 women)</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Total adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p> <ul id="CD004637-list-0004"> <li> <p>No evidence of a difference between cephalosporin and penicillin.</p> </li> <li> <p>No data available for other comparisons</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004637-list-0005"> <li> <p>cephalosporin vs penicillin (2 RCTs, 451 women)</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>CI: confidence interval; RCT: randomised controlled trial</p> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for very serious imprecision with very few events and wide confidence intervals<br/> <sup>b</sup>Downgraded one level for serious risk of bias: methods were poorly reported in most studies </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Head‐to‐head comparisons of antibiotics for prophylaxis in elective vaginal hysterectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004637-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Head‐to‐head comparisons of antibiotics for prophylaxis in elective abdominal hysterectomy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Head‐to‐head comparisons of antibiotics for prophylaxis in elective abdominal hysterectomy</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Population:</b> women having elective abdominal hysterectomy<br/> <b>Settings:</b> hospital<br/> <b>Intervention:</b> antibiotics<br/> <b>Comparison:</b> alternative antibiotics </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Illustrative comparative risks</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Antibiotics vs alternative antibiotics</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD004637-list-0006"> <li> <p><b>Total postoperative infections ‐ early and late</b> </p> </li> <li> <p><b>Abdominal wound infection</b> </p> </li> <li> <p><b>Urinary tract infection</b> </p> </li> <li> <p><b>Pelvic infection</b> </p> </li> <li> <p><b>Other serious infections</b> </p> </li> <li> <p><b>Postoperative fever</b> </p> </li> </ul> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p> <ul id="CD004637-list-0007"> <li> <p>No clear evidence of differences between groups</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD004637-list-0008"> <li> <p>cephalosporin vs penicillin (1 RCT, 220 women)</p> </li> <li> <p>penicillin plus antiprotozoal vs penicillin only (2 RCT, 155 women)</p> </li> </ul> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004637-list-0009"> <li> <p><b>Total adverse effects</b> </p> </li> </ul> </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign=""> <p> <ul id="CD004637-list-0010"> <li> <p>No data reported on adverse effects</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>CI: confidence interval; RCT: randomised controlled trial</p> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for very serious imprecision with very few events and wide confidence intervals<br/> <sup>b</sup>Downgraded one level for serious risk of bias: methods were poorly reported in most studies </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Head‐to‐head comparisons of antibiotics for prophylaxis in elective abdominal hysterectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/full#CD004637-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any antibiotic versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>293</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.19, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.21, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Abdominal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.36, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1473</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.43, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2705</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.31, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1693</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.20, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1883</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.35, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Other serious infections <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>476</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.12, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1562</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.34, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2394</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.50, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Total adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.8 [0.62, 5.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Need for therapeutic antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.37, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.59, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>853</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.35 [‐1.78, ‐0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1510</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.59 [‐0.76, ‐0.43]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any antibiotic versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Cephalosporin versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.20, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Abdominal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1528</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.25, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.46, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1668</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.31, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.09, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1528</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.39, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Other serious infections <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 3.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1028</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.25, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1463</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.49, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Total adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Need for therapeutic antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>863</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.37, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.61, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>657</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.30 [‐1.88, ‐0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>818</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.43 [‐0.67, ‐0.19]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Cephalosporin versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Penicillin versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.03, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.13, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Abdominal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.05, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.05, 4.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.21, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.31, 5.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Other serious infections <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.35, 1.20]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Penicillin versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Antiprotozoal versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Abdominal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>462</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.32, 1.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>226</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.51, 3.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.34, 2.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>375</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.17, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>662</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.22, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Other serious infections <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.14, 6.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.21, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.18, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Total adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.63, 6.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Need for therapeutic antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.15, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.15, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.86 [‐1.22, ‐0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.33 [‐1.68, ‐0.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Antiprotozoal versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Sulphonamides versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Abdominal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.35, 4.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.15, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.06, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.26, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.38, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>276</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.86 [‐1.22, ‐0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.33 [‐1.68, ‐0.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Sulphonamides versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Cephalosporin + antiprotozoal versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Abdominal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.14, 7.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.24, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.08, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.01, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.34, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.58, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Need for therapeutic antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.19, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.15, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.60, ‐0.00]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Cephalosporin + antiprotozoal versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Penicillin + antiprotozoal versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.04, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.23, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Abdominal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.03, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.07, 5.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.38, 2.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 2.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 2.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.01, 0.64]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Penicillin + antiprotozoal versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Lincosamide versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.25, 2.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐0.77, ‐0.03]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Lincosamide versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Cephalosporin versus penicillin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>470</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.55, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Abdominal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 8.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 3.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.06, 15.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>565</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.47, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.09, 2.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Other serious infections <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.90 [0.12, 69.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.12, 72.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>565</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.58, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.42, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Total adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.79, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Need for therapeutic antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>470</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.88, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>209</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.47 [‐0.97, 0.04]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Cephalosporin versus penicillin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Cephalosporin versus tetracycline</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.20, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.25, 2.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.13, 3.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐1.11, 0.71]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Cephalosporin versus tetracycline</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Cephalosporin versus antiprotozoal</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.00, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 4.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.01, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Need for therapeutic antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.00, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐3.32, ‐0.48]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Cephalosporin versus antiprotozoal</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Antiprotozoal versus lincosamide</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.0 [0.47, 34.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.60, 0.20]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Antiprotozoal versus lincosamide</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Cephalosporin + antiprotozoal versus cephalosporin only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.03, 7.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.43, 1.03]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Cephalosporin + antiprotozoal versus cephalosporin only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Cephalosporin + antiprotozoal versus antiprotozoal only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.00, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.01, 4.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [0.01, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Need for therapeutic antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.00, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.60 [‐3.11, ‐0.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Cephalosporin + antiprotozoal versus antiprotozoal only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Penicillin + antiprotozoal versus penicillin only</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.09, 17.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.57, 3.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Abdominal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.25, 3.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.09, 17.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [0.80, 4.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.20, 4.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.60 [‐3.11, ‐0.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Penicillin + antiprotozoal versus penicillin only</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Cephalosporin: early administration versus usual timing (both single dose)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Abdominal wound infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.03, 7.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.16, 14.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.16, 14.20]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Cephalosporin: early administration versus usual timing (both single dose)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Cephalosporin: one dose versus two doses</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.14, 3.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.97, 4.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Need for therapeutic antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Abdominal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.90 [0.48, 202.43]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Cephalosporin: one dose versus two doses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Cephalosporin: one dose versus three doses</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.05, 5.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.05, 5.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.42, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.72, 0.12]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Cephalosporin: one dose versus three doses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Cephalosporin: one dose versus multiple doses</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.25, 98.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Urinary tract infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 69.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 69.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.25, 98.52]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Cephalosporin: one dose versus multiple doses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004637-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Cephalosporin one gram versus two grams</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Total postoperative infections ‐ early and late <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.25, 8.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.25, 8.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Postoperative fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.43, 5.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Need for therapeutic antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.25, 8.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Vaginal hysterectomy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>237</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.60, 0.40]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Cephalosporin one gram versus two grams</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004637.pub2/references#CD004637-tbl-0024">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004637.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD004637-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD004637-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004637-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD004637-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD004637-note-0002">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD004637-note-0010">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004637\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004637\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004637\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004637\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004637\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=ZCrlluee&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004637.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004637.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004637.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004637.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004637.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727886100"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004637.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727886104"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004637.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb6faed22937f',t:'MTc0MDcyNzg4Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 